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Epidermolysis bullosa (EB) is a heterogeneous group of rare
hereditary mechanobullous diseases. Three different sub-groups
exist: simplex (EBS), with blistering within the epidermis;
junctional (EBL) with blistering at the dermo-epidermal junction
and dystrophic, either dominantly (EBDD) or recessively (EBDr)
inherited where blisters form within the dermis. The aim of
this project was to characterise collagen, collagenase and
glycosaminoglycan (GAG) metabolism in fibroblasts cultured from
the skin of patients with different forms of EB and to determine as
far as possible how two drugs currently used to treat the disease,
phenytoin and vitamin E, affect these functions.
Thirty patients donated skin samples to establish fibroblast
cultures and fibroblast lines were cultivated from 18 (7 from EBS,
6 from EBDr, 3 from EBDD and 2 from EBL)Twenty four skin samples
were examined by electron microscopy for confirmation of diagnosis and
to study certain ultrastructural features of the disease.
No difference was found between the proliferation rates of
any of the EB groups and an age-matched healthy control group
(mean - SEM: 88 - 13%). Similarly no statistically significant
difference was found between the GAG outputs of control and EB groups.
Protein synthesis in the EB group differed significantly from the
controls, with a selective increase in collagen synthesis over synthes
of non-collagenous protein. Collagenase levels were highest in the
EBDr fibroblast cultures and the bulk of the enzyme appeared to be
in the active form. The EBS cultures gave collagenase levels which
were intermediate between those of controls and EBDr, and most of the
enzyme was in the latent form which requires activation by trypsin
in vitro.
Phenytoin did not affect the proliferation rate of any of the
groups but vitamin E caused a significant increase in the rate of
I
proliferation of control fibroblasts. Phenytoin produced a decrease
in protein synthesis at 300-500 pM. The effect of phenytoin on GAG
output differed between groups; the drug increasing GAG accumulation
in controls whilst depressing levels in the EBS group. vitamin E
did not directly affect GAG secretion.
INTRODUCTION
INTRODUCTION
In the late nineteenth century a group of congenital
blistering diseases was recognised, to which Koebner in 188^ gave
the name "epidermolysis bullosa hereditaria". This name has since
become widely accepted and has come to encompass a spectrum of
clinically differing hereditary conditions. Fortunately EB remains
a relatively rare disorder, with probably less than 1,000-patients
recorded in Britain. Where intra-familial marriages are more common
in the Middle East, Asia, or where communities have been extremely
isolated in the past - the incidence of EB is increased, recessive
genes and mutations having a greater chance of being expressed.
Unfortunately "epidermolysis bullosa" (EB) is a misnomer for
a heterogeneous group of mechanobullous diseases united by the
inherent tendency of the skin to blister either spontaneously, or
after banal trauma. EB differs from other blistering conditions, in
that it is the result of a congenital defect and unlike the pemphigus
pemphigoid and dermatitis herpetiformis disorders, does not involve
any aspect of the immune system. Inheritance of the disorder is
either by autosomal dominant or recessive genes; blistering can be
in the epidermis, as the name would imply, at the junction between
epidermis and dermis, or within the dermis. Clinically the disorder
ranges from a single blister on, one hand, through to the mutilating
polydysplasia of the most severe form.
The simplest form of classification uses the level at which
cleavage of the skin occurs, determined either by light or electron
microscopy. All blisters cleaving in the epidermis are diagnostic
of the EB simplex group, all forms of which, as far as is known, are
TA3LE 1 CLASSIFICATION OF SB











B, Sb Localised to extremities. Worse
in hot weather. No scarring.
B Generalised blistering, as above.
3 Clumped tonofilaments (using EM).
Sb Bruising skin fragility, linked
with GPT locus.














at or soon after birth.
Abnormal hemidesmosomes, survival
with generalised blisters, no
scarring.
As above except blistering is
chiefly on the trunk.
As above, blistering mainly of
hands and feet
Normal hemidesmosomes, deposits






Blistering of the hand3 and feet
heal with scarring and milia.
Albopapuloid papules, blistering
more generalised, scarring and
milia.
Widespread blistering, often
mutilating and lethal, scarring
and milia.
Blistering restricted to the
extremities, scarring and milia.
Blistering confined to specific
areas of the body.
D autosomal dominant inheritance
r autosomal recessive inheritance
3 cleavage occurs through the basal cell
3b cleavage occurs suprabasally
11 cleavage occurs through the lamina lucida
d cleavage is in the dermis below the basal lamina
dominantly inherited. No disruption of the dermis occurs and therefore
no scarring is seen when the blisters heal. All blisters occurring
between the epidermis and dermis are diagnosed as junctional EB, which
is recessively inherited, whilst blisters arising within the dermis
are categorised as the dystrophic variety, which can either be
dominantly or recessively inherited (Table 1).
The Simplex Group (EBS) is composed of six different variants
according to the classification of Gedde-Dahl (1981), or five
variants according to Eady and Tidman (1983). The latter authors
disregard the Mendes da Costa variant included by Gedde-Dahl, on the
grounds that it is not a mechanobullous disorder. The five variants
include:
1) Weber-Cockayne: localised. Blistering is restricted to the
hands and feet. The blisters occur at or above the level of
the basal cell (Haneke and Anton-Lamprecht, 1982), and high
temperatures seem to exacerbate the condition.
2) Koebner: generalised. Blistering is widespread and more severe
than the localised variety. It occurs at the level of the basal
cell (Baker, 1982).
3) Herpetiformis Dowling-Meara. This form is similar in clinical
appearance to the Koebner variant and can only be distinguished
by electron microscopy. Ultrastructural examination reveals
electron-dense clumps or clusters of tonofibrils in the epidermis
(Dowling and Meara,195^; Anton-Lamprecht et al, 1979; Niemi et
al, 1983). Curiously this variant differs from the localised and
generalised simplex forms in that high temperatures ameliorate
the blistering (Gedde-Dahl, 1981).
*0 Ogna. This is characterised by a congenital bruising tendency of
the skin and traumatic serous blisters of the hands, feet and
occasionally elsewhere (Gedde-Dahl, 1971). In this type of EB
a genetic linkage with the erythrocyte glutamic pyruvic
transaminase locus has been established (Gedde-Dahl, 1981)•
5) Mottled pigmentation. This is characterised by patches of lighter
and darker skin 2 to 5 mm diameter. Hyper and hypo-pigmentation
is diffusely delineated and may be localised on extremities or
found over the whole body. Blistering is usually widespread
(Gedde-Dahl, 1981).
The Junctional Group is composed of five recessively inherited
variants, according to the classification of Gedde-Dahl (1981) or
three according to Eady and Tidman (1983). These include:
1) Herlitz: letalis. In this variant patients die at or soon
after birth (Fig. 1). The blisters form between the basal
cell plasma membrane and the basal lamina. Ultrastructurally
the hemidesmosomes are abnormal, lacking the sub-basal dense
plaque and having a rudimentary plasma membrane attachment
plaque: they are also thought to be fewer in number (Hashimoto
et al, 1976a; Anton-Lamprecht and Schnyder, 1979).
2) Non-lethal, generalised. This variant is similar in clinical
and ultrastructural appearance to the lethal variety but despite
widespread blistering, the patient is able to survive into
adulthood. Blisters heal without scarring (Pearson et al, 197^;
Hashimoto et al, 1976a).
3) Non-lethal, inverse. This is characterised by junctional
blisters located on the trunk, preferentially affecting the




showing the severity and widespread distribution
FIG. 2




EBDr patient: showing the widespread serous blisters which
encrust and heal leaving scars.
FIG, k




Neonatal blisters disappear during the first 3 to 5 months of
life and recur more frequently from about k years onwards (Gedde-
Dahl, 1981).
Included in Gedde-Dahl's classification (1981) are
4) Non-lethal, localised. This variant has localised junctional
blistering of the hands and feet.
5) Progressiva (neutrophica). This is characterised by the presence
of normal hemidesmosomes at the dermo-epidermal junction. Deposits
of amorphous material have been noted within the lamina lucida
(Gedde-Dahl, 1971). The onset of blistering is usually from early
childhood (*t years) to adolescence and this variant primarily
affects the hands and feet (Gedde-Dahl, 1981).
The Dystrophic or dermolytic form of EB is divided into dominantly
and recessively inherited groups, both characterised by blisters which
heal leaving scars or atrophic skin and various degrees of nail
dystrophy. The dominantly inherited group contains two variants,
though whether one isa more extreme clinical expression of the other
is unknown.
1) Cockayne-Touraine: localised. This is characterised by blisters
affecting the extremities, including the elbows and knees
(Hashimoto et al, 1976). Atrophic skin and milia are common at
the predilected sites (^ig. 2).
2) Pasini: generalised. Blistering is usually more generalised
and severe than the Cockayne-Touraine form. The Pasini form of
dominant dystrophic EB is distinguished by the spontaneous
appearance in late childhood or adolescence of albopapuloid
papules on the body. * An abnormality of the anchoring fibrils is
thought to be the causal defect in this disease (Hashimoto et al,
1975) and an aberration of glycosaminoglycan synthesis is thought
to be related to the appearance of the white papules (Sasai
et al, 1973; Bauer et al, 1979)-
The Recessively inherited Group of dermolytic EB includes
three variants:
1) Hallopesu-Siemens: generalised. This is characterised by
widespread serous blisters from the time of birth, which heal
with scarring and milia (Fig. 3)• There is commonly extensive
involvement of the mouth and pharynx, with frequent occurrence
of oesophageal strictures. Blistering of the extremities is
often so severe that it leads to mutilating polydysplasia
(mittening) of the hands and feet (Fig. k). In its worst form
this type of EB can be fatal but it should not be confused with
the junctional letalis (Herlitz) variant. Ultra-structurally,
• anchoring fibrils are rarely seen in the severe recessive
dystrophic type (EBDr) and this deficiency has been proposed as
a primary causal defect (Briggaman and Wheeler, 1975a). However
it is now uncertain whether this feature is an outcome of abnormal
collagenase metabolism, which is associated with severe EBDr
(Hashimoto et al, 1976b; Bauer, 1982).
2) Localised dystrophic recessive. This is characterised by
dermolytic blistering which is largely restricted to the
extremities.
3) Inverse dystrophic recessive. This is characterised by the
distribution of blisters on the trunk, predominantly around the
groin, axillae, neck and lumbar regions.
Bart's Syndrome, the hereditary, congenital, localised absence
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of skin from the lower legs, with blistering of the skin, mouth and
nail abnormalities, was previously thought to be a separate mechano-
bullous variant. It is now understood to be a feature of any of the
major variants of KB (Wojnarowska et al, 1983) and therefore does
not constitute a separate category.
Also excluded from the classification is a form of blistering
disease known as acquired EB (or EB aquisita). It is now accepted
that this is distinct from other hereditary mechanobullous disorders,
in having an immunologically based defect. Studies have shown deposits
of immunoglobulins A, M and complement C^ at the dermo-epidermal
junction in both involved and non-involved skin (Nieboer et al, 1980;
Yaoita et al, 1981). The onset of EB aquisita is late in life (over
50 years) and it appears to be more closely related to the pemphigoid
disorder of the skin than to EB.
The genetic relationship between the variants within each group
is poorly understood, despite the extensive work by Gedde-Dahl (1971)»
It is currently thought that where discrimination of a variant is
made on a quantitative basis, for example: EBS Weber-Cockayne from
Koebner; EBDr generalised from localised or EBDD Cockayne-Touraine
from Pasini, there may be a similar pathogenetic defect caused by
slightly different mutations at the same gene locus (Gedde-Dahl, 1981).
However between groups and between the variants within a group, where
clinical discrimination is based on qualitative differences, it is
thought that separate mutations at different gene loci must be
responsible, although phenotypic appearances may be deceptively
similar. The diverse range of variants in the EB group as a whole
make classification difficult and has complicated attempts to
determine the pathogenetic defects underlying each particular variant.
Little is known about the causal defect in EBS: disruption of
the basal cell implies some inherent defect within the cell, perhaps
the over-production of an enzyme or the failure to produce a vital
constituent. Equally, the significance of dermal influences on the
epidermis in this disorder is unknown, although the dermis does
influence epidermal metabolism elsewhere (Fleishmayer and Billingham,
1968; Woodley et al, 1980a; King and Tabiowo, 1980). Similarly,
although the hemidesmosomes are known to be abnormal in some patients
with junctional EB, the cause of the hemidesmosome deformity is
unknown; the epidermis or dermis being capable of producing enzymes
which could affect the integrity of the hemidesmosorae and therefore
the dermo-epidermal bond. More is known about the dermolytic,
dystrophic EB types, largely from the work of Dr. E.A. Bauer's
research group at St. Louis, U.S.A. Their studies have confirmed
that an aberrant collagenase is produced in excess in the severe
EBDr variant. They have also investigated the abnormal glycosamino-
glycan metabolism in the dominant dystrophic Pasini variant. As is
explained in chapter 1, the culture of fibroblasts from the skin of
patients with EB represents one of the few feasible avenues of
research, both in terms of defining the abnormality and in assessing
the effect of drugs on fibroblast metabolism.
It was therefore the aim of the present project to study the
skin fibroblasts of the major EB variants with the intention of
highlighting any metabolic defects by direct comparison with
fibroblasts from the skin of normal healthy subjects. In this way
the findings of previous investigators could be confirmed or
questioned, and new aspects of the disease might receive attention.
Very few drugs have been used to help ameliorate the particularly
severe dystrophic variants, they include: corticosteroids, phenytoin
• 10.
and vitamin E. None of these drugs have met with any long term success.
Phenytoin is now considered to be useful for some patients with EBDr
(Bauer and Cooper, 1981) but the unpredictable responses of patients
to this drug make it an unsatisfactory and unreliable form of treatment.
Unfortunately, it is currently one of the few therapies to offer even
limited success. Vitamin E has been used to treat both Simplex
(Ayres and Mihan, 1969) and dystrophic forms of EB (Wilson, 196^;
Smith and Michener, 1973) apparently with some success but unfortunately
few trials have been reported and without scientific investigation of
its value as a potential moderator of EB, true clinical effectiveness
is difficult to assess. The hazards of long term corticosteroid
therapy limit their use, particularly where young children are
concerned.
Although retinoids have not yet been used in the treatment of EB,
they are reported to induce the synthesis of a fibroblast-derived
inhibitor of collagenase activity in vitro (Bauer et al, 1982). It
is possible that after further research this group of compounds will
be of benefit to patients with dystrophic EB.
It should be understood that hope for an outright "cure" for
» '
this group of diseases is unrealistic and beyond the scope of this
project. However, further research is essential to distinguish the
basic underlying causes, in conjunction with a search for drugs which
can ameliorate, or rectify the various conditions. This project
represents a step in that direction.
The thesis has been divided into chapters according to the
particular aspect of the fibroblast being examined: for example
collagen, collagenase and glycosaminoglycan metabolism. Each
chapter is self-contained with its own introduction and discussion.
11.
The basic structure of the skin is described in chapter 2, along with
conclusions drawn from ultrastructural examination of some of the
patients involved in this study. The examination was not on a
morphometric basis but merely useful in confirming the diagnosis
whilst providing an insight into any ultrastructural defects that
might be present. Chapter 1 includes an introduction to fibroblast
culture and describes the basic procedures and techniques involved,






A logical approach to improving the treatment of a disease
requires that the underlying causal defects are understood. In a
disease such as EB, where there is enormous heterogeneity in clinical
appearance and severity, one of the few avenues of investigation is
to examine the source of the defect directly, by fibroblast and/or keratino-
-cyte culture, since skin is primarily a product of these two cells.
Keratinocyte culture is still a relatively recent innovation,
beset by problems: chiefly the difficulty in maintaining cultures
over long periods isolated from important dermal and serum borne
factors which must influence keratinocyte differentiation and the
difficulty in raising enough keratinocytes to perform, and repeat,
experiments. Fibroblast culture, on the other hand, provides a
comparatively easy method of analysing the production of dermal
components, using the large numbers of cells which can be obtained
from a single skin biopsy. Clearly both fibroblast and keratinocyte
culture techniques are important in the investigation of skin
diseases and ideally should be conducted concurrently. Unfortunately
technical and physical practicalities often make this impossible
and a choice has to be made between the two lines of investigation.
The more severe types of EB, such as EBDr, involve dermolytic
blisters with subsequent scarring. It was therefore the aim of this
study to establish cultures of EBDr fibroblasts, as well as fibro¬
blasts from the other EB variants for comparative purposes; then to
determine whether their characteristics, including proliferative
capacity, morphology, glycosaminoglycan secretion, collagen and
collagenase synthesis, differed from normal fibroblasts. Hopefully
13.
this would give some indication of the pathogenetic defect(s), which
could facilitate investigations into how to rectify, or at least
ameliorate, the disease.
The culture of fibroblasts in vitro has limitations and drawbacks
but studies in vivo cannot easily be made without inflicting undue
discomfort on patients with EB. The limitations of the system lie in
the artificial nature of the culture conditions - isolated from serum-
borne factors in the body and other cell types: in a situation where
the fibroblasts are forced to divide and form a confluent layer of
closely associated cells. The subdivision of confluent-layers of
cells (passaging) means that the fibroblasts' surface proteins,
including receptors, are stripped off by the general protease trypsin:
the cell is then forced to replace these components on its surface so
that it can readhere to the substratum.
As a consequence of these constraints of culture, fibroblasts
have only a limited life span in vitro. There has been much research
into ageing in vitro (Hayflick, 1965): it is now accepted that with
increasing age in tissue culture a decreasing number of cells are
capable of division - approximately 99% undergoing mitosis at passage
8, whilst only approximately 50% have this capacity at passage V7
(Merz and Ross, 1969). There is still some question regarding the
effect of the donor's age on the proliferative capacity of cells in
culture. Vracko and McFarlane (1980) found that the cumulative
replicative life span of normal fibroblasts (n = 10) decreased as
a function of the donor's age; it was not affected by the freezing
and storage process but was affected by the quality of the foetal
bovine sera used in the culture media, which seemed to differ between
lots. Ryan et al (1981), studying skin fibroblasts from monozygotic
14.
twins, concluded that the donor genotype was the most important
determinant of cell proliferation and replicative life span in vitro.
The problem of ageing in culture is further complicated by the
f
knowledge that fibroblasts from the papillary dermis exhibit a
greater proliferative capacity than those from the reticular dermis
in vitro (Harper and Grove, 1979)• These authors suggest that the
shortened life span of human skin fibroblasts from older donors may
be due to the absence or reduced number of papillary fibroblasts
resulting from age-related dermal atrophy.
In order to avoid complications related to donor age, and
induced ageing of cells in culture, all experiments in this study
were performed between passage 4-10 and the mean age of control
donors was matched as closely as possible with those of the EE
patients. Apart from determining the mean proliferation rates
of all the cell lines used in this study, it was necessary to identify
the concentration range of phenytoin and vitamin E with the greatest
effect on proliferation, thereby showing which concentrations should
be used in other experiments.
In the current study the morphology of all the fibroblasts
cultured was studied and representative cell lines were fixed and
stained for comparison. A further attempt to study the extracellular
morphology was made by indirect "staining" of the fibronectin extra¬
cellular matrix of the fibroblasts. The method of Hsieh et al (1980)
was used, which involved binding fluorescein isiothiocyanate (FITC)-
conjugated gelatin onto the fibronectin associated with the extra¬
cellular matrix of the cell (Chen et al, 1978; Singer, 1979). This
method is based on the strong affinity between gelatin and fibronectin
(Sngvall and Huoslahti, 1977) combined with the ease with which the
fluorescent tag can be conjugated to the gelatin. The extracellular
matrix can then be visualised using an ultraviolet emission microscope.
A recent study of EBDr fibroblasts in vitro suggested that they
differed from normal control fibroblasts, not only in their reduced
capacity 'to contract collagen lattices but also in their morphology
(Ehrlich et al, 1983). The findings of the present study were
compared and discussed in view of those of Ehrlich et al (1983).
METHODS
Patients
A total of 30 patients were biopsied for fibroblast culture;
12 EBS, 10 EBDr, 6 EBDD and 2 EBL (see Table 2 and Fig. 5 for details).
The clinical diagnosis, based on the patient's previous history and
condition at the time of presentation was agreed by the attending
physician and later confirmed by electron microscopy in 2k patients
(see Table *f). Normal skin to provide fibroblasts which would serve
as controls in experiments was taken from the forearm of healthy
volunteers with their informed consent. Three strains of control
fibroblasts were donated by other centres (Table 3)•
Initiation of Fibroblast Cultures
The biopsy site was sterilised with a Savlon wipe: local
anaesthetic (1-2% xylocaine without adrenalin) was injected into
the site and either a punch or incision biopsy excised. (A general
anaesthetic was used in k patients who were undergoing plastic
surgery at the time of biopsy - see Table 2). The biopsy was
halved if electron microscopy of the sample was required; otherwise
the skin was placed in a universal container full of "transport
medium" for between 1-16 hours.
Transport Medium: Dulbecco and Eagle medium with




(all from Gibco-Europe, Paisley, Scotland)
The biopsy was washed five times in sterile phosphate buffered
TABLE 2
PATIENTS INVOLVED IN EB STUDY
all biopsies were taken from uninvolved sites except EB32
No Sex , A®e x Type Biopsy Site Blister sites
EB4 F 37 S(W-C) P f hands + feet, mild
EB6 M 22 S(W-C) i u.a. feet, mild
EB8 M 39 S(K) P f generalised severe
EB9 M 42 s(w-c) P f feet, mild +
EB10a F 31 s(w-c) P f hands + feet, mild +
EB1la F 12 s(w-c) P f hands + feet, mild +
EB12a M 8 s(w-c) P f hands + feet, moderate +
EB23 F 3 s(w-c) P* f hands + feet, mild +
EB24 F 29 s(w-c) P f hands + feet, mild
EB28 M 8 s(w-c) P f feet, mild
EB29 M 32 s(w-c) P f feet, mild +
EB30 F 19 s(w-c) P f hands, feet + friction
sites, mild
+
EB32 F 1 S(D-M) i u.th generalised
EB26 F 3/12 L
»
i ch. atrophic scarring
generalised, very severe
+
EB27 M 2 L i ch. generalised, severe +
EB1 F 15 Dr(H-S) P* u.th generalised, poor +
EB2 F 13 Dr(H-S) i* u.th generalised, severe +
EB3 F 23 Dr(H-S) i u.th generalised
EB5 M 47 Dr(H-S) P f generalised, poor +
EB14 F 2 Dr(H-S) i f generalised. Died aged 3 +
EB15 M 15 Dr(H-S) i f total syndactyly, very
severe
E318 F 36 Dr(H-S) i f generalised, moderate +
EB19 M 33 Dr(?) i f mode of inheritance
uncertain, moderate
EB22 F 32 Dr(H-S) P f total syndactyly, very
severe







(years) TyP® Bi°PS7 Sit6 Blister SlteS established
EB7 M DD(C-T) p f hands i feet + mouth
EB16 M 18 DD(C-T) p f hands, feet + friction +
sites
EB17 F kO DD(C-T) p f handsi feet + friction +
sites
EB20C M 15 DD(C-T) p f haemorrhagic blisters,
mouth
EB21C F 38 DD(C-T) p f extremities, mouth
EB25 M 16 DD(C-T) i k extremities no nail +
dystrophy
*
: biopsies taken under general anaesthetic
a : EB10, 11, 12 - mother, daughter and son respectively
b : EB16 and 17 - son and mother respectively
c : EB20 and 21 - son and mother respectively
S(W-C) : Simplex Weber-Cockayne
S(K) : Simplex Koebner
S(D-M) : Simplex herpetiformis Dowling-Meara
Dr(H-S) : Dystrophic recessive, Hallopeau-Siemens
DD(C-T) : Dystrophic dominant, Cockayne-Touraine
L : Junctional, letalis: Herlitz
p : punch (either k or 5 mm) biopsy
i : incisional biopsy
f : forearm
u.a. : upper arm





CONTROL CELL STRAINS USED IN THE STUDY
No Sex Age Biopsy Site Cell line
F 22 p f +
M 5 Donation! Sick Children's +
Hospital, Glasgow.
M 13 " " +
M 37 P f +
HSF8 F 25 Donation, Royal Hospital for
Sick Children, Edinburgh.
+
HSF11 M 26 P f +
HSF13 M *t-1 P f +
HSF14 F 23 P f +
HSF17 M P f +
HSF21 M *t1 P f +
HSF22 M 19 P f +
HSF24 M 31 P f +
HSF26 M kO P f +
FIG. 5
Distribution of EB patients involved in this study
(N.B: The two EBL patients were visitors to Britain from Saudi
Arabia undergoing treatment at the Royal Hospital for
Sick Children, Edinburgh)
saline (PBS), excess fat was removed using a sharp disposable scalpel
and the skin was cut into 1mm x 1mm pieces. Groups of explants CA—8)
were placed in each well of a 6 well culture dish (Linbro; from Flow
Laboratories, Irvine, Scotland) and a sterile glass cover-slip placed
over them: complete medium was then added.
Complete Medium: Dulbecco and Eagle medium with
20% foetal calf serum
k mM glutamine
100 units/ml penicillin-streptomycin
Dishes were incubated at 37°C in a 5^ CO^ : air atmosphere.
Medium was changed every second day until a healthy outgrowth of
fibroblasts was seen emerging from beneath a layer of epithelial
cells.
Trypsinisation and first passage
When fibroblast growth was established around the explants
(average 31 days; range 12-55 days), the wells were washed twice
with phosphate buffered saline. The glass cover slips were removed
using sterile forceps and placed cells uppermost in another sterile
dish with 1 ml of 0.5% trypsin-versene solution (Gibco-Europe, Paisley,
Scotland). Trypsin-versene was also added to the wells containing
explants. The dishes were incubated at 37°C for 10 mins or until
the fibroblasts surrounding the explant had detached from the
substrate and were rounded in appearance, progress being followed
using an inverted phase-contrast microscope. The trypsinised cells
were immediately transferred to a universal container of complete
medium and centrifugea at 1,000 rev/min for 5 mins.
The supernatant was poured off and "fresh" complete medium
added, the pellet of cells was dispersed using a sterile Pasteur
pipette. The cells were then transferred to a small plastic flask
25 cm growth area (Nunc, Gibco-Europe, Paisley, Scotland) and
maintained at 37°C in a 5?» GO^ : air atmosphere. This was regarded
as the first cell line passage. A cell line is defined as the
collection of cells arising from a primary culture at the time of
the first passage. The term implies that cultures contain numerous
lineages of cells originally present in the primary culture. This
is different from a cell strain which is derived from either a
primary culture or a cell line by the selection or cloning of cells
with specific properties or markers which persist during subsequent
cultivation (Paul, 1972).
Once the fibroblasts reached confluence, they were thoroughly
washed with phosphate buffered saline (PBS) before being trypsinised,
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as described, and placed into a larger flask (85 cm growth area).
In this way many millions of fibroblasts could be obtained from a
single biopsy. After the second passage cells were routinely cultured
in complete medium containing only 10^ foetal calf serum, which was
changed thrice weekly.
Freezing and storage of Fibroblasts
By the 3rd or *+th passage, large enough numbers of fibroblasts
were obtained to permit some experiments and enable the surfeit to
be stored in liquid nitrogen. The pellet of trypsinisad cells was
resuspended in 2 mis of complete medium: a small aliquot was
removed and the total number of cells/ml ascertained using a
haemocytometer. Dimethylsulphoxide (DMSO) was added to the cell
suspension to give a final concentration of 10^6. The cells were
transferred to small plastic vials (Nunc, from Gibco-Europe, Paisley,
Scotland), at approximate concentrations of 10^/ml/vial. The vials
were immediately placed in a biological freezer for a controlled
reduction in temperature nominally 1°C/min before being placed in
liquid nitrogen, at -196°C, until the fibroblasts were required for
experimental use.
To retrieve cells from liquid nitrogen storage, the plastic vial
was immediately placed in a water bath at 37°C; as soon as the cell
suspension defrosted it was transferred to a universal container of
complete medium and centrifuged (1,000 rev/min for 5 mins), removing
the DMSO in the supernatant. The fibroblasts were resuspended in
fresh medium, transferred to a suitable flask, equilibriated with a
5% GO^ : air atmosphere and incubated at 37°C.
Determination of Viability
To test the viability of cells after recovery from freezing or
after treatment with a drug, the pelleted fibroblasts were resuspended
in a small volume of PBS. Trypan blue (0.5% solution in 0.85% saline:
Flow Laboratories, Irvine, Scotland) was added to 0.1 ml of the cell
suspension to give a final concentration of 0.0625% trypan blue.
After 2 minutes the viable cells which had excluded the blue dye and
the non-viable stained cells were counted. A total of 200 cells from
k different fields of the haemocytometer was used. The number of
viable cells obtained was expressed as a percentage of total number
of cells counted.
Determination of Proliferation Rates
The proliferation rate of each cell line was determined between
passages k and 6. Fibroblasts were seeded in 7 mis of complete
2k.
medium containing 10% foetal calf serum at approximately 10^ cells/
25 cm^ in flasks and incubated at 37°C in a 5% CO 2 '• air atmosphere.
Next day (day 1 after seeding) the medium was replaced with 7 mis
of fresh complete-medium. On day 3 four flasks were withdrawn,
trypsinised and the mean cell number determined using a Coulter counter
(model DN). The remaining four flasks received fresh medium on day 3
and k: the final cell counts were determined on day 6, using the
Coulter counter.
The proliferation rate was expressed as a percentage of the mean
increase in cell number between days 3 and 6.
Normal control cell lines: HSF22 and HSF1*f were used to examine
the effect of phenytoin and vitamin E on the rate of fibroblast
proliferation over large concentration ranges. The initial procedure
was the same as for the determination of proliferation rates,
previously described. On day 3 four flasks were removed, trynsinised
and the mean cell number determined using the Coulter counter. The
remaining flasks were divided into groups of four which then received
phenytoin (in 50% ethanol: final conc. 0.08%) at 1, 10, 50, 100, 150,
200, 250, 300, ^+00 and 500 juM, leaving a group of flasks untreated to
act as controls. Similarly vitamin E was added (in acetone: final
conc. 0.2%) at a final concentration of 10, 50, 100, 250, 300, ^fOO,
500 and 750 jug/ml. On day k all flasks received fresh medium
containing the appropriate drug concentration. All the flasks were
trypsinised and the final cell numbers were counted on day 6. The
mean increase (or decrease) in cell number at each concentration was
expressed as a percentage of the mean change in cell number between
day 3-6 in untreated cultures i.e. as the mean percentage increase
(or decrease) in proliferation rate at day 6.
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Histochemical Staining
Fibroblasts were grown on glass cover slips in 6-well dishes until
they reached the required cell density. The cells were then washed
several times with PBS, and the cover slips with adhering cells were
removed and left to dry at room temperature (12-15 mins). The fibro¬
blasts were fixed in methanol (5 mins), then stained with May-
Grunwald (12 mins) followed by Giemsa (12 mins). The coverslips were
washed twice (5 mins each) in water and left to dry. They were
- mounted on glass microscope slides using DPX mountant.
Investigation of pericellular fibronectin
The procedure followed was that of Hsieh et al, (1980).
Gelatin 20 mg/ml was mixed with fluorescein isothiocyanate (FITC:
Sigma Poole, England) kO pg/ml in 0.1M carbonate-bicarbonate buffer,
pH 9.3, in the dark for 18 hours at room temperature. Unconjugated dye
was removed by dialysis for 2k hours against PBS followed by gel
filtration through a Sephadex G-25 column (Pharmacia, Uppsala,
Sweden). The FITC-gelatin complex was collected in 2 ml aliquots:
a 0.1 ml sample from each aliquot was diluted 10-fold with PBS and
» '
the optical density was read at ^90 nm in a Unicam SP600 spectro¬
photometer. This enabled aliquots containing the highest concentration
of FITC-gelatin to be identified by light absorption of the yellow
FITC dye itself. Aliquots were stored at -20°C.
Fibroblast lines for staining were grown on glass coverslips
(22 mm x 22 mm) in 6-well dishes. The cells were washed twice
with PBS, before addition of 50 pi FITC-gelatin in 1 ml of serum-free
complete medium, in which they were incubated at 37°G for 30 mins.
The excess FITC-gelatin complex was removed by three 10 min washes
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in PBS. Finally the cells were sandwiched in glycerine:FA buffer
(9:1) between a glass microscope slide and a larger (22 mm x 32 mm)




As indicated in Table 2 only 18 cell lines were established from
the 30 biopsies taken for culture purposes (a 60% success rate) and
success in establishing primary cultures did not seem to vary between
the different EB groups: EBS 7/12, EBDr 6/10, EBDD 3/6 and EBL 2/2.
Of the unsuccessful biopsies, 9 produced enough fibroblasts to reach
the first passage but failed during or just after the first
trypsinisation.
A comparison of the different rates of proliferation between EB
and control groups is seen below:
N EBS EBDr EBDD
Number of cell lines 10 7 6 3
Mean age (years) 28.3 - ^ 21-5 19»5 - 7 2^.6
Proliferation rate (%) 87.8 - 13 123 - 16 98 - 29 106
Mean - SEM
No significant differences in proliferation rate were found
between any of the groups studied. There was no significant
correlation (r = -0.05) between proliferation rate and the age of
the donor in this study.
The responses of fibroblasts to phenytoin and vitamin E are
seen in Figs. 6 and 7. Phenytoin appeared to depress the proliferation
rate with increasing concentrations: a maximum 75^ decrease in the
proliferation rate was seen at 500 pM phenytoin. The overall effect
of vitamin E was to stimulate proliferation at concentrations over
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These experiments were repeated several times and although
there was some variation in the response of the same cell lines* the
figures given are representative.
Comparison of the morphology of representative cell lines
showed variation in the size and shape of the fibroblasts ancj/general
morphology of the cultures. No particular characteristic was special
to any one group whether control or EB(Fig. 8). The relative density
of each culture at the time of examination inevitably affected the
appearance of the cells: confluent cultures characteristically
showed the "swirling" pattern associated with fibroblast cultures,
whilst sparsely seeded cultures tended to lack a particular pattern
and the filopodia-forming intercellular connections were much more
obvious. Crossing-over of cells was observed both in control and
EB groups but only when cultures became particularly dense (Fig. 9).
This phenomenon could occur before the culture reached confluence
if seeding had not been uniform, making some areas much more dense
and therefore likely to have fibroblasts growing over the top of
their neighbours, as described by Ehrlich et al (1983).
The similar patterns of FITC-fluorescence, indicated no obvious
difference between groups (Fig. 10). Although this pattern
developed and altered as the density of the culture increased,
(Fig. 11), thin tangled fibrils becoming more dense (reflected by
an increase in the intensity of fluorescence), eventually becoming
ill-defined and finally the fibrillar pattern was replaced by sporadic,
more punctate, patches of fluorescence. In no group was the pattern
obviously different provided the cell density and the time in culture
were the same. No quantitative differences between groups was detected,
indicating similar extracellular fibronectin levels.
DISCUSSION
There was considerable variation in the time taken to establish
the primary culture. This variability seemed to be unrelated to the
donors' ages or the severity of their disease. Other factors such as
the depth of the biopsy, the size of the pieces into which the biopsy
was subdivided, and the number of skin bacteria present at the time
of biopsy, seemed to be of importance. Most of the indigenous bacteria
were successfully disposed of, firstly by skin disinfection, and
secondly by the penicillin and streptomycin in the transport and complete
medium. If bacterial contamination became a serious threat to the
primary culture a small dose of another antibiotic (such as Gentamycin)
was included in the medium of the affected well and was usually most
effective.
In one unsuccessful biopsy fibroblasts failed to appear from the
explant: in a further two unsuccessful biopsies there were too few
fibroblasts to attempt subculture. The remaining nine biopsies
produced enough fibroblasts to warrant an attempt at subculturing
and it was at this stage - the first passage - that success or
failure to establish a fibroblast line seemed to occur. In three of
these unsuccessful biopsies, areas of "ghost-like" impressions of
cells were seen following removal of the coverslip and transfer to
trypsin-versene. The reason for this is unknown, but the trauma and
tension applied to the surface of the fibroblast during the lifting
and removal of the cover-slip may have been sufficient to disrupt the
cell membrane. It is also possible that due to the location of certain
areas of cells, between explants and close to the centre of the cover-
slip, fresh medium did not always reach the cells, causing premature
exhaustion of intracellular resources and consequent death of the
fibroblasts.
Although not all of the explants from any single biopsy
established a sheet of epithelial cells before fibroblasts emerged
(Fig. 12), nearly every biopsy did exhibit some epithelial growth.
These large flat polygonal cells usually appeared within the first
week in culture, extended to surround the explant and then regressed
as fibroblasts emerged from beneath and between the epithelial cells.
This pattern of growth has been well recorded by Van der Shueren et
al (1980).
After the first passage the fibroblasts were heterogeneous in
shape and size, some cells were spindle shaped - with a single axis
of symmetry; some were sail shaped - with two axes of symmetry, and
some were large and irregular in shape (pleomorphic) (Hennis et al,
1981). There is some evidence to suggest that the sail-shaped and
pleomorphic cells are derived from the spindle-shaped cells by
selection in vitro (Hennis et al, 1981). However, without being
able to quantify the observation it was the impression in this study
that spindle shaped cells tended to proliferate faster than the large
cells and that the ratio of small to large cells tended to increase
rather than decrease with time in culture.
The heterogeneity seen between the cell lines of each group in
this study precludes general statements about differences between
control and EB fibroblasts.
By examining the fibronectin of the fibroblasts1 extracellular
matrix, a further attempt was made to find differences between control
and EB fibroblasts, either in the pattern of the matrix or in its
rate of formation. The extracellular matrix is a dense network of
fibres of different diameters which encircle the entire cell surface.
Gell-cell contact is required to initiate the formation of these
fibres which are composed almost entirely of fibronectin (>90$).
As cell density increases with prolonged time in culture (>1*t days) *
a second intercellular matrix composed of collagen is produced (Chen
I
et al, 1978). The matrix seen by FITC-gelatin staining is very
similar to that visualised by scanning electron microscopy (Chen et
al, 1978; Hsieh et al, 1980).
No differences could be seen between the intercellular matrices
of either control, EBDr or EBS cell lines. They all developed a fine
fibrous mesh-work by day 2 after seeding, providing that the seeding
density was great enough to allow immediate cell contact. The fine
fibrillar pattern did however alter with time in culture (Fig. 11),
probably as a result of the developing collagenous extracellular
matrix.
Amongst recent work on EBDr fibroblasts was a study of their
behaviour within a collagen matrix (Ehrlich et al, 1983): these
authors found that apart from a reduced capacity to contract the
\
collagen lattice the EBDr fibroblasts had an altered morphology.
They compared only two EBDr cell strains with three control cell
strains, including strains derived from the parents of one of the
EBDr patients. Donor ages were not given and must therefore be a
consideration in any conclusions drawn from the results. The EBDr
fibroblasts were reportedly abnormal, differing from controls by
growing over neighbouring cells prior to the cultures becoming
confluent (although the cells illustrating this abnormality do
appear to be at a high density). No mention was made of differences
in the proliferative capacity of control and EBDr cells, which could
have some bearing on the findings. The EBDr fibroblasts were
reported to form a greater number of "cross-overs" at greater
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angles than control cells; but unfortunately no estimate of
statistical error is given to. indicate the certainty and reproducibility
of this observation. It was also observed that the normal cells formed
filopodia at opposite poles of the cell, whilst EBDr fibroblasts
formed filopodia all around the 'periphery of the cell. This difference
in morphology was thought to be ultimately responsible for the poor
lattice-contracting powers of the EBDr fibroblasts.
It is possible that the morphological differences between control
and EB groups found by Ehrlich et al (1983), would not have been
detected by the methods adopted in this study and it is also possible
that if seeded onto a collagen substratum the cells would behave
differently. The present study showed no differences in the cellular
or extra cellular morphology of control and EB cells grown on a glass
coverslip.
No statistical difference was found between the mean proliferation
rates of control and EB fibroblast lines, indicating that in this
respect there is no evidence of hyperactivity in the SB fibroblasts.
An increased proliferative capacity in vitro could have reflected a
similar potential in vivo, thereby increasing levels of fibroblast
products in the dermis. This does not appear to be the case and any
other differences in fibroblast characteristics which were observed
do not result in sin increased proliferative capacity. In this study
there was no significsint. correlation between the age of the donor and
proliferation rate of the fibroblasts. This may be because the
majority of donors, were young adults and to show an age-related
»
decline in proliferation rate, more donors from the extremes of the
age range would be required.
Apart from using the concentrations of vitamin E and phenytoin
adopted by earlier investigators, it was necessary to establish
at which concentrations the drugs exerted an effect. Unfortunately
there was substantial variation in the results with phenytoin, even
using the same control cell line. This may be attributable to the
binding of phenytoin by serum albumin with variation between different
batches of serum. There was also a problem of precipitation of
phenytoin at concentrations higher than 200 pH. This may have
added smother variable to the system. Such variability, in response
of fibroblasts to a drug, differs from previous investigations with
other drugs (Priestley and Brown, 1980)-, indicating that phenytoin
is the cause of the variability found in the present study. However
based on these results and the data of other investigators (Shafer,
1960; Houck et al, 1972; Blumenkrantz and Asboe-Hansen, 197^ and
Bergenholtz and Hanstrom, 1979)1 phenytoin was used at 50-200 jiM
for further studies.
The response of a control cell line to vitamin E was rather
less variable than that seen with phenytoin. As the changes in
proliferation were greatest between 10-300 pg/ral vitamin E, the




1) Biopsies were taken from 30 EB patients and 18 produced viable
cell lines.
2) The mean proliferation rate of the various EB groups did not
differ significantly from that of the control group, which was
88% - 13 (3EM; n = 10).
3) Great heterogeneity of cell shape and size was seen both within
and between cell lines of both the EB and control groups: but no
particular characteristic was limited to a particular group.
*f) Dose-response curves were obtained for the effect of phenytoin
and vitamin E on the proliferation of a control fibroblast strain:
the phenytoin seemed to inhibit proliferation whilst the vitamin E






The use of the electron microscope to visualise the architecture
of the skin has greatly enhanced our knowledge and understanding of
structure with relation to function. The ultrastructural
characteristics of normal skin have been well documented (Zelickson,
1967) and will not be dealt with in detail here. However it is
necessary to clarify a few important aspects of skin structure if
abnormalities, or changes, seen in bullous conditions are to be
understood.
The basic division of skin into epidermis and dermis
distinguishes cells of an ectodermal origin from the inner cells of
mesodermal source, ^he epidermis is divided into further layers, or
strata, reflecting various stages in the differentiation of basal
cell to corneum cell, to the point at which the cell is sloughed off.
The basal cell layer therefore represents a resident population of
dividing keratinocytes, a stem cell population for the rest of the
epidermis, ^his cell layer is anchored to the basal lamina - the
electron-dense dividing line between dermis and epidermis - by
heraidesmosomes and the cells to each other by desmosoraes. Intra¬
cellular^ tonofibrils - part of the cytoskeleton - converge on these
points of contact providing strength and form to the basal cell. The
basal cells contain the expected organelles - mitochondria, endoplasmic
reticulum, ribosomes, lysosomes and have a large electron-dense
stained oval nucleus. Included in the basal cell layer are
melanocytes and sometimes Langerhans cells, though they are more
frequently found in the overlying stratum spinosum.
The stratum spinosum, or prickle cell layer, is so called
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because of the cellular conformation adopted at this stage in
differentiation. Numerous cytoplasmic projections and ridges are
seen with desmosomes appearing as prickles at the end of such
protrusions. In this cell layer keratohyalin first appears and
becomes associated with the tonofibrils.
In the overlying stratum granulosum the keratinocytes become
more flattened and elongated. The cells of this layer characteristically
contain keratohyalin granules» which form on the tonofibrils. These
gradually increase in quantity until eventually they coalesce within
the cells, just below the stratum corneum. As the keratohyalin
accumulates the nucleus of the cell disintegrates and the cytoplasmic
organelles disappear. As the cell approaches the stratum corneum the
desmosomal contacts change, with the electron-dense attachment plaque
disappearing in the overlying cornified keratinocyte.
In the stratum corneum the final product of basal cell
differentiation is seen - a flattened anuclear cell, lacking in any
cytoplasmic organelles and containing only fine filaments of keratin
embedded in an amorphous matrix. As the desmosomes finally degenerate
the keratinocyte can finally be sloughed off.
The dermis is largely an acellular matrix of collagen, elastin
and ground substance interspersed with resident fibroblasts and
other motile cell types. The dermis spans the region between the
basement membrane zone and the subcutaneous fat and can be divided
into two regions according to the size and arrangement of collagen
fibres, The papillary dermis is proximal to the basement membrane
zone, usually constituting only 10% of the full dermal thickness;
the underlying region is the reticular dermis.
The abundant randomly orientated collagen fibres, with their
characteristic cross-banding are the most obvious ultrastructural
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feature of the dermis. Type I collagen forms the majority of the
reticular dermal collagen.! having thick fibres 60-100 nm in diameter.
accounts for only 10-15% of the dermal collagen.
The other fibrous components of the dermis are the elastic
fibres. These fibres have two components; a microfibrillar
scaffolding embedded in a matrix of elastic cement constituting 90%
of the fibrei hence ultrastructurally the fibres appear as rather
amorphous electron-dense bands in the dermis. The ground substancei
composed largely of glycosaminoglycans! is not usually visualised.
Fibroblasts are responsible for the production of constituents
of the dermisi as well as the synthesis of various enzymes necessary
for the maintenance and regulation of the dermal components. Such
metabolically active cells contain extensive endoplasmic reticulum,
Golgi apparatus and ribosomes.
Biochemical aspects of the dermo-epidermal junction
The region separating the dermis from epidermis is the dermo-
epidermal junction or basement membrane zone. This site of attach¬
ment of epidermis to dermis has been well reviewed (Briggaman and
Wheeler, 1975b; Briggaman, 1982; Prunieras et al, 1983). The junction
can be divided into four components using the electron microscope:
the basal cell plasma membrane, the lamina lucida, the basal lamina
and the sub-basal lamina fibrous components.
The basal cell plasma membrane is usually highly convoluted
and is clearly recognised as the membrane boundary between cell and
lamina lucida, interrupted at intervals by electron-dense hemi-
desmosomes. Beneath the plasma membrane is the electron-lucent
lamina lucida 20-40 nm thick. Anchoring filaments traverse the
lamina lucida. These filaments are most dense beneath the hemi-
desmosomes, where they emerge from a sub-basal electron-dense
plaque and extend into the underlying basal lamina, "^he composition
of these filaments is unknown although they are susceptible to
digestion by bacterial collagenase and elastase (Kobayasi et al,
1977).
Other components of the lamina lucida, but not exclusive to
it, (reviewed by Stanley et al, 1982; Briggaman, 1982) include
laminin, bullous pemphigoid antigen, heparan sulphate proteoglycan
and fibronectin, determined by indirect immunofluorescent techniques
(Fyrand, 1979; Hintner et al, 1980; Foidart et al, 1980).
Laminin is a non-collagenous glycoprotein (Timpl et al, 1979)
vital in the adherance of epithelial cells specifically to Type IV
basement membrane collagen (Terranova et al, 1980). It is a large
asymmetrical molecule consisting of three polypeptide chains cross-
linked by bisulphide bonds (Hogan, 1981). In wound healing laminin
is laid down with Type IV collagen after re-epithelialation has
commenced (Stanley et al, 1981a). At the ultrastructural level the
formation of the basal lamina is accompanied by the simultaneous
emergence of Type IV collagen and laminin (Hintner et al, 1980).
The close association of laminin and Type IV collagen is seen in the
production of a fine fibrillar matrix produced in culture by a
keratocarcinoma-derived endodermal cell line (Leivo et al, 1982).
Kariniemi et al (1982) found that epidermal cells in culture do not
deposit laminin. This could explain the findings of Woodley et al
(1980a) indicating that the presence of living dermis is required
to produce fype IV collagen and therefore perhaps other components
of the basement membrane zone.
Bullous pemphigoid antigen is another glycoprotein, recognised
by immunoreactivity with bullous pemphigoid antibodies from patients
with that disease. The antigen appears to consist of a heterogeneous
group of closely related glycoproteins (Zhu and Bystryn, 1983).
The antigen isolated from skin consists of two components of 20,000
daltons and 9»200 daltons (Diaz et al, 1977)» whilst cultured
epithelial cells produce a high molecular weight 220,000 dalton)
bullous pemphigoid antigen (Stanley et al, 1981b). The antigen is
of epidermal origin (Diaz and Marcelo, 1978) forming at the junction
between viable human epidermis and non-viable (irradiated) dermis
(Woodley et al, 1980b). Similarly the antigen can be detected in
re-epithelializing superficial wounds at the dermo-epidermal
junction where laminin and Type IV collagen were not initially present
(Stanley et al, 1981a).
A heparan sulphate proteoglycan of approximately 750,000 daltons
has been isolated from the basement membrane and is thought to be
located in the lamina lucida (Hassell et al, 1980). It contains
approximately equal amounts of protein and covalently linked heparan
sulphate. Its function and mode of interaction with other components
of the lamina lucida and basal lamina are still unknown.
»
Fibronectin has been identified at the dermo-epidermal junction
(Fyrand, 1979; Foidart and Yaar, 1981) as well as being widely
distributed throughout most of the tissues of the body (reviewed by
Yamada and Olden, 1978; Ruoslahti et al, 1981; Stasko and De Villez,
1982). It is present in the plasma membrane of the basal cells and
in the lamina lucida, however no correlation between specific areas
of cell-substrate adhesions and fibronectin location has been
established (Couchman et al, 1979)* Skin fibroblasts produce
fibronectin both in vivo ana in vitro (Stenman and Vaheri, 1978;
Fyrand, 1979; Couchman et al, 1982): there is also an abundance
of fibronectin in serum, consequently the origin of fibronectin
located within the basement membrane eone is uncertain.
Fibronectin is a glycoprotein made up of two subunits of
220,000 daltons linked by disulphide bonds. It may exist as a
dimer or as a multimer. The subunits may not be identical, thus
producing sui asymmetrical molecule capable of localised folding.
The role of fibronectin at the basement membrane is unclear. It is
known that epithelial cells in vitro produce and deposit fibronectin.
Indirect immunofluorescent techniques have been used to show fibro¬
nectin at the margin of attaching epithelial cells and also in the
peripheral cells of spreading cell foci (Kariniemi et al, 1982). In
contrast the work of Federgreen and Stenn (1980) suggested that in
vitro fibronectin was not essential for epithelial cell spreading.
This work, however, did not take into account the effects of
endogenous fibronectin. It therefore seems likely that fibronectin
plays some role in the adhesion of epithelial cells to the substratum
whether in vitro or in vivo. It has also been suggested that fibronectin
might be involved in the orientation of regenerating epithelial cells
which proliferate at the basement membrane (Stenman and Vaheri, 1978).
The major component of the basal lamina is Type IV collagen;
also present are small amounts of Type V collagen. These collagens
differ from Types I - III in their lack of banding and fibrillar
appearance (reviewed by Kleinmann et al, 1981; Sage, 1982). Immuno-
electron microscopy was used to locate Type IV collagen at the
basement membrane in vivo (Foidart and Yaar, 1981) and it can be
shown that the development of the basal lamina in organ culture is
accompanied by the appearance of Type IV collagen and laminin
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(Hintner et al, 1980).
The production of Type IV collagen is intriguing. Laurie
et al (1980) failed to show imraunostaining in the cells associated
with the basement membrane, whereas the basement membrane itself
stained strongly. They presumed that the development of the basal
lamina is a transient activity that occurs at an early stage in
development and that once established the basal lamina required
only minimal synthesis of Type IV collagen to maintain its structural
integrity over long periods. Woodley et al (1980a) showed that
keratinocytes next to a non-living substrate failed to produce Type IV
collagen but once in contact with a living dermis an ultrastructurally
recognisable basement membrane was laid down. This is in contrast to
the earlier work of Briggaman et al (19V) who in a series of
recombination experiments, showed the basal lamina to be of epidermal
origin, being formed when living epidermis was recombined with dead
dermis. However, because the dead dermis was supported on well
vasculated living chick chorioallantoic membrane, Woodley et al (1980a)
argued that the epidermis was indeed receiving material from living
cells. Some controversy remains as to whether a viable dermis is
necessary for the development of the basal lamina which is ultimately
of epidermal origin. It is interesting that Type IV collagen could
not be detected using indirect immunofluorescent techniques against
epithelial cells in culture. Two explanations are possible;
firstly factors that only the dermis can provide are required or
secondly that production of Type IV collagen is slow or non-existent,
unless wounding of the epidermis occurs, in which case other factors
are released and may stimulate Type IV collagen synthesis by basal
cells. These factors are not produced in a culture system and
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therefore no production of this collagen occurs.
The structure and properties of Type IV collagen are further
mentioned in chapter 3. One of the most intriguing properties is
the preferential adhesion of epidermal cells to a substrate of Type
IV collagen, compared to Types I - III (Murray et al, 1979); fibro¬
blasts attach equally well to all four collagen substrates. The
slow attachment rate of epithelial cells is thought to be due to
de novo synthesis of an attachment protein (Murray et al, 1979) -
probably laminin in the light of current knowledge. Laminin is
known to be closely associated with Type IV collagen in producing
a fine fibred matrix in cell cultures (Leivo et al, 1982).
The final component of the basement membrane zone are the sub-
basal lamina anchoring fibrils. These are believed to be of dermal
origin because dermal viability is essential for their formation
(Briggaman et ail, 1971). Although their biochemical composition is
unknown, the work of Kobayasi et al (1977) suggests a collagenous
component. The fibrils were found to be sensitive to clostridal
collagenase but insensitive to elastase,trypsin and the reducing
agent dithioerythritol.
With an ever increasing knowledge of the structure and biochemical
composition of normal skin it is possible to examine abnormalities
and diseases of the skin, with a view to highlighting the causal
defect. Electron microscopy has proved a useful tool in the large
and heterogeneous EB group of diseases. Clearly some variants such
as the mild EBS Weber-Cockayne type do not require such sophisticated
technology for diagnosis but even so examination of the ultra-
structure of the skin from this group may provide a clue in the
pathogenesis of the disease. For this reason a number of skin





Twenty four patients were studied, 9 with EB simplex, 13 with
dystrophic EB and 2 with junctional EB (see Table 2 and 4 for details).
The clinical diagnosis, based on the patient's family and previous
history and signs of the disease at presentation* was proposed by
the attending physician. For comparisons with normal skin electron
micrographs from the collection at the Department of Dermatology,
Royal Infirmary, Edinburgh, were used.
PROCEDURE
The biopsy was halved: one half was prepared for tissue culture
(page 16 ) and the other, for electron microscopy, was immediately cut
into 1mm x 1mm pieces and immersed in 3% glutaraldehyde in 0.1M
sodium cacodylate buffer, with 2 drops of 1% calcium chloride (pH 7.k).
After 3 hours at room temperature the tissue was rinsed twice in 0.1M
cacodylate buffer (pH 7.4) where it remained overnight at 4°C. The
next day samples were post-fixed in 2% osmium oxide in distilled
water for 1 hour at 4°C. This was followed by dehydration of the
tissue by immersion in an ascending series of alcohols for 15 minute
periods; 70%, 95% and 4 changes of absolute ethanol. The samples
were then transferred into fresh Spurr resin comprising:
Vinyl cyclohexene dioxide (resin) 16.1 gms
Nonenyl succinic anhydride (hardener) 43.4 gms
Diglycidyl ether of propylene glycol (plasticiser) 9.8 gms
Dimethylaminoethanol (accelerator) 0.7 gms
'The resin was changed after 1 hour, 3 hours, 16 hours and 24
hours respectively, all at room temperature. The tissue was
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finally transferred to fresh resin, orientated in Taab Capsules, and
polymerised at 60°C for 2.k hours.
The blocks were sectioned on sin LKB ultratome III. Sections of
silver interference colour ( 50nm) were mounted on uncoated 200 mesh
copper grids. Routine staining was carried out using a saturated
solution of uranyl acetate in 70^ methanol for 10 minutes followed
by lead citrate (Reynolds, 1963) for 3 minutes. Sections were
examined using a Philips 301 electron microscope operating at an
accelerating voltage of 60 kV.
All processing for electron microscopy was very kindly performed




PATIENTS EXAMINED BY ELECTRON MICROSCOPY











Multiple duplication of the basal lamina
Some perinuclear oedema
Slight intracellular oedema in basal cells
Some duplication of the basal lamina
None
None
Cytolysis of the basal cell, numerous vacuoles
in the basal cells.
None






Abnormal hemidesmosomes, "torn off" phenomenon,


























• No anchoring fibrils seen, disrupted basal lamina
No anchoring fibrils seen
No anchoring fibrils seen
No anchoring fibrils seen
Basal lamina normal, anchoring fibrils present
though possibly rudimentary
Cleavage incomplete, anchoring fibrils present,
possible collagen dissolution
Single anchoring fibril present
Anchoring fibrils present, varying amounts of
material attached to the basal lamina
Some deposits of fibrillar material in the dermis,
basal lamina duplicated in places
Granular body in the dermis, duplication of basal
lamina, anchoring fibrils present
Basal lamina duplication, anchoring fibrils
present
Granular body in the dermis anchoring fibrils
present
Herniation of the basal lamina




As these biopsies were taken from clinically normal skin (except
EB32, which was taken from an involved site), blisters were not
evident; only in one patient EB23 did blistering arise spontaneously
during the biopsy procedure.
In the majority of EBS skin samples the ultrastructural changes
were minimal and comprised the following:
1) Perinuclear oedema in some but not all of the basal cells
(Figs. 13, 1*f).
2) Occasional perinuclear and cytoplasmic vacuolation (Fig. "1^+) •
Extensive cytoplasmic vacuolation and dissolution of the
cytoplasm in cells close to the cleavage site in EB32 (Fig. 15).
3) When cleavage was induced by the biopsy procedure (EB23), the
split occurred intra-basally; similarly where the biopsy was
taken from an involved site (EB32) blistering was at the same
level (Figs. 15> 16). The floor of the blister is composed
of fragmented basal cells (Fig. 16).
^) In one patient (EB32) striking granular globules were evident
in the upper layers of the stratum spinosum (^ig. 17). These
masses of electron-dense granular material were located in the
cytoplasm adjacent to the attachment plaque of the desmosomes;
possibly comprised of bundles of tonofibrils tightly clumped
together. Tonofibrils can be seen merging with the globules
(Fig. 17). Normal desmosomes and tonofibrils were seen in the
same section. In the same patient, there was further evidence
of granular clumping at the level of the blister roof (^ig. 15).
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KB Junctional-letalis
Skin taken from non-involved sites in two infants with junctional
KB blistered spontaneously during the biopsy procedure. Electron
l
microscopy showed:
1) The cleavage was between the basal cell plasma membrane and the
basal lamina. In the blister roof (Fig. 18) the plasma membrane
remained intact: hemidesmosomes, with anchoring filaments
still attached to them were visible, although few anchoring
filaments were to be seen other than in the region of the hemi-
desmosomes. The disrupted hemidesmosomes frequently lacked the
sub-basal electron-dense plaque, normally located immediately
beneath the hemidesmosomes; seen as a thin dark line in the
lamina lucida (Fig. 19).
2) Cleavage was not always "clean cut"; some darkly staining
fragments of the basal cell plasma membrane could be seen
attached to the basal lamina in the blister floor, their hemi-
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desmosomes intact (^ig. 20). The hemidesmosomes again lacked
the sub-basal plaque but anchoring filaments were present.
3) Perinuclear oedema and numerous vacuoles were striking features
of the basal cells in the blister roof (Fig. 21). The inter¬
cellular junctions, desraosomes, were normal in appearance:
the tonofilaments, dough present, were disrupted by the large
vacuoles of the basal keratinocytes.
4) The dermis of the blister floor (Fig. 20) appeared normal:
anchoring fibrils attached to the basal lamina, extended into
the dermis. The basal lamina was irregular and diffuse in
appearance; attached to it was some amorphous material and
possibly some anchoring filaments.
5^.
Some areas of the skin did remain intact. Although the
basement membrane zone looked normal at first sight some features
of interest were noted:
1) The plasma membrane attachment plaques of the hemidesmosomes
were of variable electron density and the hemidesmosomes lacked
the sub-basal electron-dense plaque (Fig. 22). Tonofibrils
were seen above the hemidesmosomes, within the cytoplasm. A
number of microcytotic vesicles were present in the cytoplasm
above the plasma membrane of the basal keratinocyte.
2) The basal lamina was discontinuous and of variable density:
some basal lamina duplication or malformation has occurred
(Fig. 23). Normal-looking anchoring fibrils were seen attached
to the basal lamina, at both levels, where duplication had
occurred.
3) There was no indication of an abnormality in the width of the
lamina lucida, which contained anchoring filaments and amorphous
material, neither of which appeared to be as dense beneath
the hemidesmosomes as they are in normal skin. Nor was there
any evidence of an abnormality within the dermis.
EB dystrophic recessive - Hallopeau Siemens
In patients with EBDr Hallopeau-Siemens it is very difficult to
obtain skin from a non-involved site. In all individuals except one,
the skin blistered just with the trauma of the biopsy procedure though
occasionally intact areas could be found.
1) The,place of cleavage was in the upper dermis just beneath the
basal lamina (Figs. 2k, 25). The epidermis looked normal.
The basal cells had normal desmosomes and hemidesmosomes. Their
cytoplasm was full of tonofibrils and a large number of densely
staining melanosomes. The intercellular space was wider than is
normal but such oedema may be expected in the roof of any blister
(Fig. 26). A contiguous basal lamina with some attached amorphous
material was seen at the under surface of the roof (Fig. 26) and
at higher magnification (Fig. 2k), appeared more diffuse and
disrupted. The lamina lucida was normal where the basal lamina
is well defined. Fine anchoring filaments were seen traversing
the lamina lucida and the electron-dense sub-basal plaque was
visible beneath the hemidesmosomes.
2) There was often very little evidence of anchoring fibrils
attached to the dermal aspect of the basal lamina, though it
is possible that k or 5 degenerative anchoring fibrils could be
discerned in Fig. 2k. This seemed characteristic of other areas
of the blister roof from this particular patient and of the other
patients examined. However in one patient, EB22, a single,
well defined fibril was evident (Fig. 27).
3) In the floor of the blister both large and small collagen fibrils
were to be seen randomly orientated within the dermis. Banding
could be seen on the thick collagen bundles even in the proximity
of the blister cavity, although there was some disruption of the
actual collagen bundles closest to the blister floor (Fig. 25).
Dermal separation was incomplete in just one patient, EB31, and
this provides interesting information concerning the pre-blistered
state of the dermis. At the apex of the narrower infolds or
involutions of the highly convoluted basal lamina, cross-banded
anchoring fibrils could be seen (Fig. 28). However elsewhere along
the basal lamina very few normal fibrils were visible although seme
degenerative fibrils may be present. The collagen of the dermis '
appeared to be undergoing focal degenerative changes and areas of
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few collagen fibres are filled with amorphous material; the fibres
themselves varied in electron density along their length, particularly
where they are located close to these regions of electron-lucent
amorphous material, although cross-banding was still clearly
discernible. Some variation in the diameter of the collagen fibres
was obvious, noticeably the particularly large fibre ~100 nm in width.
Stages of degeneration of the collagen fibres just beneath the
basal lamina was shown well in Figs. 28 and 29.
a) The beginning of degradation an area or focal point of electron
lucency in the collagen fibre; banding was still clearly visible.
b) Almost complete disruption of the collagen fibre; banding has
disappeared.
c) The complete disruption of the fibre.
Occasionally the formation of a blister cleft could be seen in
close proximity to an abnormal-looking fibroblast (Fig. 30). Again
interruption and disintegration of the collagen fibres was clearly
visible, especially in the remaining fibres spanning the cleft itself.
The fibroblast seemed to be undergoing cytolysis and a neighbouring
fibroblast, seen at higher magnification in Fig. 31, has undergone
complete cytolysis. Its plasma membrane could still be seen
surrounding the cavity.
This association of cleft formation with the presence of a
fibroblast was again seen in Fig. 32. Disintegration of collagen
could be seen above a fibroblast. The cytoplasm of this cell appears
more rarified than is usual, mitochondria and a number of vacuoles
are present.
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EB dystrophic dominant: Cockayne-Touraine
Only one skin sample taken from a non-predilected site in a
dominant dystrophic patient (EB7), blistered during the biopsy.
Generally the skin remained intact so the diagnosis was based on the
mode of inheritance and clinical features including whether previous
blistering had produced scarring and milia, the severity of blistering
and the absence of albopapuloid lesions on the body.
1) In the single blister examined the plane of cleavage was beneath
the basal lamina within the papillary dermis (Fig. 33) • The
basal cells, hemidesmosomes and anchoring filaments appeared to
be normal. The basal lamina itself was continuous and well
defined. Beneath the basal lamina amorphous material could be
seen. There was variation in the amount of tissue remaining
attached to the basal lamina after cleavage (Fig. jA). At
higher magnification, (Fig. 35), this material appeared to be
composed of anchoring fibrils and a large amount of fine fibrillar
material. The anchoring fibrils varied in appearance from
apparently normal to small, rudimentary fibrils. Some collagen
fibres with clear cross-banding could be seen in the blister
roof.
2) The blister floor shows two distinct populations of normal-
looking collagen fibres (Fig. 33). The thicker type I fibres,
diameter 75 nm, were separated by thinner, 10 nm diameter
type III fibres (Fig. 36). There was no evidence of collagen
degradation.
In the intact skin from the same patient, EB7, normal anchoring
fibrils were seen extending into the dermis (*ig. 37). In other
areas the fibrils were missing or of abnormal appearance. The
basal lamina was rather ill-defined in this section of intact skin.
The dermis appeared to be structurally normal. The intact skin.of
the other patients examined exhibited some interesting features:
1) The dermis of two adult patients, EB17 and 21, contained
filamentous-amorphous bodies (Figs. 38, 39) up to 5»3 pi in
diameter. Both were of fibrillar appearance but in Fig. 39' the
body had a densely-stained centre. The body itself was
surrounded by large collagen fibres and above it there has been
some disruption of the dermis; fine filamentous material was
visible, as well as some darkly-stained granular material.
Normal cross-banded anchoring fibrils were seen attached to the
basal lamina directly above the fibrillar body.
A dermal abnormality was also noted in the biopsy from EB16.
Fig. ^+0 illustrates this and shows condensed material within the
dermis, and fine amorphous material surrounding intact collagen
fibrils.
2) In three patients, EB16, 17 and 21, there was splitting or
duplication of the basal lamina (Fig. ^1). Unlike the duplication
often seen beneath melanocytes or dividing basal cells, the
basal lamina was of irregular thickness, becoming diffuse in
» '
areas and could be seen "trailing" down into the dermis,
particularly in Fig. kZ, This may be related to the
observation in Figs. 33 and 36 of some basal lamina apparently
deep v/ithin the dermis of a blister floor.
3) Yet another abnormality of the basal lamina could be seen in
Fig. The basal lamina, of irregular thickness and definition,
was interrupted by herniations of the overlying basal cells.
Otherwise normal hemidesmosomes, anchoring filaments and fibrils
were present. The dermis again contained ill-defined amorphous
material surrounding apparently normal collagen. A large
herniation, almost isolated in the dermis, with some disruption
























Ultrastructural examination of the skin from non-involved sites
of patients with EBS has only limited diagnostic value: clinical
assessment alone should be sufficient to distinguish the localised
Weber-Cockayne variety. However, in the more severe forms of EBS
where extensive blistering occurs, such as in EBS generalisata:
Koebner (Baker, 1982); or the recently recognised EB herpetiformis
Dowling-Meara (Gedde-Dahl, 1981; Niemi et al, 1983)* electron
microscopy is useful in confirming the diagnosis. The EB herpetiformis
Dowling-Meara variant can only be distinguished from other EBS variants
by examining the ultrastructure for the characteristic electron-dense
globules located in the upper epidermis*
Previous studies of Weber-Cockayne mild EBS involved the production
of fresh blisters by heating followed by friction (Haneke and Anton-
Lamprecht, 1982) or by friction alone (Pearson, 1967)* Interestingly,
the plane of cleavage in the experimentally induced blisters was not
the same as that of spontaneously developed blisters.
In the initial phase of blister formation (Haneke and Anton-
Lamprecht, 1982) reported oedema of the subnuclear cytoplasm to be
one of the characteristics; with "dilution" of the ribosome-rich
cytoplasm, in which small holes appeared and gradually enlarged.
Pearson (1967) described a similar change involving perinuclear
swelling, distortion of the organelles in that region and partial
loss of cytoplasmic constituents. Perinuclear oedema and cytoplasmic
vacuolation was clearly seen in the present study (Figs. 13i 1^).
Arguably this could be an artefact of fixation; however this is
unlikely as cells in a different area but from the same section
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appeared normal (Fig. 58).
In this study, no changes in the tonofilaments were seen in the
mild EBS Weber-Cockayne skin, in contrast to Haneke and Anton-
Lamprecht (1982), who suggested that the tonofilaments were slightly
more condensed than normal in sin induced blister from the skin of
mild EBS. As friction and heat can produce such changes in the tono¬
filaments (Pearson, 1965; Hunter et al, 197^), the importance of
condensed tonofilaments in EBS is questionable.
The discrepancy between the level of cleavage in spontaneous
and induced blisters is interesting. Haneke and Anton-Lamprecht
(1982) found the plane of cleavage of induced blisters to be through
the basal cells, whilst spontaneous blisters occurred at or between
the horny and granular layer: Hintner et al (1981), using immuno-
fluorescent staining of antigenefcic determinants to components of the
epidermis showed the supra-basal split to be between the stratum corneum
and stratum granulosum in EBS. It seems that unless experimentally
induced, presumably thereby exploiting a pathogenetic defect,
blistering in mild EBS occurs at a higher level than the basal cell
layer. In other forms of EBS the defect in the basal cells may be
more severe, consequently blister formation occurs at this level
following trauma (Baker, 1982). A clue to the nature of the
pathogenetic defect may lie with the observations of Niemi and
Kanerva (1981): the distension of the rough endoplasmic reticulum
and enlargement of the mitochondria could indicate the over-production
of protein, perhaps a protease, resulting in the abnormalities
associated with EBS.
Niemi et al (1983) described the abnormal tonofilament formation
of irregular electron-dense globules, now recognised as the primary
diagnostic feature of EBS herpetiformis Dowling-Meara (Fig. 17). The
development of these abnormal structures is unlikely to be an artefact
as some relatively normal desmosomes can be seen in surrounding cells.
Such clumping of tonofilaments has also been noted in epidermolytic
hyperkeratosis (bullous ichthyosiform erythroderma) (Niemi et al, 1983).
The relevance of this feature to the intra-basal cell cleavage seen
in this variant remains a mystery.
Junctional SB - letalis
Five types of junctional EB have been recorded (Gedde-Dahl, 1981);
the two cases examined here, (siblings), fit the group described by
Herlitz (1955)> i.e. EB hereditaria letalis.
Pearson (1962, 1967) was amongst the first to establish by
electron microscopy that the blister occurred between the plasma
membrane and the basal lamina, and that consequently this group was
a separate entity from both the simplex and dystrophic groups.
Recently Hashimoto et al (1976a) and Anton-Lamprecht and Schnyder
(1979) have conducted more detailed electron microphotography studies
and conclude that abnormalities of the hemidesmosomes are the primary
causal defect in this variety of EB. The evidence frofn this current
study supports an abnormality of the hemidesmosomes but indicates
that this may not be the primary defect.
The presence of abnormal hemidesmosomes, having a rudimentary
attachment plaque in the plasma membrane and lacking the sub-basal
dense plaque, agrees with the findings of Rodeck et al (1980). This
could indicate an abnormality in the mode of attachment of the anchoring
filament to the hemidesmosome; representing a weak link in the
attachment of epidermis to dermis. However it is uncertain whether
the lack of a substantial sub-basal plaque affects attachment of
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filament to hemidesmosome, as some amorphous material, which may
include anchoring filaments, remains attached to the heraidesmosomes
following cleavage. This was also noted by Pearson et al (197*0 •
Furthermore the "torn off" phenomenon described by Hashimoto
et al (1976a) and illustrated by Fig. 20, suggests either that not
all hemidesmosomes have the same inherent weakness; or that the
abnormality in structure is not as crucial as has been supposed.
The lack of a sub-basal plaque at these sites, has not apparently
weakened the bonding of plasma membrane to basal lamina. Disruption
of the plasma membrane itself has had to occur before dermo-epidermal
separation could take place. The significance of abnormal hemi-
desmosomes is still further questioned by the finding that junctional
cleavage can occur where hemidesmosoraes are structurally and
numerically normal (Tidman and Eady, 1983).
The significance of the microcytotic vesicles is uncertain.
They are related to the lysosomal, system: possibly having the
potential to release lysosomal enzymes, capable of degrading
collagen, proteoglycans and protein (Lazarus et al, 1975; Etherington,
1977).
Further evidence that the causal abnormality may be within the
basal cell itself comes from the presence of numerous vacuoles and
disruption of the cytoplasmic inclusions (^ig. 21) in areas of
separation. This is unlikely to have been fixation artefact in
material that was otherwise well fixed, not all cells had marked
perinuclear oedema, or abnormal cytoplasm: Pearson (1962) mentions
vacuoles present in basal cells of intact skin. Moreover he mentions
that electron microscopic observations were "impaired by the lack of
good cellular detail"; with the significant addendum that he did not
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think poor fixation and processing to be responsible as other
material processed simultaneously did not show such abnormalities.
Hashimoto et al (1976a) also referred to such basal cell abnormalities
but regarded them as secondary.
It is therefore conceivable that the causal defect lies within
the basal cell itself, perhaps over production of a protease, which
consequently could cause changes in the structural integrity of the
hemidesmosomes and/or disruption of the underlying anchoring filaments.
Only the slightest trauma would then be necessary to cause blistering.
Obviously further work on enzyme production, or control, in the basal
cells of patients suffering from junctional EB is necessary to confirm
whether the causal factor is simply hemidesmosome abnormality, or
whether lysosomal enzymes are involved. If an abnormality of the
hemidesmosomes is the primary defect then some abnormalities in
desmosome formation might be expected elsewhere in the basal cell
layer; this is not apparent in this study. Bauer and Eisen (1978)
found increased levels of collagenase activity in vivo but not in
vitro in junctional EB; this they regarded as a secondary effect
due to chronic wound healing. The significance of this finding,
along with the possibility of abnormal enzyme production in the
epidermis remains to be answered.
EBDr - Hallopeau-Siemens
Until recently there has been some controversy regarding the
primary causative factor in the aetiology of EBDr Hallopeau-Siemens.
Pearson (1962) suggested that the marked degeneration of dermal
collagen might be due to the presence of abnormal collagen or that a
"collagenase-like" substance might be active. This hypothesis was
substantiated by the findings of Eisen (1969b) who found collagenase
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levels to be increased six fold above the normal. However Briggaman
and Wheeler (1975)» extending their work on the formation of anchoring
fibrils and basal lamina in skin (1971)» conducted a series of
epidermal-dermal recombination experiments using EBDr and normal
skin. By replacing EBDr epidermis on normal dermis and vice versa,
they showed that EBDr dermis was not capable of producing anchoring
fibrils and consequently concluded that the primary defect lay, not
with excess collagenase production, but with impaired formation of
anchoring fibrils.
More recently, following extensive ultrastructural studies on
EBDr, Hashimoto et al (1976b) concluded that the collagen and
anchoring fibril degradation was secondary to the primary defect,
probably related to an increase of skin collagenase activity. This
would fit in with the findings of Eisen (1969b) and Bauer (1977b)
who found high collagenase levels in patients with EBDr.
The ultrastructural findings of this study are similar to those
of Pearson (1962) and Hashimoto et al (1976b). Cleavage of the skin
occurs in the upper papillary dermis just beneath the basal lamina.
The basal lamina though often ill-defined is usually continuous. Its
lack of definition in the blister roof may well be due to the trauma
of blistering, oedema of the blister cavity placing the roof under
stress.
Where blistering has occurred, only amorphous material can be
seen attached to the dermal aspect of the basal lamina. Anchoring
fibrils were rarely identified in the blister roof of severe cases.
This does not however rule out their presence in non-blistered skin
of EBDr patients and, indeed, on examination of intact skin from
one patient with milder expression, cross-banded and apparently
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normal anchoring fibrils could be seen at the apex of tight
involutions of the basal lamina. Such regions may be protected
by the topography of the skin and therefore less susceptible to
I
attack by collagenolytic enzymes.
The findings of Briggaman and Wheeler (1975) nay have been
misinterpreted. It seems possible that hormal anchoring fibrils do
not develop in EBDr dermis because the collagenolytic enzyme content
of the dermis does not allow their normal formation rather than
because the dermis is incapable of producing the fibrils.
Further evidence for collagenase being the primary causative
agent can be found by examination of the collagen fibres of the
papillary dermis where they appear to be in various stages of
dissolution. Although this might relate to the angle at which the
block has been cut, or the orientation and conformation of the
collagen fibres themselves, it does seem that in several instances
interrupted collagen fibres are connected by a line of amorphous
material, indicating that dissolution of the fibres has occurred.
Also, in agreement with Pearson (1962), a number of unusually thick
collagen fibrils were seen. Phagocytosis of these larger fibrils
was not however observed, in contrast to his report. The significance
of these larger fibres is uncertain.
The association of degenerative changes in a fibroblast, as
seen in Fig. 30» with the apparent beginning of cleavage formation
and dissolution of collagen in the surrounding dermis is of
particular interest. It could be argued that the degenerative
changes in the fibroblast are due to artefacts of fixation. This
specimen has indeed suffered from poor fixation, as indicated by
the state of the mitochondria in the overlying basal cells of the
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epidermis. However it seems unlikely that the complete destruction
of a fibroblast should have occurred (Fig. 31) in the same section
as another unaffected fibroblast (Fig. 32). Fig. 30 shows the
degenerative changes occurring both within and around a fibroblast.
Perhaps the dissolution of the surrounding collagen combined with
degeneration of dermal fibroblasts, together weaken the upper
dermis to such an extent that even the slightest trauma causes
cleavage within the skin.
It therefore seems likely that dissolution of the collagen
fibrils and anchoring fibrils are the main causative factors in
blister formation in EBDr. The presence of degenerating fibroblasts
in the upper dermis and the disintegration of collagen in the immediate
proximity of these cells also indicate that the fibroblasts are the
most probable source of active collagenase and other proteases.
The evidence from this study suggests that the dermis of EBDr
patients can produce anchoring fibrils but that they are probably
destroyed on exposure to the active collagenase of the dermis. This
is substantiated by the work of Kobayasi et al (1977)» who showed
that the anchoring fibrils were indeed sensitive to bacterial
collagenase.
An abnormality in collagen synthesis cannot be discounted.
Larger fibrils are present in the dermis, though this may not be
significant in blister formation unless the fibrils themselves are
more susceptible to enzyme attack. However there is no evidence to
support this view.
EBDD - Cockayne-Touraine
There have been few ultrastruetural reports on either the
dominant dystrophic Pasini or Cockayne-Touraine types of EB, but
Hashimoto et al (1975» 1976c) studied k patients of each type. They
thought that the anchoring fibrils were of the utmost importance in
the Pasini type, being rudimentary in areas of non-predilection as
well as at sites of blister formation. Furthermore, they concluded
that the mechanism of blistering was the same in both dominant
dystrophic types, having found that anchoring fibrils were markedly
reduced in predilected sites, but normal or only mildly reduced in
non-predilected sites of the Cockayne-Touraine type. Although the
assumption that more numerous rudimentary anchoring fibrils would
reflect increased severity of clinical expression seems logical, this
was not found. The significance of anchoring fibril numbers for
the integrity of skin is further questioned by the work of Tidman and
his colleagues (1983)* Their morphometric studies on anchoring
fibrils show that, ail though there is no difference between the sexes,
there are regional differences over the body - fewer anchoring fibrils
being found in the arm compared with the thigh or lower leg.
The present study has involved only the Cockayne-Touraine type
of dominant dystrophic EB, none of the patients having the albo-
papuloid papules on their trunk - which distinguish the Pasini type.
The findings of this study differ from those of Hashimoto et al
(1976c) with regard to the relevance of the anchoring fibrils in
blistering. Normal anchoring fibrils can be clearly seen in the roof
of a blister (Fig. 35) t as well as longer thinner fibrils (Fig. 33)•
This is in contrast to Hashimoto et al (1976c) who could not
demonstrate anchoring fibrils in blistered areas of skin. Furthermore
the presence of large cross-banded collagen fibres in the blister
roof (Fig. 35) indicates that cleavage can occur at a lower level
than the dermal anchoring site of the fibrils. This is substantiated
by the varying amounts of amorphous material located in the blister
roof (Fig. 34), indicating that cleavage is not simply related to
the defective structure of the anchoring fibrils. However it seems
that the anchoring fibril attachment site is disrupted in some
instances, as indicated by the fan-like filamentous ends of the
fibrils being free in the blister roof.
Other abnormalities of the patients in this study, include the
presence of quantities of filamentous-amorphous material surrounding
the dermal collagen in all of the patients; the presence of large
fibrillar bodies in two of the adult patients, and abnormalities of
the basal lamina in three of the patients.
The presence of filamentous material and amorphous bodies are
noteworthy. Fibrillar bodies were noticed in the dermis of the
Pasini type patients of Hashimoto et al (1975)« He concluded that
these bodies were related to the basal lamina; suggesting that they
might be derived from the herniated portions of the basal cells, with
subsequent reparation of the basal lamina resulting in duplication.
However in our patients exhibiting such bodies there was no evidence
of basal lamina herniation; although in one patient, EB25, herniation
and protrusions of the basal cells into the dermis were evident, but
no large fibrillar bodies were seen. Such findings suggest that the
Cockayne-Touraine variety of EB has a similar pathogenetic origin
to the Pasini variety, differing only in its milder clinical
expression, and absence of papules on the trunk. The lack of papules
may represent a less significant disturbance of GAG levels in the
skin, the Pasini type having been shown to involve an impaired
degradation of GAG in the skin (Sasai et ail, 1973; Endo et al,
1974; Bauer et al, 1979). Perhaps the filamentous, amorphous
material seen amongst the collagen fibres of the dermis (Fig. 36).
represents a peculiarity in GAG metabolism which may be related to
the fibrillar bodies. A disturbance in GAG metabolism could affect
the integrity of the dermis by altering collagen-GAG interaction,
with consequent aberrant fibril formation (Mathews, 1965; Mathews
ana Decker, 1968). The attachment of the anchoring fibrils to such
abnormal collagen fibres might then be destabilised, allowing cleavage
of the dermis to occur. A similar mechanism may also be at work in
the basal lamina, disrupting the stable meshwork of the Type IV
collagen, thus enabling herniations to occur, as well as the
splitting and duplication of the basal lamina seen in Figs. ^0, .
The cause of blister formation in dominant dystrophic patients
therefore seems to be far more complex than simply the anchoring
fibril defects and reduction in their numbers, suggested by Hashimoto
et al (1976c); if, indeed, they are involved in blister formation at
all. The cause may be in the over production and reduced degradation
of GAGs, which interact to cause aberrant collagen production,
whether it be the collagenous component of the anchoring fibrils,
the basal lamina itself, or the Type I and III collagens of the
dermis.
SUMMARY
Electron microscopy was used to examine skin biopsies from
patients with EB and was primarily helpful in distinguishing k main
groups, but also provided evidence to suggest certain pathogenetic
mechanisms.
EBS
Diagnosis of the Dowling-Meara Herpetiformis variant can only
be made by EM. Intra-epidermal blistering was provoked by the biopsy
procedure in the severer EBS Koebner and Dowling-Meara Herpetiformis,
but in mild EBS only cytoplasmic dilution, perinuclear oedema and
distortion of the organelles in keratinocytes were seen. In mild EBS
a defect may arise within the basal cell that is not expressed until
temperature, or friction, causes cleavage higher in the epidermis;
whilst in severe EBS the defect cannot be adequately compensated for,
and blistering consequently occurs in the basal cell layer.
EBL
Although structurally abnormal hemidesmosomes were seen,
lacking the sub-basal electron-dense plaque, it was suggested that
this is not the primary defect because a) anchoring filaments are
still attached to hemidesmosomes in the roof of the blister and
b) the "torn off" phenomenon illustrates that hemidesmosor© attachment
is sufficiently secure to withstand the trauma of cleavage. The
significance of microcytotic vesicles is questioned, particularly if
the primary defect lies within the basal cell itself, possibly em
abnormality in metabolism of a protease(s), eventually disrupting
components of the lamina lucida.
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EBDr
The suggestion that absence of anchoring fibrils might be the
primary defect in EBDr is questioned. Anchoring fibrils are present
in mild EBDr and their frequent absence in blister roofs may be due
to their destruction, perhaps because of elevated collagenase and/or
other protease levels. There is some evidence of collagen dissolution
and fibroblast degeneration in mild EBDr where cleavage has not yet
occurred. It is proposed that increased collagenase activity, and/or
other proteases, is responsible for the apparent lack of anchoring
fibrils, disruption of the dermis and blister formation.
EBDD
A similar pathogenesis is considered for Cockayne-Touraine and
Pasini EBDD, comparing these findings to the published reports on
the Pasini variant. Whether the anchoring fibrils are the primary
causal defect is questionable as they are present in intact, and in
the roof of blistered skin. An abnormality of the basal lamina is
suspected, being malformed and discontinuous in places enabling
herniations of the basal keratinocyte into the dermis to occur.
Fibrillar bodies are present in two of the patients studied. The
amount of amorphous material seen, may relate to a GAG abnormality
and may interfere with collagen metabolism - perhaps causing an





Collagen is a major structural component of the body, being
found in skin, bone, dentine and cartilage. It is invariably an
extracellular protein, providing a scaffolding, or matrix around
which tissues and organs can be organised. The form of the matrix
is largely dependent on the type of constituent collagen and its
interactions with the other components. There are known to be at
least six different types of collagen, all having the same basic
structure: three intertwined, helical chains composed of repeating
triplet amino acid sequences (reviewed by Woodhead-Galloway, 1980;
Weiss and Jayson, 1983).
Skin fibroblasts produce fibrillar collagen, which together with
glycosaminoglycans and various glycoproteins, notably fibronectin,
constitute the dermal matrix. In man 72% of the dermis, by weight,
is composed of collagen, which is predominantly of fibrillar collagen
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Types I (85-90%) and III (10-15%) and is divided into papillary and
reticular regions by the orientation and thickness of the collagen
fibres. Disruption of the basic scaffolding must necessarily have
severe consequences for the structural integrity of the skin, as is
the case with recessively inherited dermolytic EB. It is therefore
vital to investigate and understand collagen metabolism in the skin
of patients with EB, in order to further our knowledge of the disease.
Basic structure of collagen
The basic unit of a collagen fibre is a triple helical molecule
composed of three peptide chains, known as alpha (°<) chains. Each
chain contains numerous repeating sequences in which every third
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amino acid is glycine (Gly-X-Y). The "X" position in the triplet is
frequently proline, which represents 109° of the total amino acids in
collagen. The "Y" position is frequently occupied by hydroxyproline,
which is produced by post-translational modification of proline.
• l
Similarly lysine and hydroxylysine are commonly found in X - Y positions
(reviewed by Prockop, 1980, 1982).
These triplets determine the folding of the chains into a unique
triple helical conformation. Proline and hydroxyproline, because
of their ring structure give the triple helix its rigidity. Glycine,
the smallest amino acid, fits into the restricted space where all three
chains come into contact at the middle of the triple helix, explaining
the necessity for the recurring triple amino acid sequence. Where X and
Y positions axe occupied by amino acids other than proline and hydroxy-
proline, they provide precisely-positioned reactive groups that
determine lateral and longitudinal assembly of the molecules into
fibres. Differences between the various classes of collagen are due to
subtle differences in amino acid sequence.
(Gly-X-Y)-(Gly-X-Y)-(Gly-X-Y) cX chain
3 chains: collagen molecule
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Four major classes of collagen are now recognised and 6 unique
collagen types are distinguished by differences in £< chain composition
and conformation of the collagen molecule. Types I, III, IV and to a
lesser extent V are constituents of skin. Type I, produced by the
fibroblasts of the dermis, comprises §0-90$ of the total collagenous
protein, Type III 10-15& and Types IV and V constitute less than 3%
(Epstein and Munderloh, 1978; Uitto et ail, 1980). Type I collagen
is located throughout the dermis. Although Type III was once thought
to be restricted to the papillary dermis (Fleishmajer et al, 1980), it
is now thought to be found throughout the dermis (Epstein and Munderloh,
1978; Fleishmajer et al, 1981). Type IV collagen is confined to the
basement membrane of the dermo-epidermal junction, more specifically
to the basal lamina (Foidart and Yaar, 1981). Type V is also
associated with the basal lamina but may not be em integral component:
it is thought to be associated with cell surfaces and is not restricted
to the skin. The precise nature and function of this collagen is still
largely unknown (reviewed by Sage, 1982).
Types I and III are typically fibrillar collagens, being composed
of parallel arrays of collagen molecules due to their ability to form
and maintain extensive interactions along the length of the triple
helix. Type I collagen is a heterpolymer consisting of two identical
oil (1) chains and one genetically distinct 2 chain (Piez et al, 1963).
A Type I trimer has also been reported (Uitto, 1979) in which three
1 chains rich in hydroxylysine are folded together.
Type III collagen exists solely as a trimer. Although it was
thought that the chains were joined by disulphide bonds, it is now
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Type IV collagen (pages ^5-^7 ) differs from the fibrillar
types I and III, being more of an amorphous felt-like matrix (Sage,
1982), the basic unit being a heteropolymer (Crouch et al, 1980).
Recently, however, tetramers of Type IV collagen have been identified
(Duncan et al, 1983)• Because glycine is not present in every third
triplet sequence of amino- acids in Type IV collagen, there is distortion
of the triple helical structure producing regions of non-helical form
(Bornstein and Sage, 1980). It is currently thought that the Type IV
molecules form an interlocking network via the association of the
amino helical ends of each of four molecules. This alignment of
molecules produces a stable protease-resistant "73" region, so called
because of its sedimentation coefficient (Kuhn et al, 1981). The
carboxy-terminal globular domains are free to interact with like
regions of adjacent molecules, thus completing the network, as
illustrated in the following diagram.
BASEMENT MEMBRANE
TYPE IV COLLAGEN
(Timpl et al, 1981)
A hODiiL FOR THE ARRANGntaiiNT ."YiPS I v COi-LLjAuiut I'iOLSGULno IS II*.-
BASEMENT MEMBRANE
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The regions of non-helical structural domain increase the
flexibility of the molecule and may enable a'greater interaction
with non-collagenous components of the basement membrane, such as
fibronectin and bullous pemphigoid antigen.
Both Type I and III collagens are susceptible to human skin
collagenase, which specifically cleaves the triple helix at a site
one quarter of the molecule's length, 300 nm from the NH^ terminal.
Type IV collagen is resistant to the attack of human skin collagenase
(Welgus et al, 1981) but some endogenous proteases can degrade
basement membrane collagen (Liotta et al, 1979).
Synthesis of Collagen
Collagen synthesis by skin fibroblasts is a complex and highly
regulated orchestration of intracellular and extracellular events.
It has been well reviewed by Fessler and Fessler (1978), Prockop
et al (1979)» Prockop (1982) and Bauer and Uitto (1982).
Each of the genetically distinct collagen types is synthesized
as a procollagen precursor molecule, composed of pro (X chains longer
than the final product due to the presence of additional propeptides,
as illustrated in the diagram below.
DIAGRAM OF PRO-COLLAGEN MOLECULE
N-TERMINAL
GLOBULAR DOMAIN TRIPLE-HELICAL DOMAIN







Following transcription of the gene for a particular oi. chain
and modification of the resulting heterogeneous nucleic RNA, messenger
RNA is translated on the rough endoplasmic reticulum to produce single c<i
chains. These chains then undergo hydroxylation regulated by prolyl
and lysyl hydroxylase. Some of the proline and lysine residues are
thus converted to hydroxyproline and hydroxylysine respectively.
Ascorbic acid (vitamin C) is an essential cofactor for the hydroxylation
of proline (Booth and Uitto, 1981). At this early stage glycosylation
also occurs, galactosyl residues being attached to the chains by
galactotransferase, followed by the attachment of glucose to certain
galactosyl residues. The degree of glycosylation is affected by
both the primary structure and the rate of triple helix formation.
Type I procollagen requires 10 minutes for the chains to form a triple
helix, and exhibits least glycosylation. In contrast Type IV pro¬
collagen is rich in glycosylated hydroxylysine residues, requiring
60 minutes for triple helix formation (reviewed by Bauer and Uitto,
1982).
Preliminary association of the three c( chains occurs by way of
disulphide bonds between the half-cystine residues on the carboxy
terminal extensions of the pro c* chains, before the triple helix can
form. The procollagen molecule is then transported across the
plasma membrane of the fibroblast and further modification occurs
extracellularly. The procollagen is soluble at this stage, but once
conversion to collagen occurs precipitation is spontaneous. Goldberg
(1979; 1982) has recently isolated an unidentified glycoprotein on
the fibroblast (3T3) plasma membrane which acts as a specific
collagen binding site and is presumed to participate in some phase
of the extracellular maturation of collagen. Specific procollagen
peptidases remove the amino and carboxy terminal extensions from the
procollagen of Types I, II and III. In contrast Type IV apparently
retains large non-helical structural domains removed from the fibrillar
types of collagen at this stage (Grouch and Bornstein, 1979). The
model proposed by Goldberg and Burgeson (1982) for subsequent collagen
fibrillogenesis supposes that once soluble surface-bound collagen
aggregates reach a limiting size, they detach from the cell and then
combine to form insoluble fibrils.
Lysyl oxidase then facilitates the conversion of lysine and
hydroxylysine to corresponding aldehydes, which can interact with
similar residues on other fibrils to form a covalent cross-link (Siegel
and Fu, 1976). As collagen matures in the skin and the number of
cross-links increase, it becomes increasingly insoluble.
Regulation of Collagen Synthesis
Such a hierarchical assembly of several different types of
collagen by skin fibroblasts requires an extremely complex regulatory
system. Regulation of synthesis operates at any stage in the pathway,
from the nuclear events of gene selection transcription and processing
f '
of the messenger RNA, to the cytoplasmic hydroxylation and glycosylation
to the extracellular events of propeptide cleavage and fibril
formation (reviewed by Pinnell, 1982). See Table 6 for a summary of
the steps in metabolic processing.
As well as endogenous regulation of collagen synthesis, many
exogenous factors play an equally important role. The importance of
ascorbate in the hydroxylation of proline is fully recognised
(Peterkovsky, 1972; Murad et al, 1980). Ascorbate acts primarily
on the amount of hydroxyproline synthesised rather than on the amount
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of prolyl hydroxylase (Booth and Uitto, 1981). Ascorbate therefore
directly affects the efficiency of triple helix formation and the
subsequent secretion of procollagen.
Metal cofactors are equally important, ferrous iron and manganese
being necessary for hydroxylation and glycosylation while calcium and
copper are vital for the extracellular metabolic events.
Using human skin fibroblasts in culture as a model (Freiberger
et al, 1980; Booth et al, 198O; Uitto et al, 1980; Booth and Uitto,
1981) it caui be shown that hormones and serum-borne factors influence
collagen synthesis. Tan et al (1981) showed that normal human serum
could stimulate synthesis of procollagens Type I and III. Conversely
the amino terminal extension propeptides of procollagen Types I and III
inhibit Type I procollagen synthesis (Wiestner et al, 1979)» and proline
analogues inhibit procollagen production (Tan et al, 1983). Parathyroid
hormone specifically inhibits collagen synthesis by decreasing levels
of procollagen messenger RNA (Kream et al, 1980).
However, in the in vitro model system for collagen synthesis,
artificial constraints amd conditions are automatically introduced,
such as the composition of culture medium, cell density and pH. Most
of these parameters are now well documented and understood (Booth et
al, 198O; Freiberger et al, 1980). Optimal Type I and III procollagen
synthesis is achieved in "complete" medium containing 2C$ foetal calf
serum, supplemented with 25-50 pg/ml ascorbic acid, at a pH between
7.5 and 7.8 and synthesis is maximal just after visual confluency.
Earlier, Steinberg (1973) showed that in relation to total new protein,
collagen synthesis was less in logarithmically growing, than in
stationary phase cultures.
The effects of both density and cellular ageing have been examined
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in normal and keloid skin fibroblasts (McCoy et al, 1982). A gradual
decrease in collagen synthesis with ageing in culture, was found in
both normal and keloid cells, despite the latter having elevated
levels of collagen synthesis. Therefore in considering collagen
synthesis in vitro it is important to be aware of the constraints
imposed by the system.
Interactions of Collagen
Collagen has important interactions with other constituents of
the dermis, particularly fibronectin and glycosaminoglycans (GAG).
The role of fibronectin in cell attachment to collagen has been
comprehensively reviewed (Kleinman et al, 1981; Kleinman and Wilkes,
1982). Briefly fibronectin is a large glycoprotein (220,000 daltons)
found on the cell surface and in extracellular matrices. It is now
well established that fibronectin plays a role both in vivo and
in vitro in fibroblast attachment to collagen, having specific domains
for collagen binding (Ruoslahti et al, 1982). Binding to collagen
occurs along the fibre's length with a regular periodicity (Furcht, 1980).
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FIG. k5 COLLAGEN-FIBRONECTIN-CELL INTERACTION
Diagram showing the interaction between a collagen fibre and the surface
of a fibroblast. The collagen contains specific sites to which fibronectin
binds: the fibronectin contains another region that specifically
recognises the cell surface.
(Kleinman et al, 1981)
Fibronectin is an important component of adhesive interactions
in vivo (Fig. 45) and is most likely to be equally significant in
cell-matrix interactions in vivo.
I
The interaction of collagen with GAG is not yet fully understood.
However it is clear that the hydrated GAG gel interacts with the
collagen fibres of the dermis to provide tensile strength with
flexibility. The binding of GAG to collagen by electrostatic
interaction has been reviewed (Lindahl and Hook, 1978). Mathews
(1965) proposed a model for such an interaction between chondroitin
sulphate and collagen, in 'which the protein cere of the GAG was aligned
with the collagen molecules by way of the chondroitin sulphate side
chains, oucn interactions•may oe an mporcant xaccor in chs organisation
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and functioning of connective tissue during growth and development
(Mathews and Decker, 1968).
t
Effects of Phenytoin on Collagen
The relationship between phenytoin and collagenase is dealt with
in Chapter k. Phenytoin, an anticonvulsant drug (Merrit and Putnam,
1938), was found to cause hypertrophy of the gums in some epileptic
patients (Aas, 1963). Amongst its other properties was improvement
of wound healing (Shafer et al, 1958)".
The early investigations (Houck et al, 1960; Houck, 1962, 1965;
Bright, 1963) showed that phenytoin altered the chemistry of the skin,
notably by increasing collagen content. Two alternative but not
mutually exclusive explanations were proposed: the excess of collagen
could be due to an increase in collagen synthesis (Hassell et al, 1976,
1982) or to a decrease in collagen degradation (Bergenholtz and Hanstrom,
1979; Hanstrom et al, 1979).
Fibroblasts removed from the hypertrophic gingivae of five
epileptics exhibited a two-fold increase in protein synthesis, 20%
of the protein synthesised by the affected cells being collagen
compared to the 11% of the total protein produced by control cells
(Hassell et al, 1976). This suggested that the drug selects for,
or induces, fibroblasts with enhanced levels of protein synthesis
and collagen production. This work did not exclude the possibility
that collagen degradation was altered or that both synthesis and
degradation were affected. Hassell (1982) confirmed that there was
more extracellular protein in cultures of fibroblasts from hypertrophic
gingivae, including elevated amounts of collagenase compared with
normal controls. However the collagenase was less active than that
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from untreated controls. Reduced degradation, combined with increased
synthesis of collagen, are therefore important actions of phenytoin
on human gingival fibroblasts in some epileptics.
Bergenholtz and ^anstrom (1979)» using cat palatal mucosa in
organ culture, showed that up to 20 pg/ml phenytoin had no influence
on collagen synthesis. This agrees with some of the results of Hassell
et al (1976), who showed that collagen synthesis was not affected by
5 ^g/ml phenytoin in fibroblasts from non-responding patients i.e.
epileptics who did not develop gingival hypertrophy, and fibroblasts
from normal human gingivae. Similarly Blumenkranz and Asboe-Hansen
(197*0 found no change in collagen synthesis by chick embryo tibiae
fibroblasts at kk jig/ml: only at high concentrations 137 ?ig/ml was
collagen production inhibited (500 juM). Bergenholtz and Hanstrom
(1979) did find a selective increase in accumulation of mature collagen
over newly synthesised collagens, indicating an effect of the drug on
degradation.
Hanstrom et al (1979) also considered the effect of phenytoin
on enzyme release in relation to collagen degradation in the feline
palatal mucosa, using ^-glucuronidase and lactate dehydrogenase as
markers for lysosomal and cytosolic enzymes respectively. The
activities of both enzymes were reduced on treatment with phenytoin,
suggesting that the drug might have a non-specific effect upon
membrane function. This agrees with the findings of Perry et al
(1978), who showed that phenytoin blocked the resting sodium channels
of the membrane, causing hyper-polarisation and reducing intracellular
calcium.
Hanstrom et al (1979) suggested that the reduction in lysosomal
enzyme activity, caused by phenytoin, might affect collagenase
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activity because less protease would be available to activate latent
collagenase. Although this partially explains the findings of Hassell
(1982), this does not indicate why the collagenase produced is of a
lower activity following in vitro activation by trypsin. It is possible
that phenytoin causes the production of an aberrant collagenase, or an
increase in an endogenous inhibitor of collagenase activity.
Collagen Investigations
As the collagen status of EB fibroblasts had not been studied
the following experiments were designed to establish whether their
collagen synthesis was comparable with that of normal control
fibroblast lines. A reduction in synthesis could exaggerate the
effect of increased collagenase activity by exacerbating the imbalance
between enzyme and substrate.
The effect of phenytoin and vitamin E on collagen synthesis is
relative and absolute terms was also examined using skin fibroblasts.
This was done to determine whether the response of skin fibroblasts
to phenytoin is similar to that already described for gingival fibro¬
blasts (Hassell et al, 1976) and cat palatal mucosa (Bergenholtz and
Hanstrom, 1979). The effect of vitamin E on collagen synthesis in




Three cell lines, a control, an EBS an EBDr or smother (EBDD,
EBL), from donors of similar ages, were seeded in complete medium
containing 10^ foetal calf serum into each of seven plastic culture
dishes. Each dish (Linbro; Flow Laboratories, Paisley), had 6 flat-
bottomed wells with a surface area of 9,62 cm per well and received
105 cells/well. The dishes were incubated at 37°C in a 5% C0^ : air
atmosphere. After two days the cells received medium with 1C$o foetsil
calf serum supplemented with 50 pg/ml ascorbic acid. Forty eight hours
later 10 ju Ci/ml (5-^H)proline in medium with 2% foetal calf serum
and 50 pg/ml ascorbic acid but without antibiotics, was added at 1 ml/
well to 5 of the 7 dishes. The remaining dishes received identical
treatment but without the (^H)proline. All the dishes were incubated
as before for 2k hours. The unlabelled dishes were then used for
cell counts.
The 5 radioactively-labelled dishes were cooled to 4°G and the
medium was removed. The cells were rinsed with 1 ml of phosphate
buffered saline which was added to the medium. The cells were swollen
with 1 ml of distilled water at k°C for 30 minutes, after which they
were removed from the dishes and effectively homogenised with a jet
of distilled water dispensed through a fine hypodermic needle several
times. Trichloroacetic acid (TCA) was added to both the medium and
cellular fractions, to give a final concentration of 3% and
precipitate protein at k°C.
The resulting protein precipitates were collected by
centrifugation at 2000 rpm (4°C) and washed successively with
ethanol containing 2% sodium acetate, ethanol-ether (3:1) and ether.
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The dried protein pellets were then redissolved in 0.5 mis 0.2N KOH,
neutralised with 0.2 mis of 0.4N HC1 and diluted with 2 mis of Tris-
HC1 buffer containing 10 m>l calcium chloride and 10 mM N-ethyl
I
maleamide (NEM) (Sigma Chemical Co.) pH 7.6. Each fraction was
subsequently divided into two equal aliquots, one of which received
100 units of collagenase (Advanced Biofacturers Corporation, Lynbrook
New York), the other received buffer alone. All aliquots were
incubated overnight at 37°C. Protein was then reprecipitated in
cold 5% TCA containing 0.25% tannic acid, washed as before and
dried. The final residues were dissolved in 1 ml hyamine hydroxide
and added to 10 mis NE233 Scintillation fluid (Nuclear Enterprises,
Edinburgh). Samples were counted in a Packard Tri-carb 300 liquid
scintillation counter with automatic quench correction of cpm to
dpm based on external standard channel ratios.
As discussed later (page 139) the ABC collagenase used is
virtually free of non-specific proteases and the NEM added to the
buffer should inhibit the action of any non-specific proteases already
present in the culture preparation.
To examine the effect of phenytoin and vitamin E on collagen
synthesis, a similar method to that just described was adopted,
except that only one cell line was used in each experiment; three
concentrations of drug were tested simultaneously. Consequently
32 wells were seeded at 10^ cells/well for 3H-labelling, whilst 16
wells were seeded for cell counts.
The drug was added with the (^H) proline, 8 wells receiving no
drug at all, while a similar number of wells each received phenytoin
at 100, 300 and 500 pM dissolved in 50% ethanol. Equivalent
concentrations of the drug were added to the 16 wells without
10^.
A) proline. Vitamin E dissolved in acetone was added to culture
media at a concentration of 100 , 300 and 500 jig/ml.
RESULTS
Cell lines used for comparison are given below, all
between passages 5-10.
CONTROL EBS EBDr EBDD EBL
NF2 EB9 EB1 EB16 EB27
NF3 EB10 EB2 EB17






Relative collagen synthesis - the percentage of total protein
synthesis which is collagen - was calculated by the method of
Diegelmann and Peterkofsky (1972). Three EBDD lines and 1 EBL
line were included in the study, though no conclusions have been
based on those results.
The mean results for collagen synthesis between groups are
given in Table 7? and Fig. k6 a, b and c.
TABLE7 RESULTSFORCOLLAGENANDNON-COLLAGENP TEINSYNTH SISIEBC ROLG OUPS R.C.S. dpmcollagen/ 105cells dpmnon-collagen/ 105cellsCONTROLn=6 3.2-0 5 4,314-664 29,189-5,842EBSn=6 5.1-0 9
EBDrn=6 4.1-0.8
EBDDn=3L1 4.93 2









































































EBS EBDr EBS EBDr
Fig. if6 (a) and (b) show the mean relative collagen synthesis and
5
mean collagen synthesised per 10 cells respectively in control,
EBS and EBDr groups.with the corresponding mean (- SEM) percentage
difference between the EB groups and controls adjacent. The students-
paired t-test was used to test the significance of the difference










































Fig. kG (c) shows the mean non-collagen protein synthesis per 10^
cells in dontrol, EBS and EBDr groups with the corresponding mean
SEM) percentage difference between the EB groups and controls
adjacent. The students-paired t-test was used to test the
significance of the difference between controls and EB groups.
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Although the variation in dpm/10^ cells between experiments was
quite large, the experimental design enables a Student's paired t-
test to be used to test the significance of the difference between
the EB group and its corresponding age-matched control within each
experiment. The results, expressed as the mean percentage difference
between control and EB groups (Fig. *f6), indicate that relative collagen
synthesis was increased by 73$ in EBS (p<0.00l) whereas the 69$ increase
for the more variable EBDr data was not statistically significant.
However collagen synthesis per 10^ cells was elevated by approximately
the same amount in both EBS (108$) and EBDr groups (100$) over controls
(p<0.05). That is to say, collagen synthesis per cell was approximately
double that of controls, although again there was considerable
variability between experiments.
5
Non-collagen protein synthesis per 10 cells was very variable,
consequently the differences were not statistically significant.
The percentage of collagen and other non-collagen protein
secreted into the medium was also determined. Approximately 50$
of the labelled collagen synthesised over 2k hours was found in the
medium, and approximately 18$ of labelled non-collagen protein, with
no significant differences between groups.
As only three EBDD cell lines were used in experiments statistical
analysis is invalid. However the results suggest a similarity in both
collagen and non-collagenous protein synthesis between the EBDD and
EBS groups, the EBDD group differing from controls in all these
aspects. The relative collagen synthesis in the single EBL cell
line examined did not differ from the control group; although collagen
and non-collagen protein synthesis were above the mean control values,
they fall within the control range (collagen/10"' cells 1,613-13,899,
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non-collagen protein/10^ cells 11,998-60,738). The age of the
EBL patient (2 years) may explain the higher levels of protein
synthesis generally.
The effect of phenytoin and vitamin E at various concentrations
was assessed on 6 cell lines - 2 controls, two EBS and two EBDr.
The intention was to ensure that representative lines from each
group did not differ from each other in their response to the drug,
having established that differences do exist in collagen synthesis
between groups. As no difference in response to the drug was
observed, the data for the 6 strains was treated as a single group.
The raw data are given in Tables 8 and 9» Statistical analyses,
however, were performed on normalised results, owing to the large
variation between each cell line caused by extraneous experimental
conditions. To normalise the raw data in each experiment, the mean
and standard deviation in the response of a sell line to
a particular drug concentration, were determined. The mean was then
subtracted from each item of data and the result was divided by the
standard deviation. This ensured that large variations between
experiments did not mask a real effect of the drug and allowed direct
comparisons across experiments. Having normalised all the data, a
non-parametric method of statistical analysis was adopted - the
Mann-Whitney U-test - to evaluate differences between groups.



















a:-12%p<0.02;b:- 1.c8<0 01(Mann-WhitneyU-tesonormaliseddat )















The results indicate that phenytoin at 500 jiM (137 ug/ml) caused
a significant reduction in both collagen and other protein synthesised,
relative collagen synthesis was therefore not affected. At 300 juM
(82 jug/ml) only the amount of non-collagen protein synthesised was
significantly affected by the drug, the normalised data indicated that
synthesis was suppressed by 11^ (p<0.02).
Vitamin E only significantly affected protein synthesis at 100 pg/ml,
increasing non-collagen protein synthesis by 14# (p<0.00l). This




Relative and absolute collagen synthesis in control and EB groups
showed some significant differences. Perhaps most surprisingly,
because of its apparent lack of dermal involvement, the EBS group
<1
showed the greatest difference from the controls, both in relative
and absolute terms.
Relative synthesis in EBS was increased by 73% (p<0.00l),
reflected by an increase of 108% in absolute collagen synthesis.
There was no significant difference between non-collagen synthesis in
EBS and controls. The relevance of these findings is hard to assess;
the finding that trypsin-activatable levels of collagenase (pages 1^7-163)
are slightly higher than controls (1^4%), may be relevant. Increased
collagen synthesis could represent a response by the fibroblast to
increased collagenase activity, or alternatively such an increase in
collagen synthesis could have affected regulation of collagen
degradation, thereby promoting increases in collagenase levels.
Because the increase in collagenase activity was only comparatively
small and the increase in collagen synthesis comparatively large, it
is possible that an equilibrium has been established, enabling the
maintenance of an overtly normal dermis.
However, this equilibrium was seemingly disturbed in the EBDr
group. Collagen synthesis per cell was significantly increased,
being approximately double that of controls and only slightly less
than the EBS group. Neither relative collagen synthesis, nor non-
collagen protein synthesised per cell significantly differ from
controls despite non-collagen protein being elevated 40% (- 19% SEM)
because of the large variability between experiments. Therefore the
general increase in protein synthesis combined with the 38% increase
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in collagenase activity, indicated by the collagenase data (pages 151-15?)
could combine to cause destabilisation of the dermis. It is possible
that the increase in collagen per cell is a response to the excess
collagenase, the alternative - that excess collagenase is a response
to increased collagen is conceivable but unlikely as it is known
that higher collagenase levels in EBDr are due to the presence of
more messenger RNA coding for collagenase, implying increased gene
coding capacity (Kronberger et al, 1982).
Such upsets in dermal homeostasis have previously been noted.
It is now thought that amongst the contributing factors in scleroderma,
characterised by extensive induration and fibrosis of the skin
(reviewed by Leroy, 1982), is an increased biosynthesis of both
Types I and III collagen whilst collagenase levels remain unaltered
(Uitto et al, 1979). It would be interesting to know whether Type I
and III collagens are produced in the usual ratios in EBS and EBDr.
Particularly, as Type III collagen is degraded faster than Type I
by collagenase (Welgus et al, 1981).
It is interesting that a large collagen fibre (-100 nm) was
noted in an electron micrograph of EBDr skin (Fig. 28 EB31) in
agreement with the observations of Pearson (1962). Typically, EB31
showed no significant chanpe in relative collagen synthesis but
synthesis of collagen per cell was increased by 65^. It is possible
that the production of large fibres is related to the increase in
collagen synthesis observed.
There have been many studies of the effect of phenytoin on
gingival fibroblasts and cat palatal mucosa, but only Houck et
al (1972) have used human skin fibroblasts as a model, using only two
cell strains to test phenytoin at 100, 10 and 1 juM. It should be
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noted that the optimum range of serum concentration for epileptics
is 10-20 pg/ral, i.e., **0-80 pM (Reynolds et al, 1976), therefore the
concentrations used in the present investigations are well in excess
I
of therapeutic levels.
The results show that at high concentrations of the drug both
protein and collagen synthesis are significantly depressed. This is
in agreement with Blumenkrantz and Asboe-Hansen (197*0, who found
that large concentrations of phenytoin, 500 pM to 8 mM, could
reduce all protein synthesis including collagen in chicken embryo
tibia fibroblasts. At the highest concentrations, the drug is
probably having a toxic effect on the cells. The viability of cells
subjected to (100-500 pM) phenytoin in the present study did not
differ from untreated cells (90-95% viability) when determined by
trypan blue exclusion (see p. 23).
At 300 pM only other protein synthesis was significantly depressed.
Bergenholtz and Hanstrom (1979) also found changes in protein synthesis,
although it is uncertain whether these were a real effect of phenytoin,
or as they suggest, an artefact of their organ culture system.
Although 300 pM is well above the therapeutic limit, the
implications of an inhibition in non-collagenase protein are obvious
to EBDr, where production of collagenase could be curtailed. The
likelihood of this happening in vivo is small as such levels of the
drug could not be realised. Plasma proteins particularly albumin
bind to 90% of phenytoin (Richens* 1979), so that intolerably high
doses of phenytoin would therefore be necessary if plasma
concentrations were to approach 100 pM.
The finding that up to 500 pM phenytoin fails to alter collagen
synthesis is in agreement with Houck et al (1972) and Hassell et
al (1976). The latter authors found changes in collagen synthesis
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only in the gingival fibroblasts of epileptic patients who had
responded to phenytoin by producing gingival overgrowths. No change
was observed in fibroblasts from controls and non-responding
patients.
Phenytoin has been found to have a rather generalised effect
on membrane function, altering the release of both cytoplasmic and
lysosomal enzymes (Hanstrom et al, 1979). This work also verified
that phenytoin was responsible for a reduction in collagen degradation
rather than any change in synthesis, postulating that collagenase
release might similarly be inhibited. Without knowing whether collagen
degradation is reduced in human skin fibroblasts treated with
phenytoin, it is difficult to say whether the drug is likely to
have a beneficial effect on EBDr skin or not. Clinical evidence
suggests that phenytoin is only useful in a subgroup of EBDr patients
(Bauer et al, 1980). It is possible that this group equates with
the group of epileptics who respond to the drug by producing
gingival overgrowths. In epileptics this characteristic has been
attributed to selection of a unique population of gingival fibro¬
blasts inherently capable of higher collagen and protein synthesis
and "switched on" by phenytoin (Hassell et al, 1976). Perhaps a
similar mechanism is at work in the skin of EBDr patients.
Obviously further work is required to establish whether collagen
degradation is affected by phenytoin in human skin and whether
this is a general occurrence or a trait of only certain susceptible
cell lines.
The only significant effect of vitamin E was seen at 100 pg/ml.
At this concentration non-collagen synthesis was increased by
approximately (p<0.00l), and relative collagen synthesis was
correspondingly decreased. Very little is understood about the
affect of vitamin E on skin. It is known that collagen metabolism
is affected from investigations by Brown et al (196?) into vitamin E
deficient rats. Newly synthesised collagen from these rats was
unstable compared to collagen from normal rats, indicating an
abnormality in the process of cross-linking.
However, more is known about the effect of vitamin E at the
cellular level, where it serves as both an antioxidant and a
structural component of the membrane (vLucy, 1972; Betteger et al, 1980
Giasuddin and Diplock, 1981). It is thought that vitamin E stabilises
membranes by way of specific physicochemical interactions between
its phytyl side chain and the fatty acid chain of polyunsaturated
phospholipids. It inhibits the oxidative destruction of poly¬
unsaturated fatty acids in cells and their membranes high in poly¬
unsaturated fatty acids and can prevent the degradation of membrane
phospholipids by membrane bound phospholipases in vivo (Lucy, 1972).
Exactly how this related to protein synthesis in fibroblasts is
uncertain. Certainly the stabilizing of membranes, including
lysosomal membranes, and effects on permeability could be important
if neutral proteases as well as collagenase are involved in the
pathogenesis of EBDr (Takamori et al, 1983). It is curious that
the amelioratory effects attributed to vitamin E extend from EBDr
to EBS-Weber-Cockayne type (Ayres and Mihan,1969). It is possible
that membrane stabilization has an important role in both these
types of EB, with the lysosomes of the basal cell in EBS, as
opposed to the fibroblast in EBDr, being the most likely target
for vitamin E action.
The beneficial effects of increasing non-collagenous protein
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synthesis are equivocal without knowing whether enzyme release
and activity is affected by vitamin E. It is possible that if the
vitamin does have a role in promoting and stabilizing cross-linking
of collagen» then collagen degradation might be altered without
collagen synthesis being affected by the drug. In the case of EBDr




Collagen synthesis was compared between control and various
EB fibroblast lines. The relative collagen synthesis in EBS was
significantly elevated (73% p<0.00l) over control levels. Collagen
synthesis per cell was approximately doubled in both EBS and EBDr
cell lines compared with controls (p<0.05). Non-collagen protein
synthesis was not significantly altered in any of the groups
investigated.
The effects of phenytoin and vitamin E on various fibroblast
lines were studied. Phenytoin significantly decreased non-collagen
protein synthesis at 300 pM whilst depressing both collagen and
other protein synthesis at 500 pM (p<0.02).
Vitamin E only had a significant affect at 100 pg/ml, depressing
relative collagen synthesis by stimulating the synthesis of non-






The controlled remodelling of connective tissue during the growth
and development of an organism is of great physiological importance.
It requires not only a precise regulation of the enzymes involved
but also that they have a high degree of specificity for the substrate.
In vertebrates such a system was first recognised in the Anuran
tadpole Rana catesbeiana, when Gross and Lapiere (1962) detected and
assayed the protease which caused resorption of the tadpole's tail
in vivo, and solubilised fibrillar calf skin collagen in vitro.
Collagenolytic enzymes were then detected in other connective
tissues including the involuting rat uterus (Jeffrey and Gross* 1967)1
human rheumatoid synovial tissue (Evanson et al, 1967) and human skin
(Eisen et al, 1968). At first human skin collagenase could only be
detected in culture, using serum-free medium to exclude serum
inhibitors. Eisen (1969a) investigated the distribution of collagenase
in normal human skin by dissecting samples into epidermal, upper
dermal and lower dermal layers. He concluded that human skin
collagenase, unlike that from the Anuran tadpole, was a product of
the dermis, and specifically, the upper dermis. Reddick et ail (197*0,
using immuno-cytochemical techniques, later showed collagenase to be
specifically located in the papillary dermis and suggested that
fibroblasts were responsible for its production.
Investigations then followed to isolate, purify and ultimately
characterise the collagenase protein. Eisen et al (1968) found that
the enzyme degraded the collagen molecule into quarter and three
quarter fragments. Bauer et al (1970) found that there appeared to
be two enzyme proteins involved; as determined by their electro-
phoretic mobility in a polyacrylamide gel. Furthermore, on raising
antibodies to one of the enzyme bodies he found the two to be extremely
closely related, with similar antigenetic specificities. This work
I
also showed inter-species differences between the enzymes, bacterial,
crustacean and vertebrate enzymes being antigenically distinct.
The complexity of the enzyme system was increased by the
discovery that collagenase was released into culture medium in a
latent form, which requires protease (trypsin) activation in vitro
(Vaes, 1971). Vaes postulated, that there must be another factor, or
agent, released by the skin fibroblasts in culture, which could
activate the latent collagenase and which was also elicited by
trypsin activation. He did not think that the latent collagenase
was an enzyme-inhibitor complex. The following year Vaes (1972)
isolated an activator molecule similar in size to the collagenase
molecule itself, i.e. 100,000 daltons. Unfortunately there have been
no corrobatory studies concerning the activating agent.
To overcome the problem of assaying two almost identical species
of collagenase which could apparently be either in an inactive, pro-
collagenase form, or appear as an active enzyme, two methods of enzyme
assay were developed. Firstly Bauer et al (1972) developed a
radioimmunoassay that could provide a specific and accurate
quantitation of human skin collagenase in vitro and in vivo. After
enzyme purification on a Sephadex column, antibodies were raised
against the collagenase: as cross reactivity occurred between the
zymogen and active enzyme, the total immunoreactive enzyme protein
could be assayed whether it was activated or not.
Secondly Bauer et al (1975)i in a systematic investigation of
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procollagenase activation in vitro, found that different concentrations
of trypsin produced activation optimally over a period of 10 minutes
at 25°0. In this study they also demonstrated the presence of a
collagenase inhibitor capable of abolishing over 90% of the collagenase
activity whilst displaying virtually no inhibition of trypsin. This
inhibitor was thought to be a product of skin fibroblasts themselves
and could explain the previous inability to detect collagenase activity
in fibroblast cultures (Reddick et al, 1974). Welgus et al (1979)
later isolated an inhibitor from the medium of human skin fibroblasts
in serum-free conditions, with a molecular weight of approximately
31,000 daltons. The production of latent collagenase is not, however,
purely a characteristic of human skin. Werb et al (1977) showed that
procollagenase from rheumatoid synovial cells was activated by plasmin,
itself activated from plasminogen by an agent thought to be produced
by the synovial cells.
Electrophoresis of collagenase, isolated from the media of human
skin fibroblasts in culture (Stricklin et al, 1977; 1978), revealed
not just pro- and active enzymes but two pairs of enzymes - an upper
doublet of 60,000 and 55*000 daltons, which upon trypsin activation
lost a 10,000 dalton fragment producing the lower 50,000 and 45,000
dalton species respectively. This work also revealed a second mode
of activation, that of autoactivation; whereby latent enzyme without
protease interaction, or a detectable change in molecular weight,
could become active (Valle and Bauer, 1979).
Interestingly, Bauer (1977a) showed that the specific activity
of collagenase increased 6-10 fold shortly after confluence, implying
that synthesis and/or release of enzyme changed with culture density. **
Curiously, after confluence the amount of immunoreactive collagenase
had increased only 2 fold, whilst the increase in specific activity
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of the enzyme was disproportionately large. This disparity must mean
that although enzyme secretion and probably synthesis increases, some
other factor controlling enzyme activity must decrease - perhaps an
endogenous inhibitory factor of the collagenase.
Other factors that affect collagenase activity include the divalent
calcium ion (Ca^+). This ion is necessary for the thermostabilization
of the enzyme, whether in the presence of substrate or not. Increasing
collagenase activity with increasing Ca^+ concentrations is associated
with an increase in thermostability. There is however no evidence that
Ca^+ plays any role in the binding of collagenasesto their substrate
(Seltzer et al, 1976).
It is now thought that the microtubule system is intimately
involved in the synthesis and/or degradation of newly synthesised
collagenase (Bauer and Valle, 1982). The microtubular agent colchicine,
in low concentrations (10 ^M), produced a 3-fold increase in trypsin-
activatable collagenase in culture medium, without an increase in total
protein synthesis.
More is now known about the specificity and interaction of the
enzyme with its substrate (Welgus et al, 1981). Human skin
collagenase successfully degrades collagen Types I, II and III but not
IV or V and although it does degrade collagen from different species,
it is most active against specific homologous collagen Types I and III.
The cleavage of Type III collagen occurred at 10 times the rate of
homologous Type I collagen. The presence of the triple helical
conformation of the constituent collagen fibrils was an absolute
requirement for the differential selectivity of susceptible collagen
types to fibroblast collagenase: following substrate denaturation,
collagen Types I - III were degraded at approximately equal rates.
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Despite the failure of normal skin fibroblast collagenase to degrade
Type IV or V collagen, protease extracted from an invasive tumour
has been shown to degrade Type IV collagen (Liotta et al, 1979)*
The kinetics of the collagen-collagenase reaction have been
examined (Welgus et al, 1980): the degradation process was extremely
slow, one molecule of human skin collagenase degrading approximately
25 molecules of guinea pig Type I fibrillar collagen per hour at 37°C-
The explanation appears to be that only 10% of the collagen molecule
in the fibrillar form is accessible to the enzyme for binding prior to
degradation of the substrate.
The control of collagenase activity is obviously extremely complex.
There is substantial evidence that the enzyme is secreted in a latent
form and therefore requires interaction with other factors for
activation, unless autoactivation occurs. The importance and relevance
of autoactivation in vivo is still unknown. There is evidence that as
well as procollagenase the fibroblasts secrete inhibitors of the active
enzyme, representing another possible point of control. Furthermore,
large inhibitory molecules such as the <x2~macrogIobulin in serum are
























SCHEME OF SOME OF THE INTERACTIONS LIKELY TO BE INVOLVED IN THE CONTROL
OF FIBROBLAST COLLAGENASE ACTIVITY
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The interaction of these factors as well as the intracellular
controls over collagenase synthesis , compound the complexity of the
system (Woolley and Evanson, 1980). Moreover there is now evidence
that epidermal cell products can influence stromal cell response.
Activators and inhibitors from the epithelial cells of rabbit cornea
have been isolated and shown to affect collagenase activity of the
underlying stromal cells (Johnson-Wint, 1980).
COLLAGENASE AND EB
An abnormality in collagenase production is thought to be a
causal factor in the pathogenesis of epidermolysis bullosa dystrophica
recessive (EBDr).
Pearson, (1962) was amongst the first electron microscopists to
note the degenerative changes in the dermal collagen near the dermo-
epidermal junction and to suggest that collagenolysis might be occurring.
Eisen (1969b) followed up this study by investigating the collagenolytic
activity from the involved and uninvolved skin of five patients with
EBDr. He found that involved skin had a 6-fold increase in enzyme
activity, with a smaller increase in the uninvolved skin, compared
with normal control skin. Curiously Eisen also concluded that the
epidermis of EBDr skin had even more enzyme activity than the underlying
papillary dermis. He regarded increased collagenase synthesis as the
most likely explanation but thought there might also be an associated
deficiency of collagenase inhibitor in the serum of these patients.
Lazarus (1972) came to rather different conclusions, suggesting that
increased local levels of collagenase are a secondary tissue reaction
to chronic injury. He found that 2 out of 9 EBD patients had minimally
decreased serum collagenase inhibitor. It now seems likely that this
early experiment failed to detect the latent enzyme either because
of the interaction of active enzyme with serum inhibitors, or simply
failure to activate what is now known as procollagenase.
With greater knowledge of collagenase and improved techniques
Bauer et al (1977) quantitated the amounts of immunoreactive protein
present in generalised and localised EBDr, EBL and EBDD. Elevated
levels of immunoreactive human skin collagenase were found in the
blistered skin of all types of EB examined and significantly higher
collagenase levels were found in the uninvolved skin of EBDr and EBL.
Unfortunately uninvolved skin is often a misnomer, particularly for EBL
and severe EBDr, blistering almost invariably occurring during biopsy
in these types of EB. Therefore the results may be somewhat misleading
particularly if induction of a blister elevates collagenase levels.
This investigation did not examine the specific activity of the
enzyme present but concluded that the significant increase in
concentration of enzyme protein in clinically uninvolved skin of
EBDr patients was of major importance. Bauer et al suggested that
the excess collagenase may be responsible for the absence of anchoring
fibrils noted by Hashimoto et al (1976b) and also Briggaman and
» '
Wheeler (1975a).
Bauer (1977U) further demonstrated that the collagenase from
two EBDr patients was not only produced in excess but also in an
aberrant form. The procollagenase had a decreased affinity for the
Ca^+ co-factor required for enzyme activity and thermal stability:
consequently it was more thermo-labile at low Ca^+ concentrations
than control enzymes. The resulting collagenase therefore had a
diminished specific activity when expressed as activity per unit of
inmnanoreactive protein, with average values 39% and 16% of control
enzymes. Such a disparity between increased amounts of enzyme and
decreased activity poses the intriguing problem of whether there is
sufficient enzyme present to increase the rate of collagen degradation
in vivo. Bauer concluded that over-production, or decreased degradation
of a defective collagenase enzyme retaining considerable activity in
vivo was the likely cause of blistering in EBDr.
A comparative study of EBDr, EBDD, EBL and EBS (Bauer and Eisen,
1978) using tissue culture techniques revealed that, in contrast to
his earlier findings (Bauer et al, 1977)1 only EBDr showed increased
immunoreactive collagenase levels, with a mean value of that in
control cultures. Within the 10 EBDr cell strains used in the study,
there was great variation in the results. The specific activity in
8 out of the 10 EBDr strains was examined. In 3 out of 8, the activity
was decreased, in a similar number the activity was normal and in only
2 out of 8 was there a slight increase in activity. The dis¬
proportionate increase in immunoreactive enzyme protein, which could
be structurally altered, was thought to be the reason for the decrease
in collagenase activity per unit immunoreactive protein; hence the
greatly reduced catalytic efficiency in EBDr collagenase. No studies
on the collagenase activity in the other types of EB cell strains were
performed.
Studies were then concentrated on the precise characteristics
of EBDr collagenase. Valle and Bauer (1980) found that the initial
rate of accumulation of intracellular enzyme as well as the rate of
secretion were increased in 2 EBDr cell lines examined. They concluded
that excess accumulation of enzyme must be related to increased
synthesis, particularly as the rate of degradation of the enzyme
did not differ from controls. Comparison of the electrophoretic
mobilities of the EBDr procollagenase and collagenase with control
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enzyme showed no difference between them, suggesting that the
aberration in EBDr collagenase must be a very small alteration in
structure affecting the function of the enzyme. Stricklin et al
(1982) verified that EBDr collagenase was indeed similar in size
to that of normal human skin fibroblasts; with zymogens of 60,000
and 55,000 daltons, which lost a 10,000 dalton fragment to form
active enzymes. The active collagenase had similar reaction rates
and substrate specificity for the various human collagen types as
did normal human collagenase. The amino acid composition of EBDr
and normal collagenase was analysed as well as a comparison of
cyanogen bromide digestion products separated by gel electrophoresis.
The amino acid analysis showed that differences could be seen between
proenzyme quantities of proline, glycine, half cystine, methionine
and tyrosine residues, whilst the active enzymes were quite similar
in composition. Digestion product patterns of procollagenase
revealed small but reproducible differences: EBDr lacked one of the
resolved peptide bands seen in normal enzyme digests and had two
extra bands not seen in the control. This provided strong evidence
of structural differences between normal and EBDr procollagenases.
The study also confirmed that the marked decrease in thermal
stability could largely be attributed to the decrease in affinity
for the stabilizing metal co-factor Ca^+ in the pure enzyme. It
therefore seems that in EBDr there is an increased synthesis of a
structurally abnormal collagenase.
Analysis of messenger ribonucleic acids (mRNA), the intermediary
between coded gene and protein synthesised, shows that although total
translational activity was equal in normal and EBDr-mRNA preparations,
there was a 3*5 - 10 fold increase in translatable collagenase mRNA
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from EBDr cell lines (Kronberger et al, 1982). This confirms that
the increased collagenase synthesis is due to elevated levels or
preferential translation of collagenase mRNA.
It seems possible that the final explanation may be within the
collagenase gene code itself. Gene duplication can occur within the
DNA of a chromosome and it is possible that a fault or slight change
in the nucleic acid sequence coding for collagenase occurred when the
gene duplicated - thus increasing the amount of translatable collagenase
DNA and subsequent mRNA, whilst accounting for a defect in the pro-
collagenase produced.
It is known that human skin collagenase is most efficient at
degrading Type III collagen, cleavage occurring at 10 times the rate
of homologous Type I collagen(Welgus et al, 1981). Type III collagen
forms the thinner fibrils of the dermis, accounting for only 10-15^
of the dermal collagen;' immunotechniques suggest that most is found
in the upper papillary dermis (Fleishmajor et al, 1980), though
there is evidence to suggest even distribution throughout the dermis
(Epstein and Mulderloh, 1978). The consequence of increased
collagenase levels would be the rapid destruction of the thinner
Type III fibrils and hence the site of cleavage would be in the
upper papillary dermis, as indeed it is in EBDr. If the anchoring
fibrils contain a helical collagen element, susceptible to human
skin collagenase, and it is known that they are susceptible to
bacterial collagenase digestion (Kobayasi et al, 1977)♦ their
apparent absence in EBDr could be due to early destruction by the
increased levels of collagenase.
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PHENYTOIN AND COLLAGENASE
So far only two drugs have emerged that might ameliorate the
effect of increased collagenase in patients suffering from EBDr -
»
phenytoin and vitamin E. Both have been used for rather tenuous
reasons, with rather disappointing and debatable results.
Phenytoin (5-5 diphenylhydantoin; dilantin sodium) is an anti¬
convulsant drug long used in the treatment of epileptics (Merritt and
Putnam, 1938). One of the side effects observed in epileptic patients
was a fibrous outgrowth of connective tissue in the gums, so-called
gingival hyperplasia (Aas, 1963). It had already been noted in a
series of experiments by Houck (1962, 1963) that phenytoin affected
the composition of the skin in rats. HoUck found that while dermal
water and fat decreased, a unique insoluble non-collagenous protein
appeared and the drug also caused as increase in acid soluble and
insoluble collagen in the dermis. Bright (1965) confirmed that
dermal collagen increased, because the excretion of degraded collagen
in the form of proline and hydroxyproline fell in rats receiving
phenytoin. Such changes could not be explained by increased
fibroblast proliferation alone, for although phenytoin and some
of its analogues accelerated the proliferation of fibroblasts in
tissue culture, only phenytoin and its analogue 1-allyl-5-phenyl-
hydantoin produced significant changes in skin in vivo (Shafer, 1960,
1961; Houck, 1963).
Hassell et al (1976) confirmed that the gingival overgrowth was
predominantly collagen. On culturing the gingival fibroblasts he
found that their total protein synthesis had been stimulated by
the drug, with collagen synthesis increasing from 11% of the protein
synthesised to 20%. They concluded that the drug appeared to select
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for fibroblasts characterised by enhanced levels of protein synthesis
and collagen production. It is not, however, certain whether it is
phenytoin or its major metabolite, 5-(parahydroxyphenyl)-5-
phenylhydanton (HPPH) converted by liver hydroxylases, that causes
the gingival hypertrophy (Hassell and Page, 1978).
In contrastto the idea that phenytoin specifically stimulated
collagen synthesis, Bergenholtz and Hanstrom (1979)» using radio¬
active labelling methods, found that phenytoin did not influence
collagen or non-collagen synthesis but that the effect was on the
rate of collagen degradation. Hanstrom et al (1979)» using cat
palatal mucosa in organ culture, found that phenytoin caused a
36# inhibition of the cumulative release of hydroxyproline into the
medium, i.e. a decrease in collagen degradative products.
Simultaneously there were 23$ and 30% reductions in ft -glucuronidase
and lactate dehydrogenase respectively, which Hanstrom et al regarded
as markers for lysosomal and cytosolic enzyme levels. They concluded
that phenytoin, or its chief derivative HPPH, may interfere with
collagen degradation by blocking enzyme release from cells.
Hassell (1982) again demonstrated that fibroblasts from
phenytoin-enlarged human gingivae secreted 100$ more extracellular
protein, including collagen, as determined by radioimmunoassay.
However despite the elevated levels of collagenase, Hassell found no
difference in the specific activity of control and treated cells:
for some reason the procollagenase activation step was blocked by
the effects of phenytoin. Hassell postulated several mechanisms
by which this might occur and concluded that the drug probably
selects for a subpopulation of gingival fibroblasts, which are-
inherently capable of increased protein synthesis.
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There is therefore some evidence that phenytoin does affect
collagen catabolism in gingival fibroblasts by inhibiting various
factors and enzymes involved but the exact mode of action of phenytoin
is uncertain. There is no recorded evidence that phenytoin can cause
sclerotic changes in the otherwise normal skin of epileptics, as
might be expected if human skin collagenase is affected simultaneously.
PHENYTOIN AND EB
Despite this lack of any link between human skin collagenase and
phenytoin, Eisenberg et al (1978) used pharmacological doses of
phenytoin to treat two EBDr patients and also conducted in vitro
experiments on 5 EBDr patients, 2 EBDD patients, and 2 EBD patients
of unknown genetic heritage.
The clinical trial showed phenytoin to have dramatic results
with only two weeks of therapy. Blister counts dropped from 52 to
5 blisters per week and the collagenolytic activity of the skin
assayed simultaneously seemed to fall sharply. However the graph
in the text indicated that the effect required six weeks rather than
two to appear. A second patient also showed dramatic decreases in
blistering.
Eisenberg et al measured the collagenase and collagen peptidase
activity in skin samples, obtained by removing the roof of a freshly-
induced blister. The sample would therefore contain very little
dermis, if any at all, in EBDr patients where the blister forms just
beneath the basal lamina. It should also be remembered that Bauer
et al (1977) found elevated levels of immunoreactive skin collagenase
in extracts of blistered skin from EBDr, EBDD and EBL patients but
using culture techniques only EBDr strains gave consistently elevated
collagenase levels (Bauer and Eisen, 1978); the possibility being
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that induction of a blister provides sufficient disruption of the skin
to alter collagenase levels in any type of EB, including EBDD which
Eisenberg included in his study.
Predictably, Eisenberg's group found elevated collagenase
activity 3-24 fold in the blistered skin of their heterogeneous
group of EB patients, and a 19 - 52 fold increase in collagen
peptidase activity compared with two normal control samples.
To examine the direct inhibitory effect of phenytoin in vitro,
Eisenberg et al used skin collagenase from two dystrophic patients,
one of which may not have been a recessive type. The collagenase
activity in these patients was not assessed against any normal
controls. Furthermore the patients do not seem to have been included
in the previous enzyme analysis, making comparisons of collagenase
activity dubious especially as Eisenberg et al used ( C) collagen
substrates of different specific activity. Nevertheless a single,
but different, drug concentration was used with samples of collagenase
extracted from the two patients. The result showed that in one
patient 55 JuM phenytoin caused a 27.4% inhibition and in the other
patient 110 juM phenytoin caused a 51.05% inhibition: no experimental
errors or statistical information regarding the reliability of these
results were provided.
Eisenberg et al concluded that phenytoin inhibits collagenase
and collagen peptidase in pharmacological doses. Unfortunately there
is, in my opinion, insufficient evidence in this paper alone to
substantiate such a conclusion, although the findings warrant further
experimental investigation.
Bauer et al (1980) performed a clinical trial based on
Eisenberg's conclusions using phenytoin at a dose of 8 pg/ml in blood
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in 17 patients with EBDr. The response was variable: 5 of the 17
gave no response and could not be attributed to the clinical state
of the patients. The 12 patients who responded with a reduction in
l
blisters, did seem to show dose-dependence. Bauer et al also
examined the direct effect of phenytoin on purified human collagenase:
contrary to Eisenberg's results he found no inhibition. Bauer
postulated that phenytoin may act on another protein that may
secondarily inhibit collagenase: phenytoin added to human skin
explants in culture caused a decrease in collagenase activity*
paralleled by an inhibition of immunoreactive collagenase protein
in the medium, which was dose-dependent. This suggests that phenytoin
diminishes synthesis and/or secretion of the enzyme. Furthermore
no change was found in total protein synthesis at these drug doses.
These findings conflict with those of Hassell (1982) regarding the
effect of phenytoin on collagenase production in gingival fibroblasts.
Long term trials of ^ more than 75 weeks clearly show that the
EBDr patients can be divided into those who respond to treatment and
those who do not (Bauer and Cooper, 1981).
As in the studies of gingival hyperplasia it seems that phenytoin
elicits changes in only certain individuals suffering from EBDr.
Consequently it is difficult to assess the beneficial affects and to
determine why only certain individuals are predisposed to its influence.
VITAMIN E AND COLLAGENASE
Vitamin E (D-alphatocopherol) has been less extensively studied
in the treatment of epidermolysis bullosa. Only a few trial studies
have been recorded (Wilson, 196A-; Ayres and Mihan, 1969; Sehgal et
al, 1972; Smith and Michener, 1973 and Michaelson et al, 197^).
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Wilson (1964) used the drug to treat a severe case of EBDr with some
improvement whilst Ayres and Mihan (1969) successfully treated a
patient with the Weber-Cockayne variant (simplex). In a double-
blind cross-over study Smith and Michener (1973) showed that two
sisters with a "mild form of recessive EBD", underwent a convincing
amelioration in blistering whilst on vitamin E treatment.
Michaelson et al (197^) using three patients with unclassified
dystrophic EB examined the effect of vitamin E on the disease and the
skin collagenase levels in two patients before and during treatment.
One patient remained free of blisters for k months, the second for 12
months. In the third patient bullae began to reappear after three
months and an increase in vitamin E dosage was ineffective. The
collagenase levels in skin explants of two patients studied showed
that initially there was a 15% and 21% level increase of collagenase
activity in involved skin in terms of percentage of labelled collagen
solubilized after k days at 37°C. After 30 days of vitamin E therapy
this was reduced to 3% and 2% respectively. Unfortunately the authors
do not specify whether the pre-treatment skin sample was of a blister
(involved predilected) and whether the sample during treatment was
not (uninvolved predilected), as might be expected considering the
clinical improvement recorded. Also adequate controls were lacking.
There is little other evidence to suggest that vitamin E affects
collagenase levels. The work of Brown et al (1967) suggests that the
metabolism of collagen in the skin of vitamin E-deficient rats was
abnormal: rats raised on a vitamin E-deficient diet had more soluble
k
collagen in their skins than their controls. This collagen did not
form gels as readily in vitro, nor were the gels as stable at k°C.
as gels from normal rats. Vitamin E may therefore influence the
formation of intermolecular and intramolecular cross-linkages in
collagen fibrils either directly or indirectly through changes in
GAG metabolism. The mechanism is uncertain and whether this is the




The aim of the following experiments was firstly to determine
whether phenytoin and vitamin E are capable of influencing
collagenase activity directly; secondly to compare collagenase
status of representative strains from each variety of EB with control
cell lines.
Before testing the drugs against commercial (bacterial) collagenase,
or the collagenase in fibroblast culture medium, it was necessary to
prepare a radioactively-labelled collagen substrate. This was done
by the method of Lefevere et al (1979) using (^H) acetic anhydride to
label the acid-soluble collagen. The collagenase activity reported
is therefore a measure of the (%) counts left in solution after the
residual undigested collagen fibrils have been precipitated. It was
necessary to test the substrate against non-specific protease
degradation and for background levels of radioactivity following the
labelling procedure. Trypsin was used as a non-specific protease,
fibrillar collagen being highly resistant to attack because of triple
helical conformation.
Substrate labelling method
Two hundred mg of acid-soluble calf skin collagen, (Type III)
(Sigma Chemical Co. Ltd.) were solubilised in 90 mis of 0.01$ acetic
acid by stirring overnight at k°C. The pH of the collagen solution
was adjusted to 8.0 with 1M NaOH and 1M K^HPO^ and this pH was
maintained throughout the reaction procedure with adjustment when
necessary.
Three mis of benzene were added to the 250 jil of acetylating
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agent, (^H) acetic anhydride (lOOmCi/ml; 500 mCi/ramol: Araersham
International). One hundred pi aliquots of the diluted (^H) acetic
anhydride were then added to the collagen solution at 6 minute intervals
over a period of 3 hours. The solution was kept at ^°C and stirred
continually.
One hour after the final addition of acetylating agent the
reaction was stopped by adjusting the pH to ^-.0 with glacial-acetic
acid. The benzene was then removed by gently bubbling nitrogen through
the solution for k hours at k°C.
Excess radioactive label was removed by dialysis at k°C against
distilled water (15 l/day) for 30 days. The final dialysis was against
5 1 of 0.01% acetic acid for 2*f hours. The labelled collagen solution
was then stored at ^°C.
The specific activity of the mixture was measured using a Packard
Tri-carb 500 liquid scintillation counter. Twenty five pi aliquots
were added to 1 ml of water and measured in 10 mis of scintillant
composed of Triton X-100 (Koch-Light Laboratories Ltd.) and NE 233
(Nuclear Enterprises Edinburgh) in a 1t2 ratio.
To test the purity of the substrate the action of 50 jug trypsin
(Type III bovine pancreas, Sigma Chemical Co. Ltd.), in 25 pi Tris-HCL
buffer containing 5 mM CaCl^ pH 7*5 was compared to a range of
collagenase concentrations (Advanced Biofactures Corporation, U.S.A.)
chromatographically purified form III collagenase and a Tris-HCL
buffer blank. The collagenase from ABC has previously been found to
be largely free from other non-specific proteases (Miller and Udenfriend,
1970; Verbruggen et al, 1981). It should be noted that bacterial
collagenase will attack the non-helical o( chains at many loci. This
differs from human skin collagenase which only cleaves native, triple
helical collagen specifically at a position one quarter of the distance
from the COOH terminal end of the molecule.
Assay for purity of substrate - method
Test solutions containing 0.5 Units (U) - 250 U of collagenase
in Tri-HCL buffer were added to 250 pi (^kOO jig) labelled substrate
and the final volume was made up to 775 pi with Tris-HCL buffer.
Similarly 50 Jig trypsin was added to 250 jil of substrate and 500 pi
buffer added, the blank, necessary to determine background levels of
activity, contained 525 pi buffer and 250 pi substrate only.
Samples were incubated for 2.5 and 5 hours at 37°C. The residual
fibrillar substrate was then precipitated by adding 100 pi phospho-
tungstic acid and 100 pi 4M HC1. After 15 minutes the samples were
centrifuged at 8500 g in a Beckman J2-21 centrifuge for 10 minutes.
One hundred pi aliquots of supernatant were used for scintillation
counting.
Test for inhibition of collagenase by phenytoin or vitamin E - method
Phenytoin (5-5 diphenylhydantoin sodium salt: Sigma Chemical
*
Co. Ltd.) was dissolved in 50% ethanol (EtOH) so that 25 pi aliquots
were added to 750 pi test solution gave a final concentration of 50,
100, 150 and 200 pM phenytoin. Triplicate test solutions contained
250 pi labelled substrate, 100 U collagenase (A.B.C.) in 500 pi Tris-
HCL-CaCl^ buffer. Four controls were prepared:
1) 100 U collagenase and no drug, to determine the maximum number of
counts which could be released during the course of the assay.
2) 100 U collagenase and 25 pi of 50% EtOH alone, to test the effect
on the collagenase of the vehicle in which the drug was dissolved.
3) 50 jig trypsin to determine the non-specific counts released.
*0 No enzymes, buffer only to ensure that the background level of
radioactivity was constant after preparation of the substrate.
Vitamin S 1Da tocopherol acetate (Sigma Chemical Co. Ltd.), was
dissolved in acetone so that 25 pi aliquots added to 750 pi test
solution gave a final concentration of 10, 50, 100 and 200 pg/ml of
vitamin E. As described above the solutions were in triplicate,
using 250 pi of labelled substrate and 100 U collagenase in 500 pi
Tris-HCl-CaCl^ buffer. Controls were those previously described
except that acetone replaced 50^ EtOH as the drug vehicle.
All the tubes were then incubated at 37°C for 2.5 hours.
The substrate was precipitated by adding 100 pi k% phospho-
tungstic acid and 100 pi HC1. After 15 minutes the samples were
centrifuged at 8500 g for 10 minutes. One hundred pi aliquots of
supernatant were counted in a Packard scintillation counter as
previously described.
Assessment of collagenase status in representative cell strains -
method
Each human skin fibroblast line, Table 10, obtained and cultured




















NF5 P5 EB1 P4 EB9 P9 EB16 p8
HSF14 P5 EB2 P4 EB12 P5 EB17 P9
HSF22 P7 EB14 p6 EB29 P4 EB25 P5
HSF26 P7 EB18 P4 EB30 P7 - EB26 P5
The cells were routinely cultured in complete medium containing
10% foetal calf serum, in an atmosphere of 5% in air at 37°C.
Medium was changed thrice weekly and the cultures observed daily. At
confluence, the medium was removed and the cells were washed thoroughly
with 5 changes of PBS. A minimum amount (20 mis) of serum-free medium
was applied to the cells and the cultures were re-incubated for 72
hours. The medium was then removed from the cells and the media from
the 3 flasks of each cell line pooled. The total cell number was
estimated by counting an aliquot of cells in the Coulter counter.
The pooled medium from each cell line was concentrated 10-fold
to a final volume of 6 mis by vacuum dialysis at 4°C through
Millipore immersible-CX ultra filters, nominal pore size 10 >000
daltons. The concentrate was then dialysed against Tris-HCl-CaCl^
buffer for 24 hours at 4°C. The resulting preparation was either
assayed immediately or stored at -20°C for a few days until required.
Collagenase assay
The method was based on that of Bauer et al (19*75)» using
several different trypsin concentrations to activate the latent
1*4-3.
enzyme in the crude medium extract.
Duplicate 100 pi aliquots of pre-prepared medium were activated,
using final concentrations of 0, 0.2, 0.*f, 0.6, 0.8, 1.0 and 2.0 pg
trypsin (Type III bovine pancreas, Sigma Chemical Co.) per sample,
at 25°C for 10 minutes. The reaction was then stopped with a 5-fold
excess of soya bean trypsin inhibitor (B.D.H.) and the sample was
diluted with 275 pi Tris-HCl buffer before adding 250 pi of the
labelled collagen substrate. Various controls were necessary:
1) A blank containing substrate and no crude medium sample to
determine background levels of radioactivity.
2) Labelled substrate and trypsin at 20 pg/ml, without trypsin
inhibitor, to ascertain the maximum level of counts released
from the substrate by any uninhibited non-specific proteases.
3) 100 U of collagenase (A.B.C.), to assess the effect of collagenase
activity on the substrate and to provide a constant for comparisons
between experiments.
The samples were then incubated at 37°C for k hours and processed
as previously described.
RESULTS
Substrate labelling and purity - Results
The specific activity of the substrate, based on 200 mg protein,
7
was 2.5 x 10 dpm/mg, the total activity in 125 mis being 2.25 mCi.
This was comparable with the results of Lefevere et al (1979) who
achieved a specific activity of 5*93 x 10^ dpm/rag collagen, using
an (^H) acetic anhydride label of 5 fold lower activity (100 m Ci/mmol)
than was used in this experiment. The following results are given in
terms of the 100 pi aliquots and not the total radioactivity released
into the test solution (975 }*1 total final volume).
The purity of the acetylated substrate was determined by digestion
with the non-specific enzyme trypsin. In 2.5 hours 48,500 dpm were
released, representing 9% of the total collagenase labile radioactivity
(maximum 5-5 x 10^ dpm) as illustrated in Fig. 48. Similarly in 5
hours 10^ of the total collagenase-labile radioactivity was released
by 50 pg of trypsin. The background, as determined by the sample
without enzyme, represented only 2.9% of the total radioactivity
released by collagenase (Table 11).
TABLE 11 SUBSTRATE SPECIFICITY
per 100 ul aliquot
Total radioactivity dpm 1.03 x 10^
Maximum collagenase releasable dpm 5«5 x 10^
ii.
Mean trypsin releasable dpm 4.85 x 10
ij.
Background level dpm 2.11 x 10
1^5o
FIG. A8
Collagen lysed over 2.5 hrs and 5 hrs at 37°C with increasing units











• - H released (dpm x 10 ) from 250 }il of labelled collagen
substrate following incubation with collagenase for 2.5 hrs.
O - as above, following incubation with collagenase for 5 hrs.
- level of released following incubation with 50 pg of
trypsin for both 2.5 and 5 hrs.
l46o
Increasing the incubation period of enzyme and substrate from 2.5 h
to 5 h did not appear to alter the total number of dpm released
(Fig. 48). This agrees with Lefevere et al (1979) who found that the
use of larger amounts of substrate - 570 jig (cf 400 fig) enabled a
sensitive detection of enzyme to be made, which was not improved by
incubation times longer than 2.5 h; smaller amounts of substrate
required much longer incubation times for equivalent sensitivity.
Therefore seemingly large amounts of substrate 250 jil (400 jig) were
used in the collagenase studies.











100 U collagenase +
25 Ul 50^ EtOH ^72,789
+
9,601












THE EFFECT OF PHENYTOIN
ON BACTERIAL COLLAGENASE
100 U collagenase +
25 ul acetone 524,986
+
12,884












THE EFFECT OF VITAMIN E
ON BACTERIAL COLLAGENASE
14?.
From Fig. 49a based on the data in Table 12 it cam be seen that
phenytoin at 50-200 pM does not impair bacterial collagenase function.
Although a small decline in collagenase activity was seen, maximum
5% at 150 pM phenytoin, a finding which was reproducible between
experiments; in no experiment was the decline significantly different
from control values.
The effects of vitamin E on collagenase were rather curious
(Fig. 49b). The results suggest that the acetone in which the drug
was dissolved (final concentration 1.6%), may have enhanced the action
of the collagenase: 10% more radioactivity was released when 25 pi
acetone was included in the enzyme and substrate test solution
compared with the enzyme alone. None of the vitamin E concentrations
significantly inhibited the activity of the collagenase. These findings
were reproducible.
Collagenase status in representative cell lines - Results
Collagenase activity was assessed as dpm collagen substrate
released per 10^ cells. Fig. 50 illustrates the results of
individual experiments contributing to the mean result for each
concentration of trypsin used in the experiment. The results from
each experiment are pooled in Fig. 51» based on Table 13. As the
results have been presented as dpm/10^ cells, the data for radio¬
activity released by the trypsin control is not directly comparable.
However the mean value of trypsin dpm was (40,569 - SEM 1,433)
compared with the range of dpm released by the prepared media before
cell number is taken into account (44,933 - 1,008 - 110,931 - 1,869).
This means that the media released 1% - 13% of collagenase labile
radioactivity over the trypsin background level.
FIG. 49(a) 148.
The effect of phenytoin on (bacterial) collagenase activity as
determined by dpra released from 250 pi of collagen substrate after































The effect of vitamin E on (bacterial) collagenase activity as determined
by dpm released from 250 pi of collagen substrate after incubation




















100 UNITS OF COLLAGENASE:
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Fig. 50 (a), (b), (c) and (d) illustrates the activation patterns of
representative cell lines in four different experiments: • - controls;
O - EBS; ▲ - EBDr; □ - EBDD and ■ -EBL. The dpra x 10*^ released
from labelled collagen after activation of collagenase with











Mean activation pattern of all the cell lines (control n = k, EBS n
EBDr n = 4^ EBDD n = 3> EBL n = 1) in each group^given as dpm x 103
released from 3h labelled collagen after activation of collagenase




A comparison of mean initial levels of collagenase activity prior to trypsin
activation (blank), with the mean activated level of collagenase for each
«rroup after incubation with trypsin (cross hatched)at 25°C for 10 mins


















Fig. 50 illustrates the large variation in activated collagenase
levels between cell lines and between experiments. This is not
because of variation in experimental technique or conditions, as the
result for a control of 100 U collagenase remained relatively constant
across experiments (mean 393»765 - 11,482). Fig. 51 shows clearly
that the levels of collagenase after activation are generally highest
in the EBDr cell lines, with cells from the EBS group falling between
control and EBDr levels.
Fig. 50 also indicates that the collagenase level is relatively
constant regardless of the trypsin concentration used in activation.
Therefore to obtain overall levels of collagenase activity in the
different groups before and after activation, the results for final
levels of collagenase activity have been pooled (Table 14, Fig. 52).
TABLE 14 INITIAL AND MEAN ACTIVATED LEVELS OF COLLAGENASE ACTIVITY
IN EB AND CONTROL GROUPS
NORMAL EBDr EBS EBDD EBL
Initial level 5286 - 300 8847 - 1353 3615 - 458 3963 - 153 2349
Activated level
of collagenase
activity 6931 - 246 9406 - 560 7928 i 308 6518 - 337 4748
t SEM







































In assessing the results it is necessary to take, into account
the variation between cell lines as well as between groups of cells.
A hierarchical or nested analysis of variance was performed on the
control and EBDr groups of cell lines* as they apparently showed the
greatest mean difference (Fig. 51)•
The values in Table 15 show that the probability of the variation
between groups being greater than the between cell line variance, was
not significant. That is to say that the variation seen between
individual cell lines within a group was great enough to mask any
significant variation between the normal and EBDr groups, or any other
groups. Unfortunately in one of the four experiments (Fig. 50a) the
EBDr levels of collagenase activity were lower than the control and
both control and EBDr results in this experiment represented the
opposite extremes of the group ranges.
(Expts. 1-4 normal range 5022-11205 EBDr 4079-15464
Expts. 2-4 normal range 5022-8743 EBDr 7021-15464).
If this experiment is ignored and a nested analysis of variance
applied the results just fail to be significant (Table 16).











































The probability of variation between groups divided by variation
between cell lines within a group being significant is (0.1 ?p>0.05) -
thus giving some indication of the validity of the difference between
EBDr and control cell lines based on a minimal number of experiments.
A non-parametric method of analysis, the Mann Whitney U-test,
when applied to the comparative mean results (Table 13) for activation
at various concentrations of trypsin, indicated that the EBDr and EBS
levels of collagenase activity were composed of independent populations
of results, both groups having a p value of 0.001. EBDD did not
differ from the controls, having a p value of 0.469. This method of
analysis does not take into account the variation within the mean
results but again indicates a difference between EB groups and
controls. Obviously several more comparative collagenase assays are
necessary to make a statistically significant and therefore conclusive
statement about the differences between normal and diseased cell
lines.
Fig. 50 also shows an interesting difference between the amount
of activation of procollagenase produced by the smallest (0.2 pg)
concentration of trypsin. The results show that there is the
greatest difference between initial levels and activated levels
of collagenase in the simplex group (Table 17).
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The Mann-Whitney U-test, which ascertains whether two independent
groups have been drawn from the same population, was used to test the
significance of comparative percentage increase in collagenase
activity, because it can be applied to very small samples.
The results confirm that the simplex group is an independent
population, U = 0, where n^ = 4, n^ = 4, p = 0.014. A significant
difference therefore exists between these two groups, control and
simplex, in their activation characteristics, but not between control
and EBDr groups (U =8, p = 0.557)» or between the controls and EBDD.
Within a group the change in collagenase activity can be tested for
significance using a paired-sample t test. Although the number in
each group is small (n = 4) the following results were obtained:
Controls t = 1.312 Not significant
EBS t = 3.943 p<0.05
EBDr t = 3.08 p<0.1
EBDD t = 1.70 Not significant (n = 3)
It is therefore possible to say that the difference in collagenase
activity is significantly increased by trypsin activation at the 35%
confidence limits in EBS. Thus in the EBS group there is a large
» '




Neither phenytoin nor vitamin E had a direct effect on the
activity of bacterial collagenase in this system. Eisenberg et
al (1978) used collagenase extracted from the skin of two patients
with epidermolysis bullosa to test directly the effect of phenytoin
on activity. As has already been noted, adequate controls were
lacking in his experiments, but Eisenberg concluded that at 55 pM
there was a 27.^% inhibition and at 110 pM a 51.05% inhibition of
collagenase activity. These drug concentrations compare with the
concentrations used in the present investigation where there is no
evidence that phenytoin has the direct effect claimed by Eisenberg.
This conclusion therefore agrees with Bauer et al (1980), who found
no inhibition in enzyme activity at approximately 30 pM, with maximal
inhibition of purified skin collagenase being 5.5% at about 70 pM
phenytoin. Bauer's data indicated that phenytoin affected the skin
fibroblast itself, in culture, and by doing so decreased the synthesis
or secretion of collagenase.
It would be interesting to determine whether the major metabolite
of phenytoin, 5-(parahydroxyphenyl-5-phenyl-hydantoin) also has this
affect on the synthesis of collagenase by fibroblasts in vitro,
particularly as HPPH can cause gingival hypertrophy in cats (Hassell
and Page, 1978).
There is no conclusive experimental work, to date, involving
vitamin E in collagenase metabolism or activity. The results of
this experiment indicate that vitamin E does not act directly on
collagenase. Curiously it seems that the vehicle acetone alters
the collagen substrate; perhaps by making the site of enzyme
attachment and action more readily available to the collagenase, or
159.
by affecting the collagenase molecule itself* and improving its
efficacy. This finding is purely an artefact of the experimental
design. Taking into account the effect of the vehicle alone on the
collagenase, vitamin E failed to produce any significant diminution
in collagenase activity in this experimental system.
Although the collagenase activity in too few cell lines has been
determined to enable categorical statements, there is sufficient evidence
to give a strong indication of qualitative differences in collagenase
levels between the various groups.
Clearly there is considerable variation between cell lines within
a group (Fig. 50). The nested analysis of variance showed that the
variation between cell lines within a group was statistically
significant and therefore sufficient in any other parametric analysis
to nullify variation seen between groups. Consequently although the
within-group pooled results for non-activated and activated collagenase
(Table 15), and also the mean values plotted for each trypsin
concentration (Fig. 51), indicate that the EBDr cell lines have a
higher initial collagenase level and also remain above the control
group when activated, it is not possible to perform a parametric
test (t test) to substantiate the findings. Similarly the simplex
group, which appears to have lower levels of collagenase prior to
activation than the controls, apparently contains greater levels of
procollagenase and is therefore more markedly stimulated by trypsin,
the final collagenase activity exceeding that of the control group.
The non-parametric method of statistical analysis, the Mann-Whitney
U-test was used to determine whether the pooled results (Table 13,
Fig. 51) were independent of each other. By this method the EBDr
160.
and EBS mean activated collagenase results were significantly different
from the control (p<0.00l) whilst EBDD did not significantly differ
from the control.
Such' heterogeneity in results has been recorded before by Bauer
and Eisen (1978), who found great variation within groups. Their EBDr
group varied not only in collagenase activity but also in levels of
immunoreactive collagenase present in culture medium. In one out of
four experiments in the present study, the EBDr cell line appeared to
have less collagenase activity than the. controls. Interestingly three
out of eight in Bauer and Eisen's study (1978) also had lower activity
than controls. It is also noteworthy that where the EBDr cell lines
in Bauer's investigations were similar or above normal, the magnitude
of increase above control levels (28%) was not dissimilar to that
found in the present study (36%). The tentative conclusion is there¬
fore that the EBDr cell lines do possess greater levels of collagenase
activity prior to and following activation in vitro but that the scale
of the difference is not very great and is highly variable.
Bauer and Eisen (1978) also examined EBS, EBDD and EBL for
levels of immunoreactive collagenase i.e. total collagenase present
whether active or not. They found that these three groups and controls
showed no significant difference in levels of collagenolytic protein
present as detected by a specific antibody against the enzyme. In
the present study the EBDD group did not seem to differ from controls
in the amount of active collagenase present, neither did the single
letalis cell line. However the EBS group is intriguing in that although
the initial level of collagenase, prior to activation, appears to
be within the normal range, once activated elevated levels of
collagenolysis can be detected compared with controls. As Bauer
and Eisen failed to detect any difference in the simplex group
using immunoreactive techniques , it is interesting to speculate
whether some of the procollagenase in this group is masked by an
inhibitor of its activity, which upon exposure to trypsin renders
the zymogen active. The presence of such an inhibitor-enzyme
complex might alter the antibody recognition site (epitope) on the
procollagenase molecule, preventing detection by immunoreactive
techniques. The idea that there is some endogenous inhibitory or
controlling factor in the media of cultured fibroblasts is not new.
Bauer (1977a) found a disproportionate (6-10 fold) increase in
enzyme activity compared with 2 fold levels of immunoreactive protein,
just after the cells had reached confluence; the point being that
although collagenase synthesis and secretion doubles, some other
element in the control of activity diminishes thus enabling collagenase
activity to increase 6-10 fold.
It is possible that collagenase or procollagenase from the
simplex group is complexed with an inhibitor or somehow compromised
so that trypsin activation had a greater effect than on any other
group. The Mann-Whitney U test indicated that only the simplex group,
when compared with the control, represented a significantly different
population of results (p = 0.01*0. Similarly using a paired t-test,
the difference between levels of activity before and after activation
was only significantly different in the simplex group (p<0.05). The
EBDr cell lines although showing a consistent activation pattern
demonstrate only a very slight increase in activity (9%) upon
exposure to trypsin. The reason for this is probably the increased
thermolability of the EBDr procollager.ase enzyme, due to its reduced
affinity for the Ca++ ion (Bauer, 1977b; Stricklin et al, 1982).
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Alternatively it could be due to the diminished production of the
inhibitor postulated to be responsible for the altered simplex
activation characteristics.
The relationship of these results to the situation in vivo can
only be a matter of speculation at present. Clearly an excess of
thermally-instable collagenase, with a preference for Type III collagen
in the dermis, has the potential to produce blisters with cleavage
in the papillary dermis. The relationship between collagenase levels
and the presence or absence of anchoring fibrils remains uncertain.
The electron microscopy in the present study suggests that with one
exception (Fig. 27) in the severe form of EBDr, no anchoring fibrils
are present. However in a milder localised form of EBDr (EB31)
anchoring fibrils can be seen at the apex of a tightly convoluted dermo-
epidermal junction (Fig. 28). As collagenase levels are higher in
the involved skin of EBDr and in severe EBDr any skin taken for
ultrastructural purposes spontaneously becomes "involved" i.e. blisters,
the likelihood of finding intact anchoring fibrils, if they are
susceptible to collagenase, is greatly diminished. Hence they may
be present in mild EBDr where the skin remains virtually intact on
biopsying.
The results of this study and those of Bauer and Eisen (1978)
indicate that EBDD cells in culture resemble controls in their
collagenolytic activity. The uninvolved skin of EBDD patients
in vivo also showed no significant difference in activity (Bauer
et al, 1977). Blister formation was associated with significant
increases in tissue levels of immunoreactive human skin collagenase
however. Unfortunately Bauer et al give no data for the collagenase
levels in a friction-blistered control group, the possibility being
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that induction of a blister may automatically alter collagenase
activity in that area. The elevated collagenase levels of EBDD
in involved skin would therefore be a secondary consequence of
blister formation occurring for other reasons.
Collagenase production in the EBS group remains an intriguing
and unsolved problem. Blistering in this group occurs in the epidermis
with no evidence of dermal involvement and yet the results of this
study suggest an excess production in the dermis, not necessarily
excess or increased activity. Perhaps the simultaneous presence of
an inhibitor prevents the full potential of the collagenase being
expressed and thus prevents formation of blisters within the dermis.
The role of the dermis, if it has one, in blistering within the
epidermis remains completely obscure.
164.
SUMMARY
Collagenase exists as a pro- and active enzyme, the conversion
being made in vitro by trypsin. Autoactivation can occur. EBDr
I
cell lines are known to produce excess amounts of aberrant collagenase
with a reduced catalytic efficiency. Phenytoin has been found to
affect collagenase activity in some EBDr cell lines in vitro and
to be beneficial to only some EBDr patients clinically. Little is
known about vitamin E and it has been used to treat various types
of EB with varying degrees of success.
The findings of this investigation suggest that:-
1) Neither phenytoin nor vitamin E directly inhibits the action
of bacterial collagenase on a labelled collagen substrate.
2) EBDr cell lines have elevated levels (- 36%) of collagenase
activity over controls.
3) Little change is seen on activation of EBDr collagenase
s
indicating that most must already be present in an active form.
4) There is large variation between cell lines in levels of collagenase
activity.
3) The EBS levels of collagenase fall between EBDr and control
levels but were not significantly greater than controls.
6) The EBS group undergoes a significant increase in levels of active
enzyme after trypsin activation, with a 124$ increase compared
with a J>Cf& increase in activity in controls.
7) The EBDD group and single EBL cell line failed to differ from






Apart from collagen, the other'major constituent of the dermis
is the "ground substance" or extracellular matrix. This matrix is
composed of a variety of complex macromolecules vital to the regulation
and maintenance of the integrity of the dermis and of the skin as a
whole. These macromolecules are predominantly proteoglycan consisting
of polysaccharide covalently linked to protein. The polysaccharide
constituent chains, collectively known as glycosaminoglycans (GAG),
include hyaluronic acid, chondroitin k and 6 sulphates, dermatan
sulphate, keratan sulphate, heparan sulphate and heparin (reviewed
by Lamberg and Stoolmiller, 197^; Kennedy, 1979; Silbert, 1982).
Proteoglycans were previously termed "mucopolysaccharides",
before the importance of the protein backbone was fully appreciated.
Mucopolysaccharides were introduced to describe hexosamine-
containing polysaccharide materials of animal origin, usually
associated with viscous secretions. The term "mucopolysaccharide"
is less frequently used today, being imprecise. The term "glyco¬
protein" covers a range of covalent carbohydrate-protein macro¬
molecules of similar composition, which have been classified
according to their biological function and are a separate group
from the proteoglycans, as understood today.
Glycosaminoglycans form a chemically related group, each GAG
consisting of a chain of altering monosaccharide units. These are
an acidic monosaccharide, D-glucoronic acid or L-iduronic acid
(except for keratan sulphate which contains galactose rather than
uronic acid) and a basic monosaccharide, galactosamine or
glucosamine. These monosaccharides are either N-acetylated or
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N-sulphated: the resultant disaccharide therefore has acidic
properties. Variation between the various GAG types occurs in
differences in: polysaccharide chain length, the extent of sulphation,
the position of the sulphate groups, the relative proportion of the
uronic acids and differences in mode of linkage to protein.
Hyaluronic acid and chondroitin sire the only non-sulphated GAGs
occurring naturally; hyaluronic acid being a polymer of repeating
disaccharide units of N-acetyl-D-glucosamine and D-glucuronic acid,
(chondroitin is an isomer of hyaluronic acid). The chain length of
HA can vary from 100-20,000 disaccharide units depending on the
tissue from which it was extracted. Embryonic tissues, vitreous and
synovial fluids are rich in hyaluronic acid and it representsv 50^ of
the GAG in skin.
The chondroitin 4 and 6 sulphates are the sulphated variants of
chondroitin, consisting of N-acetyl-D-galactosamine and D-glucuronic
acid. They exhibit considerable structural heterogeneity both with
respect to the degree of sulphation and chain length. The chondroitin
sulphate chains are much shorter than those of hyaluronic acid, being
composed of 20-100 repeating disaccharide units. The chondroitin
sulphates are the major GAG of cartilage but constitute only 1C$ of
the GAG in skin.
Dermatan sulphate is an isomer of chondroitin ^-sulphate in which
the D-glucuronic acid units have been replaced by L-iduronic acid.
The structure is different from chondroitin k-sulphate only in the
orientation of the carboxy group on every other monosaccharide
residue along the chain. However its physiological properties differ
from the chondroitin sulphates. In skin dermatan is sulphated at
the ^-position (and forms 4-0% of the total GAG) and in the umbilical
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cord at the 6-position, suggesting that differences in biological
function may originate in subtle structural variations.
Keratan sulphate contains no hexuronic acid, having instead
D-galactose linked to N-acetyl-D-glucosamine. Varying amounts of
raannose, fucose, sialic acid and N-acetyl galactosamine, as well
as other monosaccharides provide a large degree of structural
heterogeneity. Keratan sulphate has not been isolated from the skin.
Heparan sulphate and heparin, consist of alternating D-gluco-
samine and D-glucuronic acid units, as does hyaluronic acid. However
in contrast to the latter, they contain considerable amounts of L-
iduronic acid. The glucosamine moieties in heparan sulphate may be
N-acetylated or N-sulphated and in heparin nearly all glucosamine
moieties are N-sulphated.
The GAG-chondroitin sulphates, dermatan sulphate, heparin and
heparan sulphate are each attached to a protein core (Fig. 53) by
means of an oligosaccharide link. Each GAG is linked at its reducing
end to a trisaccharide of galactosyl-galactosyl-xylose. The latter
is linked to the hydroxyl group of serine in the protein chain. As
the first sugar of the GAG chain is always glucuronic acid, which is
added to the terminal chain by a specific enzyme, differing from the
enzyme involved in the incorporation of glucuronic acid into the
polysaccharide chain, it is therefore considered as part of the
linkage group.
FIG. 33
THE STRUCTURAL RELATIONSHIP BETWEEN THE GAG COMPONENT AND A
PROTEOGLYCAN AGGREGATE AS A WHOLE
Glycosominoglycan—
Protein Core —
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The precursors of GAG synthesis are uridine nucleotide-sugars,
derived from D-glucose by several monosaccharide interccnversions
involving pyrophosphorylase type reactions. The intracellular level
of the various sugar precursors are important in the regulation of
synthesis due to feedback inhibition. The ordering of the sugar
sequence is not specified by a template but by the specificity of
the individual enzymes - glycosyl transferases ~ which catalyze
transfer of the monosaccharides to the growing chain.
It is now'understood that the core protein and glycosyl
transferases are synthesised in the rough endoplasmic reticulum,
where the initiation of GAG chains and synthesis of the linkage
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region also occurs. The growing chain passes from rough to smooth
endoplasmic reticulum and then to the Golgi apparatus where sulphation
and completion of the chain occurs. The product is transferred to
the exterior by vacuoles.
The half-life of GAGs in vivo has been found to be relatively
short. Hyaluronic acid in the skin of young rabbits and rats has a
half life of 2-5 days (Schiller et al, 1955)» dermatan sulphate
7-lk days in young animals although it may be longer in older animals
(Schiller et al, 1956; Davidson and Small, 1963). Chondroitin sulphate
has a half life of 17 days in rats.
Since the enzymatic degradation of GAG was first noted following
the injection of "spreading factor" from testicular extracts and
Indian ink, into skin (Hoffman and Duran-Reynals, 1931)» investigations
into the enzymes involved in GAG degradation have been conducted.
The best known endoglycosidase is testicular hyaluronidase, degrading
hyaluronic acid into fragments of various sizes by attacking & -linked
N-acetylglucosaminyl groups at random within the chain (Weissman et
al, 195^; Weissman, 1955). The chondroitin sulphates are also known
to be degraded by "hyaluronidase" (Meyer and Rapport, 1950) although
the presence of sulphate groups seems to hamper the speed of the
reaction, chondroitin being similar to hyaluronic acid in reaction
kinetics. Although hyaluronidase has been isolated from rat skin
(Cashman and Laryea, 1969) embryonic chick skin, and chick fibroblast
cultures (Orkin and Toole, 1980), it has not been found in human skin
fibroblast cultures. No skin endoenzymes capable of degrading
dermatan sulphate or heparan sulphate have yet been discovered.
Enzymes do however exist in the liver and spleen capable of
degrading heparin and heparan sulphate.
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A number of exoglycosidases aire known to exist including
glucuronidase, galactosidase and N-acetyl-hexosaminidase. These
enzymes, by definition, are not capable of cleaving sin intact GAG,
they attack a terminal non-reducing sugar only after sm endoenzyme
has begun degradation. Similarly the sulphatases have no action on
the intact GAG. The group of mucopolysaccharide storage diseases
(the mucopolysaccharidoses), in which there is an excessive
accumulation of acidic polysaccharides in tissues (and cultured
fibroblasts), accompanied by an siltered urinary excretion profile,
illustrate the importance of exoglycosidase enzymatic regulation of
GAG metabolism by cells. The absence of enzymes such as o(-L-
iduronidase and /^-glucuronidase, as well as other lysosomal
glycosidases and sulphatases, have been found to be responsible for
eight varieties of mucopolysaccharidoses affecting skeletal and
connective tissue as well as mental development (Dorfman and Matalon,
1976; Fluharty, 1982).
V
Degradation of the core protein of proteoglycans may be important
in the turn-over and therefore regulation of GAG synthesis, illustrated
by the injection of papain into rabbits' ears. This resulted in
rapid loss of rigidity of the ear with a simultaneous mobilization
and excretion of GAGs (Thomas, 196^+).
The function of GAGs in skin and the significance of their
interaction with other components of the dermis are highly complex
and not yet completely understood. Taken as a group, GAGs influence
the hydration, permeability and elasticity of the dermis (Kennedy,
1979), as well as being involved in the adhesion (Schubert and
La Corbiere, 1980) aggregation and motility of fibroblasts in vitro
(Dnderhill and Dorfmann, 1978; Abatangelo et al, 1982).
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Hyaluronic acid is the predominant GAG (80-90%) synthesised
by skin fibroblasts in culture medium and presumably secreted into
the interstitial spaces in vivo (Gallagher et al, 1980; Fukui et al,
1981; Slack et al, 1982). Hyaluronic acid is thought to be chiefly
\
responsible for determining the water content of skin: because of
its intrinsic high degree of hydration and interactions between its
own molecules, the passage of interstitial water is impeded,
consequently increasing tissue rigidity and resistance to compression
(Kennedy, 1979).
Investigations into the mechanism of cell adhesion in vitro
have shown that GAGs are of importance. It has been found that
fibronectin has specific binding sites for hyaluronic acid, heparan
sulphate and will bind, though to a lesser extent, heparan sulphate
(Yamada et al, 1980). Heparan sulphate is understood to be important
in binding extracellular fibronectin to the cell surface, the fibro¬
nectin then links the cell to the substratum. However the accumulation
of hyaluronate-chondroitin complexes at these adhesion sites appears
to cause a destabilisation of binding through interactions between
hyaluronic acid and the cell surface fibronectin, possibly by
altering or hampering heparan sulphate binding (Rollins and Culp,
1979; Laterra et al, 198O; Schubert and La Corbiere, 1980;
Abatangelo et al, 1982). Hyaluronic acid is also known to be important
in cell-cell adhesions and interactions (Underhill and Dorfman, 1978).
Although it has become clear that heparan sulphate is important
in cell substrate adhesion in vitro (Laterra et al, 1980), the work
>
of Gallagher et al (1980) demonstrates that culture conditions may
not accurately reflect the situation-in_jrivo. Their work showed that
whilst heparan sulphate was the major sulphated GAG produced by
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human skin fibroblasts when cultured on a plastic substrate, dermatan
sulphate synthesis could be increased three-fold on a collagen
substrate and consequently became the major sulphated GAG synthesised.
This work also demonstrated that reduced levels of sulphated GAG
present in the culture medium could be attributed to their interaction
with the collagen gel upon which the fibroblasts were being grown.
The interaction of GAG with collagen has previously been
mentioned (p 98). There is substantial evidence that the organisation
of collagen fibrils in tissues, is related to the amount and type of
proteoglycan present (Mathews, 1965; Mathews and Decker, 1968; Oegema
et al, 1975)* It has been shown that the precipitation of collagen
fibrils at 37°G is markedly reduced in the presence of small amounts
of proteoglycan monomer. The protein core of the monomer does not
itself retard fibrillogenesis although it does bind to collagen.
Therefore it is the interaction of GAG with collagen that appears to
be of significance, the GAGs binding to collagen by electrostatic
forces.
The sulphated GAGs have been shown to inhibit leucocytic
lysosomal enzyme activity in vitro to different degrees, heparin
being the most effective. The type and apparent distribution of the
sulphate bond are the important factors in determining the degree of
interaction (Avila, 1978). Whether this finding has any significance
to fibroblast lysosomal enzyme activity is unknown.
Cultured skin fibroblasts have made a useful model for studying
factors which might affect GAG production, both in diseased
conditions: such as mucopolysaccharidoses (Frantoni et al, 1968)
and EB (Bauer et al, 1979); as well as for examining the constraints
of culture conditions: such as cellular ageing in vitro
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(Schachtschabel and Wever, 1978; Matuoka and Mitsui, 1981; Vogel
et al» 1981); pH of the culture milieu (Lie et al, 1972) and the
effects of drugs on fibroblasts in vitro (Priestley and Brown,
1980). However the in vitro model is complicated by the finding
2
that cell density (cells/cm ) can influence the rate of GAG synthesis
and secretion in culture, GAG secretion per cell decreasing with
increasing cell density (Morris, 1960; Hronowski and Anastassiades,
1980; Oakley and Priestley, 1983)• The present investigation confirmed
and attempted to take into account the influence of cell density on
GAG secretion.
GAG and EB
An abnormality in GAG production has been linked with the
pathogenesis of EBDD-Pasini, the variant in which albopapuloid
nodules occur on the body. The work of Sasai et al (1973) suggested
that in their single patient the nodules occurred because of an
increase in the amount of degraded sulphated GAG in the skin. Endo
et al (197*0 examined the urinary GAG profile of the same patient
and found the major GAG present to be partially degraded dermatan
sulphate. Lower levels of partially degraded chondroitin sulphate,
the major GAG in normal urine, were found. They concluded that
the substance accumulated in the skin was most probably dermatan
sulphate.
In a more extensive study using seven EBDD-Pasini patients,
Bauer et al (1979) were able to show that the disturbance in GAG
metabolism was a genetic characteristic of these patients. Their
study of cultured skin fibroblasts revealed an increased accumulation
of the sulphated GAGs both intra- and extracellularly, probably due
to increased synthesis; degradation rates were comparable to control
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values. This aberration in GAG metabolism was found to be unique
to the Pasini variant of EB. Bauer et al (1979) suggested that the
presence of excess sulphated GAGs in the dermis might impair collagen
fibril formation resulting in an intrinsic instability which could
result in trauma-induced blistering.
The effect of phenytoin on the degradation of sulphated GAGs
was examined in organ cultures of cat palatal mucosa (Hanstrom and
Jones, 1979) and in cultures of fibroblasts from both normal and
phenytoin-enlarged gingivae (Kantor and Hassell, 1983)# The results
of Hanstrom and Jones (1979) indicated that phenytoin inhibited the
extracellular degradation of sulphated GAGs without influencing
degradation in the intracellular GAG pool. In accordance with the
finding that phenytoin reduced collagen degradation (Bergenholtz
and Hanstrom, 1979; Hanstrom et al, 1979), Hanstrom and Jones (1979)
proposed that the same mechanism inhibiting cytosolic and lysosomal
enzyme release, was responsible for the reduced extracellular
sulphated GAG degradation. Kantor and Hassell (1983) also found an
increase in the accumulation of sulphated GAGs, but ascribed the
increase to elevated synthesis and not decreased degradation. This
agrees with their previous results indicating elevated anabolic
activity in fibroblasts from phenytoin-enlarged human gingivae
(Hassell et al, 1976; Hassell, 1982). As phenytoin apparently
increases sulphated GAG accumulation, whether by increased synthesis
or decreased degradation, it is unlikely to be of any benefit to
patients with the EBDD-Pasini variant.
No investigations into the effect of phenytoin on GAG production
in either control or EB skin fibroblasts have been made. It was
therefore the aim of this investigation to establish the level of
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GAG production in various representative cell lines and then to
examine the effect of phenytoin at various concentrations on GAG
output. Simultaneously it was possible to assess any changes in the
proliferation of the fibroblasts induced by the drug.
Phenytoin has been implicated in hyperplastic enlargement of
human gingivae. Hassell et al (1976), however, pointed out that
"hyperplasia" was a misnomer, as the resident connective tissue cells
to not appear to be abnormal in morphology or number (Han et al,
1967). Recently Modeer et al (1982) have demonstrated that the
major metabolite of phenytoin 5-(parahydroxyphenyl)-5-phenylhydantoin
(p-HPFH) decreased the number of gingival fibroblasts per culture,
by interference with the mitotic process, without affecting the
total protein and DNA-content of the cultures. In contrast, the
experiments of Shafer (i960), using "fibroblast-like" cells
originally isolated from human gingivae, indicated that cell
proliferation in vitro was stimulated (103$) at concentrations up
to 200 pg/ml. Houck et al (1972), using human skin fibroblasts in
culture, showed that phenytoin increased cell population doubling
times between 2-20 pg/ml, (i.e. decreased proliferation rate),
»
the optimal concentration being 5 pg/ml phenytoin. The recent work
of Al-Ubaidy et al (1981) suggests increased mitotic activity in
enlarged gingivae isolated from responsive epileptics and also in
rat fibroblasts treated with phenytoin in vitro, supporting the
view of gingival enlargement as hyperplasia. This work (Al Ubaidy
et al, 1981) fails to define the concentration of phenytoin used, the
number of cultures and biopsies and no indication of experimental
error is given. Thus the question of hyperplasia versus hypertrophy
of phenytoin-enlarged gingivae remains equivocal.
The effect of vitamin E on the proliferation and GAG secretion
of a group of normal control cell lines was also studied in the
present work; no such studies having previously been reported.
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METHOD
The effect of phenytoin and vitamin E on GAG accumulation and
fibroblast proliferation
GAG production was measured in all the fibroblast lines used
in the current study. To determine the effect of phenytoin on GAG
output and its influence on growth in individual cell lines, 6 lines








Fibroblasts were seeded at 10^ cells/flask in complete medium
containing 1C$ foetal calf serum, into 2k Nunc plastic flasks
(25 cm^ growth area) and incubated at 37°C in a ^ CO2 : air
atmosphere. The medium was changed on day 1 after seeding. On day 3«
A- flasks were removed and cell numbers determined, following trypsin-
versene treatment, using a Coulter counter. Phenytoin at 50, 100,
150 and 200 juM was added to the medium, using k flasks per
concentration, leaving an untreated group as a control both for GAG
output and for fibroblast proliferation relative to day 5. (Similarly
in other experiments vitamin E was added at 10, 50, 100 and 250 jag/ml
on day 3 to the six control strains examined.) Twenty four hours
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later the medium was removed and replaced by "fresh" medium containing
the same drug concentrations.
On day 6 after seeding, the medium was removed from the flasks
and 1 ml of phosphate buffered saline, used to rinse the cells, was
added to each sample. The final cell number was determined after
trypsinisation using the Coulter counter. The proliferation of the
fibroblast lines was expressed as a percentage of the mean increase
in cell numbers between days 3 and 6. Cells treated with drug
were compared in terms of the percentage change in growth rate,
relative to day 6.
The medium was dialysed against o.1M sodium acetate buffer
pH 4.9 for 3 days before being concentrated to about 3 nils using
Lyphogel (Gelman-Hawksley Ltd). Each sample was digested with 2 mg
hyaluronidase (Sigma type 1) overnight at 37°C, before precipitation
of protein at 4°C in 5% trichloroacetic acid (TCA). After
centrifugation at 18,000 g for 30 mins, the uronic acid content of
the supernatant was assayed using metahydroxydiphenyl reagent
(Blumenkrantz and Asboe-Hansen, 1973) with a glucuronolactone
standard. The GAG secreted, in terms of uronic acid output from
each culture group, was determined by subtracting the uronic acid
content of each batch of medium (assayed along with the experimental
n





The relationship between GAG (jug/10 cells/^8 hrs) accumulation
in culture medium and cell density can be seen in Fig. 5^ using nine
I
lines of control (normal) fibroblasts. This hyperbolic curve can be
transformed to a linear relationship by plotting the GAG data on a
logarithmic scale (Fig. 55). The relationship between cell density
and the GAG levels can then be expressed as
y = -0.0922x + 2.6191
(r = -0.^902, df = 87, p < 0.001)
7 5
where y is the log GAG/10 cells/^+8 hrs, x is cell density as 10 cells/
2
25 cm . The slope of the line is therefore an index of the change in
GAG secretion with increasing cell density.
GAG secretion in the different groups of fibroblasts is compared
in the following table (Table 18).
No significant difference can be detected between groups, both
EBS and EBDr values falling within the normal range. (EBDD is to small
a group for statistical analysis.
Using the equation derived above to predict whether the final
cell density has influenced the value for mean GAG secreted, it can be
seen that the predicted values, except in the EBDD group, fall within
the range of observed values; confirming the similarity between control,
EBS and EBDr groups.
The effect of phenytoin on the rate of fibroblast proliferation
and on GAG secretion can be seen in Fig. 56 a and b. Clearly phenytoin
had no significant affect on the proliferation rate of any group at the
concentrations used in these experiments, although there was large
intra-group variability. It can therefore be assumed that any changes
in GAG accumulation must be a direct effect of the phenytoin and not
FIG. 54
The relationship between GAG output jag/10 cells/A-8 hrs and cell density-
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The relationship between log GAG output pg/10 cells/^+8 hrs and cell
density in control fibroblast cell lines. Linear regression analysis
based on 89 individual observations from nine different cell strains.


























(a) - Mean (- SEM) percentage change in GAG accumulation in (blank) control,
O - EBS-and ▲ - EBDr cell lines (n = 6) with increasing
concentrations of phenytoin.
(b) - Mean (- SEM) percentage change in proliferation of control, EBS
and EBDr cell lines (n = 6) produced by increasing concentrations of
phenytoin.
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an indirect result of differences in the final cell density due to
an altered proliferation rate.
The effect of phenytoin on GAG secretion is more complex, with
»
different effects on the four groups. The drug appears to have
increased GAG concentration in the media of control cell lines (30#)
at 50 pM phenytoin (p <f 0.05; Students paired t-test). In contrast
GAG levels in the simplex group were depressed with increasing
phenytoin concentrations, maximal reduction in GAG (32#) occurring
at 200 pM (p<0.02; Students paired t-test).
Maximal elevation of GAG induced by phenytoin is seen in the
EBDr group at 200 pM, but the 70# increase fails to be significant
(0.5 > p > 0.1) due to the variability in response to phenytoin
within the group.
The significance of the variation in response to phenytoin
between groups was assessed using the non-parametric Mann-Whitney
U-test. No statistical difference was observed between control and
EBDr groups at any given concentration of the drug. In contrast the
difference in response of EBS compared to the control group was
significant at every concentration except 100 pM phenytoin.
(50 pM: p< 0.008 U = 3; 150 pM: p 4 0.0V? U = 7; 200 pM: p<0.004
U = 2).
Effect of Vitamin E on proliferation rate and GAG secretion in
control cell lines
On a group of six controls, the mean effect of vitamin E was
to increase the rate of fibroblast proliferation (Fig. 57b).
However there was a large intra-group variation in response. .Using
the non-parametric Wilcoxon matched-pairs signed-ranks test,

































































- Mean (- SEM) percentage change in GAG accumulation in control cell
lines Cn = 6) with increasing vitamin E concentrations.
- Mean (i SEM) percentage change in proliferation of control cell




the proliferation rate being increased by and 73^ respectively.
The mean effect on GAG levels in control fibroblasts is shown
in Fig. 57a. At no vitamin E concentration was a statistically
significant change in GAG accumulation found. To determine whether
the change in GAG secretion was attributable to the change in
proliferation rate and therefore the final cell density, the predicted
GAG output for the mean cell density at each concentration was
calculated (Table 19)•
The percentage changes in predicted GAG levels induced by the
drug, given the associated change in mean final cell density, are of
the same magnitude as those experimentally observed. The largest
discrepancy between predicted and observed GAG values is seen at
10 pg/ml vitamin E, where the percentage change in observed GAG (1#)
is much less than was predicted by the graph (-22%). This suggests
that there may be an increase in GAG accumulation attributable to
the direct effect of the drug. From Fig. 57a, illustrating the
mean percentage change in GAG secretion, it can be seen that this
increase is in fact reflected in the experimental data: 10 pg/ml
vitamin E causing a mean percentage change in GAG of +13# (- 17).















































The measurement of GAG production in culture medium is complicated
by the inverse relationship between cell density and GAG secretion
(Hronowski and Anastassiades, 1980; Oakley and Priestley, 1983) and
the age related decline in GAG synthesis (Schachtschabel and Wever,
1978; Vogel et al, 1981). All GAG analyses were therefore performed
on cell lines between passages 4-10: in the experimental procedure
5 2
any cultures that failed to reach a density of 2.5 x 10 cells/25 cm
were discounted from the results. Cultures which had a final cell
density greater than this were located on the asymptote of the hyper¬
bolic density versus GAG output curve and therefore were not expected
to be unduly biased by cell density. Ideally all measures of GAG
should be made at identical cell densities: in practice this is
impossible because different rates of proliferation and different
plating efficiencies create the differences seen in final cell density.
However by using the linear relationship between cell density and the
\
logarithm of GAG secretion, it was possible to predict the GAG values
that might be observed at particular mean cell densities: thereby
confirming that the experimental results were not unduly biased. It
is interesting that the EBDD group (n = 3) does seem to have higher
values of GAG secretion than are predicted. Although there is
insufficient evidence to be statistically significant, this result
could indicate further similarities (p. 83) between the EBDD-Cockayne-
Touraine and Pasini variants. Bauer et al (1979)» using three EBDD-GT
fibroblast strains, concluded that there was no difference between
them and controls; it is however, possible that relatively small
differences in GAG secretion could be masked by differences in the
final cell density.
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In terms of overall GAG production, there appears to be no
difference between either EBS or EBDr and control fibroblasts. However ,
percentage differences between the GAG levels in EBS and controls in
response to phenytoin are striking; the GAG output of controls and
EBDr being generally increased, whilst the simplex group show a
reduction in levels of GAG in the medium.
The finding that the GAG content of the culture medium is higher
after phenytoin treatment of EBDr and control cell lines agrees with
the findings of Hanstrom and Jones (1979) and Kantor and Hassell
(1983). The former postulated that phenytoin was hindering extra¬
cellular GAG degradation but not intracellular catabolism: whilst
the latter authors thought the increase was due to elevated synthesis.
In the present study it is impossible to say whether phenytoin is
increasing GAG synthesis or decreasing the rate of degradation.
The intra-group variability in response to phenytoin was also
noted by Hanstrom and Jones (1979). In their work only 3 out of 5
cultures of cat palatal mucosa showed an inhibition of GAG degradation
by phenytoin. Similar variability was seen in the present cell
culture system.
» '
The reason for such variability and the reason for the opposite
response of the simplex group is unknown. The EB3 cell lines could
either have synthesised less GAG or increased the rate of GAG
degradation with increasing phenytoin concentration. Without further
investigations it is impossible to know which is the more likely
explanation, or why the simplex group should differ from controls
and EBDr in their response.
The finding that the proliferation rate was not significantly
altered by phenytoin in any of the groups studied is in contrast to
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Shafer (i960), Houck et al (1972) and Al-Ubaidy et al (1981). Shafer.'
(i960) did, however, note differences between the response of different
cell types, rat fibrosarcoma cells showing no detectable change in
growth rate. Whether the high serum concentration - 30% foetal calf
serum, the age of the cell cultures - passage 17 - or their source -
human gingivae, were relevant in determining the response to phenytoin
is unknown. Houck et al (1972) found that the maximal response in
growth rate of fibroblasts to phenytoin occurs at 5 V1g/®l (19 pM)
phenytoin, well below the lowest concentration used in the present
study (50 pM). The data of Houck et al (1972) were derived from only
two fibroblast cell lines, and in view of the variability in response
to phenytoin seen in the present study, it is possible that they are
not truly representative of a larger collection of fibroblast lines.
The clinical relevance of the present findings is hard to assess
without knowing whether the change in GAG levels present in culture
medium is due to increased synthesis or decreased degradation in the
case of controls and EBDr and whether decreased synthesis or
increased degradation is responsible for the 32% depression in GAG
concentration seen in the simplex group. Whether, as suggested by
Hanstrom and Jones (1979)» an inhibition of degradative enzymes is
the answer, or whether an increase in synthesis is responsible
(Kantor and Hassell, 1983), an increase in the GAG content of the
dermis might be beneficial. The work of Mathews and Deckar (1968)
indicated that GAGs affect collagen fibril formation and
aggregation in solution. Chondroitin k and 6 sulphates and
hyaluronate, over a certain molecular weight, retarded the rate of
collagen fibril formation but increased the degree of aggregation of
fibrillar collagen. It is possible that.in vivo such properties are
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important in stabilising the dermis of EBDr patients, although the
variability in response of fibroblast strains to the drug make
phenytoin's usefulness in vivo unpredictable.
Vitamin E caused no statistically significant change in GAG
accumulation in culture medium at 10 , 50, 100 and 250 jig/ml. It did
however significantly increase the proliferation rate of the fibroblast
lines up to 72# at 250 jig^ml vitamin E (p<T0.05). The decline seen
in GAG accumulation, though not significant, is probably a direct
result of the increase in proliferation and therefore the higher final
cell densities observed. The stimulation of proliferation may explain
the rather generalised beneficial effects attributed to vitamin E
after treatment of patients with different EB variants including
simplex and dystrophic types. An increase in the number of fibro¬
blasts with increased non-collagenous protein synthesis (see p. 106)
might help stabilise the dermis. How this might apply to the intra-
epidermal blistering types is unknown. Further research is required
to answer such questions.
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SUMMARY
1) No significant difference in the amount of GAG secreted into the
culture medium was detected between control, EBS and EBDr fibroblast
groups (n = 6): the mean GAG value for control cell lines was
13^ fg/107 cells (i 28 SEM n = 10).
2) Phenytoin at 50 pM increased GAG levels by 30$ (p<.0.05) in
control cell lines but at 250 pM GAG levels in the EBS group were
depressed by 32$ (p<0.02). The mean proliferation rate was unaffected
in all groups.
3) The main difference in response to phenytoin in terms of GAG
secretion of the EBS and control group was statistically significant
(p <0.05) at all drug concentrations, except 100 pM phenytoin.
k) Vitamin E at 50 and 250 pg/ml increased the rate of proliferation
of control fibroblasts by and 73$ respectively (p<0.05); no




The aim of this project was to study fibroblasts from the skin
of EB patients, with the intention of uncovering any metabolic
differences which could separate them from the fibroblasts of
normal, healthy subjects; and to examine the effects of phenytoin
and vitamin E on fibroblast function. There were however several
problems in fulfilling such a task.
Apart from the scarcity of patients, one important difficulty
lay in defining correctly the class of EB in each case - the lack
of familiarity with this rare disease making precise diagnosis
difficult at first. In this study the variants which were
quantitatively different: EBS Weber-Cockayne and Koebner; EBDr
Hallopeau-Siemens and the localised variant, were regarded as single
groups. Unless these variants are shown to be caused by different
pathogenetic defects, rather than distinguished by somewhat arbitrary
clinical demarcations of the body, it seems reasonable to make such
generalisations for investigative purposes. Some variants are so
rare that sub-groups would have to be very small, making the significance
of results obtained questionable, unless a much longer term and more
widespread search can be made to collect sufficient material of
each particular type. However, in terms of clinical diagnosis
and therefore of prognosis, it is probably of more value to recognise
all the variants; a patient with localised EBDr having a much better
prognosis than a counterpart with EBDr Hallopeau-Siemens.
Having found the patient, classified the type of EB and
collected a skin biopsy, further difficulties arose during fibroblast
culture. The time taken to obtain adequate numbers of fibroblast
cultures was am important consideration. Three to four months could
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elapse from the time of biopsy until enough fibroblasts were obtained
for use in experiments. It was impossible to obtain all the skin
biopsies at the same time, and only 6 to 8 could be cultured
simultaneously, consequently a disproportionate amount of time was
spent simply establishing the material for investigation.
The validity of cell culture systems in research remains a
controversial subject. In culture, cells are isolated from all
endogenous influences, including the many serum-borne factors, from
other types of cell and from the influence of their immediate
surroundings. This must affect their behaviour and function to a
considerable extent. In addition, the substratum on which the fibro¬
blast lives in vitro, i.e. glass, plastic or collagen, can influence
GAG metabolism (Gallagher et al, 1980) and probably other aspects of
cell behaviour too.
However, alternative means of direct investigation are
impractical at present. Collagen matrices, more closely mimicking
in vivo conditions, might be preferable but their use adds further
complexities. The alterations in cell metabolism or behaviour
should apply equally to all the cell lines grown in culture in this
study, and differences detected between groups of cell lines should
be valid. The underlying metabolic defects in mucopolysaccharidoses
and the Ehlers-Danlos syndrome have already been successfully
determined by using cultured fibroblasts.
Collagen metabolism is the most important of the fibroblast
characteristics examined in culture. As the most severe form of
EB is the dermolytic, dystrophic type, and because collagen synthesis
had not previously been examined in SB, it was important to investigate
this aspect of EB fibroblast function. Both EBS and EBDr cell lines
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were found to produce more collagen, in absolute terms, than equivalent
control cell lines. However relative collagen synthesis in EBDr cell
lines did not significantly differ from controls. This indicates a
general increase in protein synthesis in the EBDr group reflected in
the results for non-collagen protein synthesis, which although were
not statistically significant due to ihe large intra-EBDr group
variability, were increased kCf% - 19 (mean - SEM) over equivalent
controls and must therefore be considered relevant. Such a general
increase will, presumably, include collagenase, tfiich represents 0.1-1%
of the protein synthesised by normal skin fibroblasts (Valle and Bauer,
1979). It has been shown previously (Kronberger et al, 1982) that
collagenase synthesis is disproportionately increased in EBDr cell
lines, due to increased quantities of mRNA coding for collagenase.
Therefore the inherent imbalance between collagen and collagenase
production persists despite an increase in absolute collagen synthesis
in the EBDr cell lines, (detected as a 36% increase in collagenase
activity over that of controls in the present study.) As a result of
this imbalance in collagen metabolism and the lack of any other
metabolic abnormalities, it would seem the most likely cause of
disruption and destruction of the dermis in the EBDr variant.
Curiously, fibroblasts from the EBS group were found to differ
from controls in several ways. This had not been anticipated, as
EBS is usually taken to be a disorder of the epidermis. Collagen
synthesis was significantly increased, both in relative and absolute
terms, over equivalent control and EBDr groups, whilst collagenase
activity for the group as a whole was intermediate between that of
the control and EBDr groups. It is possible that the increased
collagen synthesis adequately compensates for any slight increase in
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collagenase levels. A second finding with EBS fibroblasts was that
the difference between pre- and post-activation levels of collagenase
differed significantly from corresponding controls: much more of the
I
collagenase in the EBS group apparently being in the pro-collagenase
form. Possibly the EBS fibroblasts produce more collagenase inhibitor,
or less endogenous collagenase activator (the equivalent to trypsin
in vitro), and therefore any imbalance in collagenase metabolism is
better controlled. This important difference between EBS fibroblast
characteristics and those of controls warrants further research.
Ideally collagen synthesis and collagen breakdown should be measured
in the same terms (e.g. pg collagen/10^ cells/hour), so that the
balance can be more easily assessed. Furthermore the type of nascent
collagen and the relative proportions in which the various types
are produced by fibroblasts, are important considerations and require
further investigation. An abnormality in the basic collagen molecule
could affect collagenous components of the dermis, including such things
as the anchoring fibrils by rendering the collagen more susceptible
to collagenase attack; thus providing a possible explanation for the
apparent lack of anchoring fibrils in EBDr skin (Briggaman and
Wheeler, 1975).
These results suggest similarities between the simplex and
EBDr groups that have not been appreciated hitherto; whether such
anomalies within the dermis of the simplex group affect the epidermis
is unknown. It is possible that the dominant gene(s) causing
blistering within the epidermis are linked with (or close to) the
recessive trait altering collagen and collagenase metabolism, which
affects the dermis^ In EBS a mutation in the dominant gene affecting
the integrity of the epidermis is inherited along with the collagen-
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collagenase genes, whose products, although differing from
controls, compensate each other so that the dermis appears to be
normal. In EBDr only the collagen-collagenase gene products sire
imbalanced, the work of Kronberger et al (1982) suggests that
multiplication as well as mutation of the collagenase gene has
occurred, which could result in disruption of the dermis. Such
genetic speculation is, however, beyond the scope of this project.
Unfortunately too few dominant dystrophic cell lines were obtained
to make the results significant. However the data support the idea
that EBDD has a different aetiology from the recessive dystrophic
group since collagenase activity was the same as in controls.
Relative and absolute collagen synthesis seemed to be higher than
controls and on a par with EBS levels, but variation between the
three lines was so considerable that it would be unwise to speculate
from this finding.
The close similarity of the data with those from the simplex
group for collagen and non-collagen protein synthesis, is notable
and deserves further study.
An abnormality in glycosaminoglycan production has previously
been attributed to the Pasini variant of EBDD (Bauer et al, 1979)*
The GAG results obtained in this study, taking into account the final
cell density of the cultures, indicate that the Cockavne-Touraine
group may also involve an aberration in GAG metabolism, though
probably to a lesser extent than the Pasini variant. An increased
accumulation of GAG within the dermis may lead to collagen
destabilization and disruption of the dermis. Obviously, many
more cell lines need to be studied.
The single EBL cell line appeared to resemble most closely
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those in the control group, suggesting no overt abnormality of
fibroblast metabolism. In particular there is no evidence, from
this study or from the data of other workers (Bauer and Eisen, 1978),
to suggest that excessive collagenase activity features in the
pathogenesis of EBL. Therefore there is no reason to suppose that
phenytoin would be useful in the treatment of EBL; and in fact the
two patients involved in this study did not benefit from a course
of phenytoin treatment. Further research, using more cell lines,
is needed to consolidate these findings.
It proved difficult to assess the effect of drugs on the various
fibroblast characteristics examined. The difficulties lay in
obtaining reproducible results and in the variability in results
between cell lines of the same group. The reason for the poor
reproducibility of results, particularly where phenytoin is
concerned, is unlikely to be the inherent variability in the culture
system. Previous work has shown that consistent results can be
obtained using fibroblast culture to test the effect of various
corticosteroids (Priestley and Brown, 1980; Priestley et al,
1983) and other drugs. The most likely explanation of such
experimental variability, is the binding of phenytoin to serum albumin:
the amount bound may differ from experiment to experiment depending
on small variations in the amount of albumin present in the foetal
calf serum in the culture medium. It is not known whether the
variability in the response of cell lines to phenytoin reflects the
variability in response of patients in vivo, but the work of Bauer
et al (1980) indicates that this might be the case. They found
that in a patient unresponsive to phenytoin only a small reduction
in collagenase expression could be achieved by adding the drug to
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skin fibroblasts in culture, in contrast to the more positive
response of fibroblasts from patients who were responsive to the
drug. It has been suggested that "responsiveness" to phenytoin is
genetically modulated, both in the treatment of EBDr (Bauer et al,
1980) and in the development of gingival hyperplasia (Hassell et al,
1976).
Phenytoin had no statistically significant effect on the mean
proliferation rate of any of the groups, although there were effects
on individual cell lines. At high concentrations (500 uM) phenytoin
depressed both collagen and non-collagen protein synthesis by 10-20%,
whilst at 300 uM only non-collagen protein synthesis was depressed.
Bauer et al (1980) found that phenytoin reduced synthesis and/or
secretion of collagenase at 10 pg/ml (v 37 pM). The small reduction
in non-collagen protein synthesis found in the present study might
include a decrease in collagenase synthesis. No alteration in the
percentage of nascent collagen or other protein secreted by the cell
into the culture medium was detected: the results of this study
therefore suggest that diminished collagenase activity with
phenytoin treatment is due to reduced synthesis. Phenytoin had no
significant effect on GAG production in EBDr cell lines, although
opposite responses were seen in EBS and control groups. Control
cell lines accumulated more GAG in the culture medium at 30 pM,
whilst for EBS cell lines GAG levels were depressed by a similar
amount (32%) at 200 pM. This also points to a further difference
between control and EBS fibroblasts.
The response of fibroblasts to vitamin E differed from their
response to phenytoin, and was more reproducible. Vitamin E caused
a dose-dependent increase in the rate of proliferation of control
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fibroblasts, without significantly altering GAG secretion. Vitamin
E also stimulated synthesis of non-collagenous protein by 14%,
depressing relative collagen synthesis. The clinical implications
of these findings are very difficult to assess. An increase in
non-collagenous protein synthesis in the EBDr group, could be
detrimental to the patient, favouring the over-production of an
aberrant collagenase. However it is not known whether all non-
collagenous protein synthesis is stimulated to the same degree.
Perhaps levels of inhibitors of collagenase are elevated to the same
or a greater extent as collagenase levels. There have been very few
large clinical studies on the effects of vitamin E; certainly Wilson
(1964) reported a marked improvement in one patient with "severe
EBDr", as did Seghal et al (1972) with their three patients with
dystrophic recessive EB. Vitamin E has also been used to treat
the EBS Weber-Cockayne variant, reportedly with considerable success
(Ayres and Mihan, 1969). Very little is known about the effect of
vitamin E on human skin: much more research and properly organised
long term trials are needed before it can be recommended as a reliable
treatment for EB.
This project has fulfilled its aims, in that it does represent
a step towards an understanding of some of the underlying defects
involved in the heterogeneous EB group. Advances in unravelling
the complexities of such a rare disease are necessarily slow but
progress is being made, and must continue. Future research should
involve determining the true differences between variants in order
to avoid further confusion in the diagnosis and treatment of what
may be completely different conditions with a similar clinical
appearance. Such research should include detailed biochemical
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studies of both fibroblasts and keratinocytes, from all of the
recognised EB variants. Having established the basic pathogenetic
defect(s), the possibility of finding and testing potentially
effective drugs becomes more realistic. In the short term, however,
the finding that retinoids can suppress fibroblast collagenase in
vitro (Bauer et al, 1982) points the way to clinical trials of these
drugs in EBDr.
Parallels exist between the state of our knowledge of EB today
and our past knowledge of other confusingly heterogeneous disorders,
such as the Ehlers-Danlos syndrome and the mucopolysaccharidoses;
now reasonably well understood conditions, bringing hope of successful
treatment. It is to be hoped that progress leading to a more complete
understanding of EB will continue to be made.
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